Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028192	s-igg2	g/l (g/l)	3061	4147	0.00%
3028192	s-igg2	— (—)	1414	1879	100.00%	Distribution not available
3028192	s-immunoglobuliinig,alaluokka2	g/l (g/l)	24	26	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Undetermined asthma

292

213

14.35

317.62

1.7

1.2

2.85

3.15

g/l

1.31

212

141

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1325

2823

3.35

317.41

1.4

2.70

3.06

g/l

9.03

959

1919

Acute pancreatitis (for exclusion)

459

636

7.56

314.41

1.6

1.3

2.91

2.93

g/l

0.07

210

467

Certain disorders involving the immune mechanism

568

679

8.91

307.65

1.9

1.3

2.43

2.93

g/l

6.48

423

473

Systemic connective tissue disorders

677

1189

5.89

307.65

1.7

1.3

2.79

2.93

g/l

1.11

494

819

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

961

2001

4.56

307.65

1.5

1.3

2.92

2.96

g/l

0.21

683

1378

Asthma (diagnoses ohter than nonallergic)

1333

2882

4.03

307.65

1.5

1.3

2.82

2.99

g/l

2.48

982

1973

Inflammatory bowel disease treatment related agents

1996

2064

5.62

307.65

1.5

1.2

2.85

3.11

g/l

5.57

1421

1387

ILD medications: prednisolone, methylprednisolone, prednisone

1932

1823

6.13

307.65

1.5

1.2

2.82

3.15

g/l

7.56

1384

1206

ILD medications

1942

1870

5.82

307.65

1.5

1.2

2.84

3.14

g/l

6.64

1392

1240

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1279

1873

4.35

307.65

1.4

1.3

2.71

3.14

g/l

10.69

931

1235

Immunodeficiency with predominantly antibody defects

276

54.18

307.65

2.1

1.3

1.88

2.64

g/l

3.17

229

Pneumonias (Asthma/COPD co-morbidities)

1357

2826

3.38

307.65

1.4

2.70

3.07

g/l

9.23

984

1919

Bronchiectasis

267

150

19.43

307.65

1.4

1.3

2.86

2.79

g/l

0.16

197

105

Asthma-related infections

1096

2028

5.47

307.65

1.5

1.3

2.76

2.96

g/l

2.63

827

1397

1279

1873

4.35

307.65

1.4

1.3

2.71

3.14

g/l

10.69

931

1235

Asthma, unspecified (mode), excluding more controls

746

887

6.74

307.65

1.5

1.3

2.83

3.17

g/l

3.95

520

563

ILD medications: immunosuppressive drugs

1030

1602

6.32

307.65

1.6

1.2

2.79

3.11

g/l

4.86

738

1072

907

1551

5.99

307.65

1.5

1.3

2.76

2.93

g/l

1.88

687

1065

Asthma, hospital admissions 3, pneumonia

682

1074

6.56

307.65

1.4

1.3

2.67

2.94

g/l

2.87

518

736

Asthma (only as main-diagnosis)

1223

1036

7.29

307.65

1.5

1.3

2.81

3.20

g/l

6.64

896

644

Pneumonia, organism unspecified

1245

2550

3.59

307.65

1.4

2.66

3.07

g/l

10.61

901

1721

Influenza and pneumonia

1432

2806

3.41

307.65

1.4

1.3

2.70

3.09

g/l

10.94

1042

1903

Asthma, unspecified (mode)

749

922

6.57

307.65

1.5

1.3

2.83

3.17

g/l

4.01

523

583

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1355

2778

3.56

307.65

1.5

1.3

2.66

3.09

g/l

11.43

970

1932

Asthma, hospital admissions , main diagnosis only

1265

2929

3.94

307.65

1.5

1.3

2.81

2.99

g/l

3.02

934

2002

Asthma, including avohilmo

1534

2811

3.21

307.65

1.5

1.3

2.88

2.99

g/l

1.38

1125

1892

Chronic sinusitis

758

1468

5.30

307.65

1.5

1.4

2.89

3.01

g/l

1.05

574

982

Undetermined asthma, excluding more controls

292

206

14.84

307.65

1.7

1.2

2.85

3.13

g/l

1.18

212

137

Asthma, hospital admission 2, infections

1096

2028

5.47

307.65

1.5

1.3

2.76

2.96

g/l

2.63

827

1397

Oral corticosteroids

1974

1962

6.24

307.65

1.5

1.2

2.82

3.15

g/l

8.13

1408

1312

Asthma, excluding more controls

1259

993

6.90

307.65

1.5

1.3

2.85

3.20

g/l

5.42

922

620

Fever of other and unknown origin

893

1683

5.03

307.65

1.4

1.3

2.69

3.06

g/l

6.39

642

1167

First line medication for Crohn's disease

1817

1843

5.49

307.65

1.5

1.2

2.84

3.14

g/l

6.47

1291

1237

Asthma (only as main-diagnosis), excluding more controls

1215

993

7.46

307.65

1.5

1.3

2.82

3.20

g/l

6.36

890

620

Asthma

1279

1036

6.76

307.65

1.5

1.3

2.84

3.20

g/l

5.54

941

644

Immunodeficiencies

351

140

30.80

307.65

2.0

1.3

2.04

2.78

g/l

4.57

282

Chronic lower respiratory diseases

1613

2637

3.36

307.65

1.4

1.3

2.87

3.01

g/l

1.83

1188

1763

Abnormal findings on diagnostic imaging of lung

753

1394

5.41

307.65

1.4

1.3

2.86

2.96

g/l

0.65

552

965

Asthma-related pneumonia or sepsis

682

1074

6.56

307.65

1.4

1.3

2.67

2.94

g/l

2.87

518

736

Asthma-related pneumonia

680

1069

6.57

307.65

1.4

1.3

2.67

2.94

g/l

2.89

516

734

All pneumoniae

1362

2839

3.36

307.65

1.4

2.69

3.07

g/l

9.96

987

1926

Acute pancreatitis

459

559

8.61

307.65

1.6

1.3

2.91

2.95

g/l

0.14

210

413

Asthma (mode)

1238

1040

6.67

307.65

1.5

1.3

2.86

3.19

g/l

4.99

914

647

Asthma/COPD (KELA code 203)

1241

2621

3.39

302.87

1.5

1.3

2.79

3.01

g/l

3.72

924

1752

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

291

129

17.48

287.72

1.5

1.2

3.00

3.29

g/l

0.79

202

Other systemic involvement of connective tissue (FG)

474

747

6.51

284.34

1.8

1.2

2.85

2.91

g/l

0.24

348

510

Second line medication for Crohn's disease

856

2272

3.85

278.18

1.6

1.3

2.79

2.95

g/l

1.42

610

1586

L04AX Other immunosuppressants

835

2217

3.85

271.27

1.6

1.3

2.80

2.96

g/l

1.52

599

1540

Autoimmune diseases related-to ILD

1086

2979

3.25

265.70

1.4

2.96

2.95

g/l

0.07

746

2071

Other pulmonary diagnosis

891

1046

4.32

263.93

1.3

2.88

3.20

g/l

3.89

629

651

Excluding asthma or asthma-COPD overlap

889

1046

4.31

262.66

1.3

2.89

3.20

g/l

3.72

625

651

ILD differential diagnosis

884

1040

4.31

261.18

1.3

2.89

3.19

g/l

3.61

622

647

COPD differential diagnosis

884

1041

4.30

260.91

1.3

2.88

3.19

g/l

3.63

623

647

Other systemic involvement of connective tissue

490

878

5.77

260.26

1.8

1.3

2.83

2.89

g/l

0.28

359

607

COPD/asthma/ILD related infections

1216

1875

3.29

252.18

1.4

1.3

2.79

3.14

g/l

7.31

882

1236

COPD/asthma related infections

1216

1875

3.29

252.18

1.4

1.3

2.79

3.14

g/l

7.31

882

1236

Abnormalities of breathing

1114

2030

3.30

247.86

1.4

1.3

2.85

3.04

g/l

2.41

794

1361

Cough

589

1230

4.69

246.13

1.4

1.3

2.88

2.97

g/l

0.52

443

832

Asthma and opportunity respiratory infection

186

21.71

243.50

1.4

1.3

2.80

2.76

g/l

0.07

131

Allergic asthma (mode), excluding more controls

355

480

7.42

241.23

1.5

1.3

2.85

3.11

g/l

1.70

289

303

Other and unspecified immunodeficiencies with predominantly antibody defects

142

56.13

240.63

2.2

1.4

1.74

2.75

g/l

2.19

116

Acute sinusitis

753

1878

3.81

237.17

1.5

1.3

2.89

3.04

g/l

1.43

569

1268

Allergic asthma (mode)

355

491

7.26

236.44

1.5

1.3

2.85

3.11

g/l

1.78

289

310

Other respiratory diseases principally affecting the interstitium

332

453

7.63

230.34

1.4

1.3

3.02

2.87

g/l

0.61

232

315

1282

2340

2.93

225.73

1.4

1.3

2.82

3.09

g/l

4.78

939

1558

Autoimmune diseases excluding thyroid diseases

1257

2412

2.93

225.17

1.4

1.3

2.90

2.97

g/l

0.61

890

1668

Disorders of gallbladder, biliary tract and pancreas

1165

2576

2.95

222.10

1.5

1.3

3.00

2.96

g/l

0.32

694

1905

GASTRO-related operations

932

1307

3.62

221.97

1.4

1.2

2.94

2.96

g/l

0.10

616

1021

Any gastric operation

932

1307

3.62

221.97

1.4

1.2

2.94

2.96

g/l

0.10

616

1021

Other interstitial pulmonary diseases

297

373

8.33

221.52

1.4

1.3

3.04

2.95

g/l

0.27

207

257

Interstitial lung disease

297

377

8.24

219.56

1.4

1.3

3.04

2.95

g/l

0.29

207

260

Interstitial lung disease endpoints

297

377

8.24

219.56

1.4

1.3

3.04

2.95

g/l

0.29

207

260

Non-allergic asthma (mode), excluding more controls

287

343

8.50

219.36

1.5

1.2

2.74

3.10

g/l

2.09

216

223

ILD, hospital admissions

295

372

8.30

219.32

1.4

1.3

3.03

2.95

g/l

0.25

205

259

ILD, hospital admission 2, with pulmonary infections

207

161

13.55

217.32

1.4

2.83

3.15

g/l

1.03

144

114

ILD medications: azathioprine

290

366

8.22

215.04

1.7

1.2

2.83

3.04

g/l

0.86

206

256

General symptoms and signs

1268

2222

2.89

214.87

1.4

1.3

2.83

3.06

g/l

3.62

909

1512

Autoimmune diseases excluding thyroid diseases, strict definition

1206

2336

2.91

214.33

1.4

1.3

2.89

2.97

g/l

0.72

859

1625

Non-allergic asthma (mode)

287

357

8.17

212.28

1.5

1.2

2.74

3.10

g/l

2.03

216

230

Reimbursement for rheumatic diseases

774

2316

3.39

208.90

1.5

1.4

2.80

2.95

g/l

1.52

562

1610

Azathioprine

290

383

7.86

206.90

1.7

1.2

2.83

3.03

g/l

0.81

206

269

Bacterial pneumonia (organism specified)

580

1289

4.18

206.07

1.4

2.56

3.04

g/l

7.29

420

881

ILD, hospital admissions 1, main diag only

267

324

8.64

205.00

1.4

1.3

3.03

2.90

g/l

0.41

186

228

Bacterial pneumoniae

532

1080

4.45

203.01

1.4

2.62

3.10

g/l

6.71

388

731

ILD, hospital admissions 3, with pneumonia sepsis

183

146

13.25

189.31

1.2

1.3

2.84

2.99

g/l

0.37

127

Chronic rhinitis, nasopharyngitis and pharyngitis

465

1046

4.55

189.28

1.4

2.87

2.97

g/l

0.59

376

708

Symptoms and signs involving the circulatory and respiratory systems

1145

2045

2.84

187.98

1.4

1.3

2.90

3.04

g/l

1.47

815

1367

Bacterial pneumonia, not elsewhere classified

498

1025

4.38

186.70

1.3

2.63

3.10

g/l

6.06

362

691

Obesity related asthma

470

1094

4.40

183.21

1.4

1.3

2.76

3.01

g/l

1.92

331

731

Bronchitis

1187

3025

2.60

180.73

1.4

1.3

2.72

3.07

g/l

8.69

867

2059

Nonhereditary hypogammaglobulinemia

102

53.51

172.62

2.3

1.3

1.61

2.90

g/l

1.88

Other acute lower respiratory infections

683

2031

3.26

171.37

1.5

1.4

2.61

2.99

g/l

6.62

500

1406

Chronic pancreatitis

241

324

7.77

169.65

1.9

1.2

3.21

3.06

g/l

0.45

124

241

Acute upper respiratory infections

1128

2748

2.60

169.30

1.4

1.3

2.81

3.03

g/l

3.25

829

1859

Dyspnoea

980

2848

2.67

163.22

1.4

2.83

2.98

g/l

1.62

694

1991

Autoimmune diseases

1194

2423

2.54

161.19

1.4

1.3

2.97

g/l

0.03

838

1677

Used for control exclusion in common control thyroid runs

1128

2215

2.61

159.66

1.4

1.3

3.00

2.98

g/l

0.16

773

1552

Examination and observation for other reasons

690

1274

3.33

157.39

1.5

1.3

2.95

3.03

g/l

0.46

584

752

Bacterial infection, other or unspecified

588

1577

3.42

156.75

1.4

2.59

3.04

g/l

6.30

422

1086

Asthma and allergy, excluding more controls

212

265

8.11

155.72

1.5

1.3

2.81

3.08

g/l

1.16

177

Asthma and allergy

212

269

7.99

153.77

1.5

1.2

2.81

3.08

g/l

1.17

177

174

Acute bronchitis

519

1450

3.57

151.06

1.5

1.3

2.57

2.95

g/l

5.21

382

1006

Diseases of the respiratory system

621

857

3.67

150.92

1.4

1.3

2.84

3.21

g/l

4.09

436

534

Selective deficiency of immunoglobulin G [IgG] subclasses

65.16

149.92

2.5

1.3

2.12

3.16

g/l

1.16

Other bacterial diseases

1005

2760

2.54

148.75

1.4

2.69

3.02

g/l

5.50

711

1909

Kela reimbursement Agammaglobulinemia (D80-84)

62.03

148.43

2.2

1.4

1.95

3.08

g/l

0.90

Pain in joint

648

1329

3.27

147.57

1.4

2.95

3.01

g/l

0.28

475

891

Enlarged lymph nodes

264

456

5.97

145.90

1.5

1.2

2.85

3.10

g/l

1.20

191

320

Other diseases of pleura

503

1265

3.58

143.44

1.5

1.4

2.55

2.99

g/l

5.37

348

868

Any reimbursement code in KELA

652

975

3.39

141.92

1.4

1.3

2.87

3.13

g/l

2.61

458

674

Cholangitis (primary sclerosing, PSC)

144

125

12.20

141.36

1.8

1.2

3.39

2.79

g/l

1.98

Suggestive for eosinophilic asthma

188

237

8.31

139.96

1.9

1.3

2.99

2.94

g/l

0.13

145

160

Acute upper respiratory infections of multiple and unspecified sites

806

2256

2.71

137.65

1.4

1.3

2.75

3.05

g/l

4.45

592

1532

Other diseases of biliary tract

161

171

9.84

137.11

2.1

1.3

3.28

2.90

g/l

0.92

126

Septicaemia

457

1225

3.65

136.93

1.4

1.3

2.64

2.97

g/l

2.70

322

857

Other diseases of upper respiratory tract

1103

2404

2.41

135.28

1.4

1.3

2.86

3.01

g/l

1.79

806

1597

Other necrotizing vasculopathies

159

170

9.88

135.05

1.4

2.54

2.89

g/l

1.08

116

125

Tramadol

828

1994

2.70

134.82

1.4

2.77

3.15

g/l

6.57

589

1374

Anaemias

341

463

4.99

134.13

1.4

1.3

2.95

3.07

g/l

0.40

239

336

Other specified/unspecified systemic involvement of connective tissue

154

160

10.25

133.80

2.4

1.4

2.83

2.92

g/l

0.19

124

108

Early onset COPD, excluding more controls

218

341

6.51

132.64

1.6

1.3

2.51

3.22

g/l

5.19

154

222

Finngen Rheumatological endpoints

1023

2407

2.45

132.49

1.5

1.3

2.89

3.02

g/l

1.34

730

1635

FESS (DNB20)

250

454

5.73

131.50

1.7

1.4

3.02

2.96

g/l

0.22

179

312

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

161

181

9.33

131.45

1.7

1.4

3.28

3.00

g/l

0.65

107

124

Gastrointestinal diseases

630

972

3.28

130.98

1.5

1.3

2.89

3.01

g/l

0.74

438

715

Ethmoidectomy

255

477

5.56

129.85

1.7

1.4

3.04

2.95

g/l

0.35

183

332

Diseases of oesophagus, stomach and duodenum

1090

2880

2.32

128.29

1.4

2.98

2.97

g/l

0.10

778

1988

Other necrotizing vasculopathies (FG)

137

128

11.31

128.09

1.5

1.3

2.61

2.81

g/l

0.43

Explicit Sepsis

479

1378

3.39

128.08

1.4

1.3

2.67

2.95

g/l

2.13

340

964

Diseases of liver

426

1206

3.60

126.31

1.3

1.4

3.03

2.91

g/l

0.66

276

850

Pain in throat and chest

819

1914

2.64

126.27

1.4

1.3

2.87

3.05

g/l

1.98

600

1276

Other septicaemia

398

1074

3.70

122.44

1.4

1.3

2.66

2.97

g/l

2.29

284

757

Abnormal findings on examination of blood, without diagnosis

515

1551

3.16

122.08

1.6

1.3

3.07

2.98

g/l

0.43

362

1066

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

550

1818

3.00

121.17

1.4

1.3

2.90

3.03

g/l

0.96

379

1205

Headache

653

1992

2.77

119.92

1.5

1.3

2.86

3.05

g/l

2.02

482

1373

Bacterial Sepsis

465

1262

3.33

118.75

1.4

2.56

2.99

g/l

4.48

328

868

Codeine

945

2208

2.37

113.70

1.4

2.78

3.14

g/l

6.99

656

1526

Certain infectious and parasitic diseases

988

2126

2.35

112.89

1.4

1.3

2.82

3.06

g/l

3.26

687

1449

Opioids

989

2258

2.32

111.71

1.4

2.83

3.14

g/l

5.27

684

1558

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

354

397

4.51

110.96

1.3

2.91

3.05

g/l

0.62

248

257

Medical observation and evaluation for suspected diseases and conditions

688

1277

2.78

110.79

1.5

1.3

2.86

3.03

g/l

1.37

526

755

Vasomotor and allergic rhinitis

434

1337

3.24

109.40

1.4

1.3

2.95

2.97

g/l

0.08

343

895

Other diseases of pancreas

136

156

9.11

109.28

1.7

1.3

3.03

3.01

g/l

0.03

111

Polyarthropathies

712

1846

2.60

109.04

1.4

2.79

3.00

g/l

2.08

519

1268

Other and unspecified dermatitis

554

2008

2.80

107.78

1.5

1.4

2.90

2.95

g/l

0.27

398

1409

Dermatitis

636

2480

2.60

106.94

1.5

1.4

2.91

2.95

g/l

0.20

457

1747

Other immunodeficiencies

27.39

106.56

2.3

1.3

2.76

2.73

g/l

0.03

Other soft tissue disorders, not elsewhere classified

911

2492

2.28

103.54

1.4

1.3

2.89

2.98

g/l

0.80

669

1697

Parasetamol

792

1637

2.49

103.18

1.4

1.3

2.93

3.07

g/l

1.27

557

1082

Infections, IBD-co-morbidities

199

234

6.31

103.03

1.6

1.2

2.69

3.11

g/l

1.75

138

159

Other specific joint derangements/joint disorders

758

2110

2.43

101.70

1.3

1.4

2.97

2.99

g/l

0.13

552

1449

Mixed connective tissue disease

144

194

7.82

101.53

1.8

1.5

2.77

2.90

g/l

0.32

114

131

Implicit bacterial Sepsis

385

1071

3.34

100.09

1.4

2.53

3.02

g/l

5.17

272

743

Symptoms and signs involving the digestive system and abdomen

963

2178

2.23

98.59

1.4

1.3

2.87

2.97

g/l

0.84

655

1526

L04AA Selective immunosuppressants

313

861

3.72

97.25

1.5

1.3

2.63

2.90

g/l

1.90

231

604

Sicca syndrome [Sjögren]

159

251

6.60

96.65

1.6

1.4

2.76

2.77

g/l

0.01

104

180

Gastro-oesophageal reflux disease

663

2439

2.43

95.06

1.4

2.88

2.94

g/l

0.30

459

1691

Abdominal and pelvic pain

949

2177

2.21

94.82

1.4

1.3

2.88

2.97

g/l

0.69

643

1525

Primary_lymphoid and hematopoietic malignant neoplasms

290

772

3.83

94.31

1.4

2.14

2.98

g/l

9.09

209

543

Other diseases of intestines

1037

2921

2.08

93.03

1.4

1.3

2.91

2.97

g/l

0.49

739

2022

Malaise and fatigue

449

1280

2.96

93.00

1.3

2.72

3.03

g/l

2.73

324

894

Primary_lymphoid and hematopoietic malignant neoplasms

290

782

3.79

92.66

1.4

2.14

2.97

g/l

8.73

209

548

Adrenocortical insufficiency

10.96

89.88

1.7

1.4

2.35

2.71

g/l

0.94

Codeine or tramadol medication

1068

2944

2.02

88.16

1.4

2.77

3.06

g/l

5.43

737

2031

Implicit Sepsis

672

2235

2.36

87.63

1.4

2.71

3.02

g/l

3.73

462

1547

Low back pain

698

2340

2.32

87.30

1.5

1.3

2.82

3.03

g/l

2.51

494

1587

Dermatitis and eczema

1024

3356

2.02

87.12

1.4

1.3

2.90

2.96

g/l

0.48

729

2313

Other disorders of adrenal gland

111

133

8.86

86.51

1.6

1.4

2.31

2.80

g/l

1.82

Noninfective enteritis and colitis

510

1987

2.60

85.91

1.3

1.4

2.92

2.91

g/l

0.03

342

1405

Nasal polyp

235

576

4.16

85.85

1.7

1.3

2.99

3.01

g/l

0.06

192

387

Other special examinations and investigations of persons without complaint or reported diagnosis

629

1277

2.51

83.44

1.4

1.3

2.87

3.03

g/l

1.29

456

755

Other diseases of blood and blood-forming organs, wide

285

816

3.57

83.41

1.4

2.56

2.91

g/l

2.27

190

574

Exclusions for E4_PCOS_BROAD

256

684

3.84

83.05

1.5

1.4

2.55

2.85

g/l

1.69

126

508

Haemorrhage from respiratory passages

304

840

3.40

81.72

1.4

1.3

2.88

3.02

g/l

0.57

211

559

Heart failure, not strict

675

2043

2.30

80.74

1.5

1.4

2.65

3.00

g/l

4.59

472

1406

Drug-induced adrenocortical insufficiency

17.20

80.65

1.9

1.4

2.15

2.63

g/l

1.00

Vocal cord dysfunction

165

295

5.29

79.05

1.7

1.2

2.75

3.14

g/l

1.75

109

201

Other disorders of white blood cells

110

146

7.90

78.56

1.4

2.66

2.78

g/l

0.23

102

Dorsalgia

915

2439

2.05

77.43

1.4

1.3

2.85

3.02

g/l

2.00

645

1653

Diagnoses used for exclusion with ILD

289

875

3.36

77.38

1.4

1.3

3.11

2.92

g/l

0.84

196

626

All influenza

265

759

3.55

77.33

1.5

1.3

2.66

3.03

g/l

2.68

198

532

Diseases of the skin and subcutaneous tissue

942

2336

2.04

77.06

1.4

1.3

2.88

3.01

g/l

1.20

658

1581

Budesonide

154

293

5.37

76.75

1.4

1.2

3.23

3.08

g/l

0.36

104

200

Idiopathic pulmonary fibrosis

107

142

7.80

76.19

1.4

1.2

3.27

2.90

g/l

0.96

104

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

126

200

6.53

76.16

1.5

1.4

2.34

2.98

g/l

1.75

139

Viral Sepsis

226

588

3.92

76.10

1.4

2.44

2.93

g/l

3.81

164

423

Disorders of other endocrine glands

461

1787

2.57

75.91

1.5

1.3

2.57

2.89

g/l

3.29

267

1282

Implicit viral Sepsis

225

585

3.92

75.84

1.4

2.42

2.93

g/l

4.14

163

420

Neurological diseases

847

2039

2.11

75.72

1.3

1.4

2.89

3.01

g/l

0.91

580

1434

Diseases of salivary glands

241

663

3.71

74.88

1.6

1.3

2.89

2.97

g/l

0.27

160

442

Oedema, not elsewhere classified

282

854

3.33

74.59

1.6

1.3

2.85

3.04

g/l

0.93

210

596

Nausea and vomiting

272

795

3.41

74.59

1.4

1.3

2.84

2.85

g/l

0.03

201

576

Disorders of lacrimal system

422

1613

2.65

74.25

1.5

1.4

2.96

2.89

g/l

0.31

292

1128

Cardiovascular diseases

647

1535

2.32

73.99

1.4

1.3

2.86

3.00

g/l

0.98

444

1098

Cholelithiasis, broad definition with cholecystitis

723

2320

2.15

73.94

1.4

1.3

3.00

2.95

g/l

0.23

459

1715

General examination and investigation of persons without complaint and reported diagnosis

581

1277

2.44

73.94

1.4

1.3

2.89

3.03

g/l

1.05

479

755

Neurological diseases, wide definition

321

464

3.51

73.89

1.4

1.2

2.90

2.96

g/l

0.18

219

320

Unspecified acute lower respiratory infection

199

485

4.20

73.41

1.5

1.4

2.70

3.02

g/l

1.59

149

333

Other diseases of the respiratory system

221

581

3.88

73.31

1.4

1.3

2.19

2.95

g/l

8.69

157

414

Other respiratory disorders and diseases

221

581

3.88

73.31

1.4

1.3

2.19

2.95

g/l

8.69

157

414

Respiratory disorders in diseases classified elsewhere

18.28

73.11

1.9

1.3

2.26

2.77

g/l

0.88

Sulfasalazine

252

728

3.50

72.51

1.4

1.2

2.83

3.14

g/l

1.70

176

491

Osteoporosis

249

676

3.57

72.49

1.5

1.3

2.50

2.80

g/l

1.40

175

461

Other disorders involving the immune mechanism, not elsewhere classified

10.69

72.44

2.5

1.3

2.70

2.91

g/l

0.35

Wegener granulomatosis

18.05

72.05

1.8

1.4

2.42

2.62

g/l

0.19

Other heart diseases

509

1364

2.49

71.73

1.4

1.3

2.82

2.99

g/l

1.16

358

965

Eosinophilic disease (BM)

23.28

71.69

1.6

1.2

2.97

2.45

g/l

0.76

Oxycodone

320

1048

2.99

70.24

1.5

1.4

2.67

3.14

g/l

3.83

219

733

Pain in limb

698

2394

2.12

70.04

1.4

1.3

2.82

2.99

g/l

1.61

513

1639

Other disorders of lacrimal gland

358

1302

2.79

69.56

1.6

1.3

2.96

2.90

g/l

0.29

247

905

Other arthritis (FG)

313

1059

3.00

69.42

1.4

1.3

2.84

2.97

g/l

0.54

225

719

Irritable bowel syndrome

307

1028

3.03

69.41

1.5

1.4

2.93

2.94

g/l

0.04

213

702

Other inflammatory liver diseases

113

178

6.60

68.88

1.3

1.4

3.11

2.98

g/l

0.23

121

COPD

348

1016

2.85

67.78

1.4

1.3

2.60

3.00

g/l

3.61

250

666

Pain (limb, back, neck, head abdominally)

636

1417

2.26

67.61

1.4

2.82

2.96

g/l

1.11

456

952

Pneumonia due to other infectious organisms, not elsewhere classified

11.37

67.54

1.4

1.3

2.05

2.79

g/l

1.50

Cardiovascular diseases (excluding rheumatic etc)

662

1767

2.18

67.08

1.4

1.3

2.83

3.01

g/l

1.63

445

1254

Lower back pain or/and sciatica

904

3313

1.91

66.61

1.4

2.84

3.01

g/l

2.08

642

2276

Other chronic obstructive pulmonary disease

333

969

2.89

66.36

1.4

1.3

2.59

2.99

g/l

3.54

239

636

Episodal and paroxysmal disorders

1003

2763

1.87

65.22

1.4

2.88

2.97

g/l

0.75

679

1944

Aplastic and other anaemias

383

1403

2.62

65.19

1.4

2.73

2.93

g/l

0.96

239

989

Other heart diseases, wide

859

2767

1.94

65.01

1.4

2.87

2.96

g/l

0.68

594

1941

Cholelithiasis

677

2291

2.09

64.53

1.4

1.3

2.97

2.95

g/l

0.11

429

1694

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.66

64.36

2.6

1.3

2.56

2.95

g/l

0.82

Simple and mucopurulent chronic bronchitis

9.87

64.26

1.3

2.56

2.53

g/l

0.04

Hypothyroidism and >3 levothyroxin purchases

275

469

3.41

64.15

1.4

1.3

2.96

3.16

g/l

0.85

183

332

Hypothyroidism, levothyroxine purchases

275

469

3.41

64.15

1.4

1.3

2.96

3.16

g/l

0.85

183

332

COPD (mode)

203

418

3.89

63.85

1.3

2.65

3.17

g/l

3.29

148

262

Pain, not elsewhere classified

258

820

3.19

63.78

1.7

1.3

2.76

3.05

g/l

2.25

205

566

5-aminosalicylic acid

204

559

3.70

63.69

1.4

1.2

3.13

3.10

g/l

0.08

125

374

Hypothyroidism (congenital or acquired)

276

474

3.38

63.60

1.4

1.3

2.97

3.16

g/l

0.82

184

335

15.22

63.57

1.5

1.3

2.59

2.58

g/l

0.01

Disorders of thyroid, IBD co-morbidities

167

267

4.61

63.07

1.4

1.2

2.94

3.23

g/l

1.08

119

174

Other dorsopathies, not elsewhere classified

892

2467

1.92

63.02

1.4

1.3

2.88

3.03

g/l

1.51

627

1675

Other headache syndromes

410

1673

2.48

62.97

1.4

3.00

2.98

g/l

0.04

291

1178

Disorders of eyelid, lacrimal system and orbit

730

2900

1.99

62.52

1.5

1.4

2.91

2.94

g/l

0.18

516

2027

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.32

62.18

2.0

1.3

3.36

2.51

g/l

1.84

Osteopathies and chondropathies

498

2103

2.27

62.02

1.5

1.4

2.67

2.94

g/l

2.33

347

1470

Temporomandibular joint disorders

175

440

4.04

61.82

1.5

1.4

2.97

3.03

g/l

0.16

114

312

Pleural effusion

155

356

4.44

61.79

1.5

1.3

2.94

3.04

g/l

0.20

104

251

Spondylopathies

672

1972

2.08

61.73

1.4

2.81

3.04

g/l

2.39

463

1327

Other specified/unspecified arthritis

277

937

3.00

61.56

1.4

2.88

2.95

g/l

0.24

196

641

Other and unspecified anaemias

350

1293

2.65

61.31

1.4

2.73

2.93

g/l

0.88

219

909

Allergic rhinitis

358

1374

2.62

61.29

1.4

1.3

2.94

2.92

g/l

0.07

290

943

Sleep disorders (combined)

867

3038

1.88

60.95

1.3

1.4

2.92

2.98

g/l

0.41

570

2134

Condition for Implicit Sepsis (Organ dysfunction codes)

717

2631

1.99

60.89

1.3

1.4

2.72

3.02

g/l

3.88

488

1837

Rheumatoid arthritis

310

1008

2.83

60.81

1.5

1.4

2.64

2.97

g/l

2.56

230

688

Other joint disorders

795

2168

1.97

60.31

1.4

2.95

2.99

g/l

0.23

571

1487

Other anaemias

351

1306

2.62

60.25

1.4

2.74

2.93

g/l

0.78

220

916

Viral pneumonia

148

336

4.50

59.94

1.3

2.61

3.11

g/l

1.84

106

242

Fibrosis and cirrhosis of liver

109

191

5.90

59.68

1.2

1.5

3.23

2.95

g/l

0.77

130

Intestinal infectious diseases

822

3433

1.88

59.20

1.4

1.3

2.77

2.99

g/l

3.10

577

2386

Diseases of the eye and adnexa

774

1968

1.98

59.15

1.4

1.3

2.92

2.97

g/l

0.31

553

1334

Dental caries

279

962

2.91

58.78

1.5

1.3

2.61

2.96

g/l

2.55

210

656

Childhood asthma (age<16), excluding more controls

141

232

4.89

58.67

1.3

1.2

2.83

3.12

g/l

0.93

101

142

Childhood asthma (age<16)

141

233

4.87

58.43

1.3

1.2

2.83

3.12

g/l

0.94

101

142

ILD-related respiratory insufficiency

10.91

58.40

1.2

2.25

2.89

g/l

1.37

Endocrine, nutritional and metabolic diseases

770

2002

1.97

58.06

1.4

1.3

2.83

3.01

g/l

1.85

511

1429

Migraine

466

1749

2.29

58.04

1.4

1.3

2.97

2.95

g/l

0.06

335

1251

Symptoms and signs involving the skin and subcutaneous tissue

606

2990

2.03

57.68

1.5

1.3

2.86

2.97

g/l

0.71

470

2072

Soft tissue disorders

909

2565

1.85

57.53

1.5

1.3

2.90

2.98

g/l

0.60

642

1749

Hernia of abdominal wall, postoperative

147

343

4.34

57.34

1.5

1.2

2.70

2.91

g/l

0.59

273

Arthropathies

818

2183

1.92

57.28

1.4

2.90

2.98

g/l

0.65

587

1501

Dorsopathies

899

2502

1.84

55.99

1.4

1.3

2.92

3.02

g/l

0.77

628

1705

Methotrexate

141

325

4.41

55.95

1.6

1.2

2.60

2.97

g/l

1.43

101

228

Other noninfective gastroenteritis and colitis

265

924

2.91

55.77

1.5

1.3

2.76

2.86

g/l

0.32

185

664

COPD, hospital admission 2, with asthma infections

272

805

2.92

55.62

1.4

2.44

2.98

g/l

5.33

196

552

Eosinophilia

13.81

55.33

1.6

1.2

2.97

2.66

g/l

0.38

Pneumocystosis

15.79

55.17

1.6

1.4

1.88

2.62

g/l

1.11

Respiratory insufficiency

8.42

55.16

1.3

2.02

3.03

g/l

4.20

Hypertensive diseases (excluding secondary)

510

1337

2.24

55.05

1.4

1.3

2.81

3.05

g/l

2.08

340

939

Diseases of the musculoskeletal system and connective tissue

490

1072

2.31

54.64

1.4

1.3

2.82

2.99

g/l

1.22

346

733

Complications of surgical and medical care, not elsewhere classified

823

3237

1.83

54.52

1.4

2.87

3.00

g/l

1.09

597

2231

Sarcoidosis

168

451

3.81

54.34

1.4

1.3

3.27

3.00

g/l

0.92

110

324

Other diseases of pericardium

8.16

53.94

1.4

1.2

2.82

3.01

g/l

0.26

Provisional assignment of new diseases of uncertain etiology

431

1928

2.26

53.74

1.5

1.3

2.78

2.95

g/l

1.32

324

1339

Infection due to other mycobacteria

17.39

53.51

1.3

2.91

2.85

g/l

0.05

Codes for special purposes

431

1932

2.25

53.47

1.5

1.3

2.78

2.95

g/l

1.32

324

1342

L04AD Calcineurin inhibitors

161

427

3.88

53.14

1.4

2.62

2.88

g/l

0.82

112

310

Dentinal caries

245

838

2.95

52.95

1.5

1.3

2.63

2.95

g/l

1.92

184

569

Chronic laryngitis and laryngotracheitis

150

379

4.03

52.78

1.4

1.3

2.88

2.94

g/l

0.14

110

252

Diarrhoea and gastroenteritis of presumed infectious origin

621

2900

1.96

52.54

1.4

1.3

2.81

3.00

g/l

2.01

439

2023

Inflammatory bowel disease

331

1333

2.51

52.50

1.3

3.14

2.96

g/l

0.87

217

933

COPD, hospital admissions 3, with asthma pneumonia sepsis

228

629

3.12

52.40

1.4

2.37

3.03

g/l

6.52

167

437

Other intervertebral disc disorders

689

2192

1.94

52.00

1.4

2.93

3.05

g/l

0.90

486

1478

Symptoms and signs concerning food and fluid intake

120

259

4.73

51.72

1.5

1.3

3.01

2.95

g/l

0.11

193

Covid-19 confirmed case

284

1072

2.69

51.47

1.6

1.3

2.53

2.96

g/l

3.93

192

728

Functional dyspepsia

252

894

2.86

51.45

1.4

3.03

2.85

g/l

0.74

185

610

Colitis, primary sclerosing

11.97

51.23

1.4

1.2

3.43

2.36

g/l

2.76

Persons encountering health services for examination and investigation

543

1277

2.14

51.08

1.4

1.3

2.89

3.03

g/l

0.98

404

755

Fungal Sepsis

8.63

50.86

1.4

2.27

2.66

g/l

0.79

Other functional intestinal disorders

381

1579

2.32

50.24

1.5

1.4

2.70

2.92

g/l

1.42

267

1110

Mycoses

268

997

2.73

50.05

1.5

1.3

2.99

2.93

g/l

0.23

182

703

Diseases of the digestive system

383

1684

2.29

49.50

1.5

1.4

2.97

2.92

g/l

0.17

258

1160

Implicit fungal Sepsis

9.02

49.45

1.4

2.19

2.67

g/l

1.06

Antihypertensive medication - note that there are other indications

593

1615

2.02

49.16

1.4

1.3

2.90

2.97

g/l

0.46

402

1148

Depression medications

287

507

2.87

48.96

1.4

1.3

2.93

3.18

g/l

1.46

198

357

Renal failure

339

1293

2.42

48.80

1.4

2.64

2.96

g/l

2.39

212

905

Complications of medical and surgical care

599

2972

1.93

48.67

1.4

2.85

2.98

g/l

0.90

430

2064

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

111

7.02

48.60

1.5

1.4

2.78

3.01

g/l

0.31

Protozoal diseases

8.89

48.53

1.5

1.4

2.07

2.77

g/l

1.58

Anxiety disorders, excluding more controls

724

2615

1.85

48.31

1.5

1.4

2.88

3.01

g/l

1.18

528

1796

Biological medicines for asthma

12.29

48.30

1.4

1.3

2.72

2.75

g/l

0.04

Voice disturbances

260

974

2.71

47.92

1.4

1.3

2.73

2.90

g/l

0.98

185

679

Fibromyalgia

116

260

4.57

47.90

1.6

1.4

2.93

2.94

g/l

0.01

180

Primary biliary cholangitis (PBC)

12.75

47.43

1.2

3.43

2.71

g/l

1.25

Other diseases of liver

197

639

3.14

47.36

1.3

1.4

2.91

2.87

g/l

0.11

125

451

Purpura and other haemorrhagic conditions

159

452

3.59

47.31

1.5

1.4

2.67

2.93

g/l

1.12

121

324

Hypopituitarism

117

268

4.51

47.14

1.5

1.3

2.72

2.85

g/l

0.28

206

Persons encountering health services in other circumstances, wide

1000

3080

1.69

47.10

1.4

1.3

2.82

2.99

g/l

2.13

718

2117

Rheumatoid arthritis, including avohilmo

346

1494

2.34

47.04

1.5

1.4

2.68

2.90

g/l

1.56

254

1026

Sleep apnoea

753

2848

1.80

46.85

1.3

1.4

2.92

2.98

g/l

0.34

495

1998

Rheumatism, unspecified

155

440

3.59

46.17

1.8

1.3

3.03

2.84

g/l

0.61

115

306

Viral infections characterized by skin and mucous membrane lesions

382

1732

2.23

46.13

1.5

1.4

2.62

2.92

g/l

2.46

281

1207

Coagulation defects, purpura and other haemorrhagic conditions

207

702

3.00

46.05

1.5

1.4

2.65

2.92

g/l

1.42

154

494

Explicit bacterial Sepsis

115

264

4.45

46.01

1.4

2.76

3.05

g/l

0.65

194

Osteoporosis with pathological fracture (FG)

121

6.45

45.81

1.6

1.2

2.08

2.78

g/l

2.73

Chronic hepatitis, not elsewhere classified

7.88

45.74

1.5

1.4

3.18

2.54

g/l

1.42

Abnormalities of heart beat

266

1021

2.60

45.65

1.3

2.83

3.02

g/l

0.94

181

678

Urticaria and erythema

357

1583

2.28

45.62

1.5

1.4

2.78

2.91

g/l

0.79

265

1109

Persons encountering health services for specific procedures and health care

907

3313

1.70

45.60

1.3

1.4

2.72

3.01

g/l

4.86

646

2293

Ulcerative colitis

256

977

2.66

45.49

1.3

3.13

2.95

g/l

0.71

168

689

Other general symptoms and signs

130

6.20

45.48

1.7

1.3

2.66

2.77

g/l

0.19

Sleep apnoea, including avohilmo

790

2929

1.76

44.90

1.4

2.95

2.98

g/l

0.15

516

2047

Other chronic obstructive pulmonary disease, including avohilmo

403

1548

2.18

44.89

1.4

2.65

2.98

g/l

3.29

295

1058

Cardiac arrhythmias

556

1883

1.97

44.65

1.3

1.4

2.92

2.98

g/l

0.35

375

1327

Early onset COPD

218

775

2.85

44.48

1.6

1.4

2.51

2.96

g/l

3.20

154

525

Seropositive rheumatoid arthritis

220

784

2.83

44.37

1.5

1.3

2.68

2.95

g/l

1.41

164

532

Ulcerative colitis, NAS

169

521

3.31

44.28

1.3

1.4

3.12

2.93

g/l

0.54

116

375

Other antidepressants

861

2604

1.73

44.26

1.4

2.84

3.05

g/l

2.62

584

1800

Other pleural conditions

204

4.90

44.22

1.5

1.3

2.87

3.16

g/l

0.63

148

Anxiety disorders

771

3132

1.75

44.15

1.5

1.3

2.89

2.95

g/l

0.39

559

2148

Cholecystectomy

562

2629

1.90

43.53

1.4

3.05

2.93

g/l

0.70

349

1866

Chronic kidney disease

233

863

2.72

43.44

1.4

1.3

2.55

2.96

g/l

2.49

150

616

Neurotic, stress-related and somatoform disorders

761

3116

1.75

42.89

1.5

1.3

2.89

2.95

g/l

0.37

553

2143

Symptoms and signs involving speech and voice

293

1226

2.42

42.86

1.4

2.70

2.92

g/l

1.61

210

847

Hypermobility syndrome

165

5.38

42.80

1.6

1.4

2.80

2.89

g/l

0.19

115

Myalgia

219

798

2.78

42.63

1.5

1.3

2.91

2.93

g/l

0.07

160

542

Polymyalgia rheumatica

115

281

4.16

42.41

1.5

1.3

2.89

2.90

g/l

0.01

200

Neoplasms

691

2042

1.82

42.31

1.4

2.88

3.04

g/l

1.40

467

1437

Complications of procedures, not elsewhere classified

641

3083

1.81

42.09

1.4

2.88

2.99

g/l

0.74

471

2125

Lumbar disc prolapse

507

2072

1.96

41.93

1.4

2.92

3.04

g/l

0.79

352

1392

Sciatica+with lumbago

407

1864

2.09

41.60

1.4

1.3

2.85

3.03

g/l

1.29

294

1265

Disorders of conjunctiva

686

3276

1.76

41.26

1.5

1.3

2.79

2.94

g/l

1.36

515

2264

COPD, hospital admissions

333

1253

2.27

40.91

1.4

2.59

2.96

g/l

3.53

239

843

Depression or dysthymia

598

1788

1.88

40.85

1.4

3.01

3.08

g/l

0.38

409

1237

Dentofacial anomalies [including malocclusion]

265

1071

2.47

40.77

1.4

1.3

2.87

2.95

g/l

0.32

177

747

Dysphagia

197

695

2.87

40.75

1.4

1.3

2.95

2.98

g/l

0.09

136

490

Constipation

688

2800

1.77

40.72

1.4

2.79

2.92

g/l

1.10

469

1990

Streptococcal septicaemia

211

4.65

40.66

1.4

1.3

2.65

3.04

g/l

0.82

159

Pulmonary heart disease, diseases of pulmonary circulation

258

1044

2.50

40.59

1.4

2.79

2.92

g/l

0.53

195

723

Persons encountering health services for other counselling and medical advice, not elsewhere classified

894

3077

1.66

40.53

1.4

1.3

2.80

2.99

g/l

2.52

671

2114

Other disorders of fluid, electrolyte and acid-base balance

245

937

2.55

39.95

1.4

1.3

2.63

2.96

g/l

2.00

167

637

COPD, early/later onset

333

1264

2.24

39.82

1.4

2.59

2.96

g/l

3.45

239

852

Multiple myeloma and malignant plasma cell neoplasms

6.69

39.77

1.4

1.3

1.52

2.85

g/l

3.20

Symptoms and signs involving the nervous and musculoskeletal systems

469

2429

1.94

39.61

1.6

1.4

2.81

2.93

g/l

0.72

339

1704

Renal tubulo-interstitial diseases

677

2973

1.76

39.53

1.4

2.63

3.00

g/l

5.53

458

2085

Benign neoplasm of colon, rectum, anus and anal canal

434

1533

2.04

39.29

1.4

2.78

3.07

g/l

2.83

320

1071

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

139

410

3.45

39.13

1.5

1.4

2.30

2.92

g/l

3.10

287

Chronic diseases of tonsils and adenoids

602

2089

1.83

39.09

1.3

2.76

2.98

g/l

2.28

449

1385

Pneumonia derived septicemia

7.56

38.80

1.4

2.34

2.82

g/l

0.85

Nutritional anaemias

378

1777

2.09

38.70

1.4

1.3

2.88

2.94

g/l

0.21

279

1241

Other disorders of skin and subcutaneous tissue

526

2601

1.86

38.62

1.4

2.84

2.96

g/l

0.72

380

1807

Other symptoms and signs involving the nervous and musculoskeletal systems

361

1721

2.12

38.53

1.6

1.3

2.77

2.94

g/l

1.05

260

1202

Pneumonia due to Streptococcus pneumoniae

6.67

38.48

1.5

1.2

2.14

2.86

g/l

2.35

Drug-induced cataract

8.66

38.43

1.5

1.3

2.59

2.68

g/l

0.10

Benign neoplasm of colon, rectum, anus and anal canal

449

2081

1.96

38.27

1.4

2.80

2.99

g/l

1.51

333

1424

Spondyloarthritis

171

580

2.99

38.05

1.4

1.3

3.09

2.98

g/l

0.31

118

410

Multiple myeloma, excluding all cancers (controls excluding all cancers)

107

6.28

38.04

1.4

1.53

2.88

g/l

3.63

Inflammatory diseases of the central nervous system

105

261

4.12

37.99

1.5

1.4

2.75

2.93

g/l

0.34

181

Hypertensive diseases

669

2148

1.77

37.90

1.4

2.82

2.99

g/l

1.54

452

1500

Giant cell arteritis

7.34

37.90

1.2

1.5

2.77

2.66

g/l

0.14

Metabolic disorders

752

2760

1.70

37.72

1.5

1.4

2.73

3.02

g/l

4.53

532

1911

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

769

3126

1.68

37.53

1.4

2.72

3.00

g/l

3.93

529

2216

Later onset COPD, excluding more controls

109

206

4.16

37.49

1.1

1.3

2.72

3.02

g/l

0.88

133

Bleeding

631

2612

1.77

37.35

1.4

2.99

2.95

g/l

0.20

445

1811

Hypertension

666

2146

1.77

37.27

1.4

2.81

2.99

g/l

1.65

449

1498

Unspecified jaundice

6.62

37.15

2.0

1.2

3.08

2.94

g/l

0.17

Colitis, primary sclerosing, strict definition

11.06

36.88

1.4

1.2

3.38

2.40

g/l

2.35

Multiple myeloma and malignant plasma cell neoplasms

107

6.18

36.88

1.4

1.52

2.88

g/l

3.56

Nerve, nerve root and plexus disorders

825

3160

1.65

36.84

1.4

2.91

3.00

g/l

0.76

579

2174

Intestinal malabsorption

118

5.87

36.61

1.3

3.26

2.72

g/l

1.19

Spondylopathies (FG)

146

463

3.20

36.56

1.5

1.3

3.17

2.99

g/l

0.53

103

309

Benign neoplasm: Colon

375

1391

2.08

36.55

1.4

2.82

3.05

g/l

1.78

274

979

Hypertension, essential

634

2045

1.78

36.46

1.4

2.81

3.02

g/l

2.03

426

1422

Other and unspecified iron deficiency

267

1155

2.33

36.26

1.5

1.3

2.82

2.90

g/l

0.28

195

811

Benign neoplasm: Colon

381

1854

2.03

36.25

1.5

1.4

2.83

2.98

g/l

0.98

280

1275

Pulmonary embolism

234

955

2.48

36.22

1.4

2.80

2.92

g/l

0.47

173

658

Benign neoplasms

663

2152

1.75

36.19

1.4

2.87

3.06

g/l

1.90

455

1503

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

391

1205

2.07

36.11

1.5

1.3

2.95

3.08

g/l

0.64

258

848

Diverticular disease of intestine

510

1815

1.88

36.04

1.6

1.4

2.86

3.00

g/l

1.01

381

1240

Diseases of arteries, arterioles and capillaries (FINNGEN)

201

511

2.78

35.97

1.4

2.85

3.10

g/l

0.95

146

344

Abnormal findings on diagnostic imaging of other body structures

125

364

3.50

35.93

1.6

1.4

3.38

2.85

g/l

1.64

257

Dialysis, with operation codes

137

423

3.30

35.92

1.4

2.31

3.01

g/l

3.71

304

Migraine with aura

220

876

2.54

35.92

1.4

3.00

2.97

g/l

0.11

160

625

Pulmonary heart disease

234

961

2.46

35.74

1.4

2.80

2.91

g/l

0.42

173

664

Diseases of the ear and mastoid process

954

3043

1.59

35.54

1.4

2.88

2.99

g/l

1.22

669

2124

Abnormal results of function studies

100

252

4.06

35.53

1.5

1.3

2.94

3.01

g/l

0.16

179

Iron deficiency anaemia

327

1534

2.13

35.48

1.5

1.4

2.80

2.95

g/l

0.66

240

1069

Nephropathy related operations

134

412

3.32

35.39

1.4

2.35

2.92

g/l

2.74

295

Diseases of pulp and periapical tissues

296

1351

2.21

35.38

1.5

1.3

2.74

3.04

g/l

2.14

224

918

Conjunctivitis

614

3106

1.73

35.07

1.5

1.3

2.80

2.92

g/l

1.02

468

2140

Heart failure and antihypertensive medication

216

543

2.65

34.98

1.4

1.3

2.71

2.96

g/l

0.94

145

381

Crohn disease

150

498

3.07

34.81

1.2

1.4

3.21

2.96

g/l

0.78

100

359

Other diseases of hard tissues of teeth

516

2109

1.84

34.81

1.5

1.3

2.81

3.02

g/l

1.83

363

1434

Persons encountering health services in other circumstances

326

1556

2.11

34.69

1.4

1.3

2.78

2.92

g/l

0.70

197

1064

Other specified/unspecified necrotizing vasculopathies

12.49

34.64

1.4

2.67

2.51

g/l

0.12

Atrial fibrillation and flutter

265

732

2.38

34.39

1.3

2.78

3.09

g/l

1.92

185

505

Hypothyroidism, strict autoimmune

506

1818

1.85

34.35

1.3

3.06

2.99

g/l

0.30

344

1278

Mood disorders, excluding more controls

746

2744

1.66

34.27

1.4

2.90

3.02

g/l

0.99

528

1882

Unspecified chronic bronchitis

8.14

34.21

1.3

1.4

2.84

2.50

g/l

0.47

Acute renal failure

168

599

2.84

34.21

1.4

1.3

2.68

3.02

g/l

1.45

428

IBD patients in KELA-register

229

952

2.43

34.15

1.2

1.3

3.23

2.95

g/l

1.20

139

671

Other gastritis (incl. Duodenitis)

184

690

2.70

33.98

1.5

1.4

3.04

2.88

g/l

0.49

136

469

Recurrent or chronic depression

355

1245

2.07

33.94

1.3

2.94

3.04

g/l

0.50

254

869

Glomerular diseases

174

636

2.78

33.85

1.6

1.3

2.40

3.03

g/l

4.47

116

452

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

2492

1.86

33.85

1.4

2.86

2.96

g/l

0.52

332

1725

Noninfectious colitis NAS

140

454

3.13

33.82

1.5

1.4

2.85

2.89

g/l

0.08

105

330

Benign neoplasm of other and ill-defined parts of digestive system

162

571

2.88

33.75

1.5

1.4

2.79

2.88

g/l

0.29

117

392

SLE (Finngen)

6.85

33.74

1.6

1.5

2.69

2.80

g/l

0.14

Chronic periapical parodontitis

187

710

2.67

33.73

1.6

1.3

2.86

3.01

g/l

0.47

133

471

Syncope and collapse

293

1193

2.19

33.61

1.3

2.90

3.08

g/l

0.80

202

827

Other and unspecified disorders of white blood cells

100

6.10

33.56

1.3

2.35

2.64

g/l

0.43

Polyarthrosis

163

552

2.86

33.44

1.6

1.5

2.78

2.86

g/l

0.21

107

384

Depression

770

3273

1.63

33.41

1.4

2.91

2.98

g/l

0.46

546

2247

Diaphragmatic hernia

280

1282

2.20

33.26

1.4

1.3

2.88

2.91

g/l

0.09

210

888

Biological medication for rheuma

178

665

2.72

33.25

1.3

1.4

3.17

2.89

g/l

0.98

120

456

Pericarditis

7.02

33.24

1.2

2.73

2.93

g/l

0.26

Benign neoplasms

787

2705

1.63

33.06

1.4

1.3

2.89

3.04

g/l

1.33

545

1867

Heart failure,strict

351

1242

2.05

32.66

1.4

2.59

3.03

g/l

4.16

238

836

Candidiasis

139

459

3.08

32.59

1.5

1.4

2.98

2.85

g/l

0.31

324

Infections of the skin and subcutaneous tissue

470

2587

1.82

32.53

1.4

2.79

2.97

g/l

1.32

355

1785

IBD (strict) with PSC

12.00

32.46

1.3

3.47

2.79

g/l

0.74

Collagenous colitis

260

3.85

32.44

1.4

2.70

2.86

g/l

0.28

188

Diseases of middle ear and mastoid

487

2209

1.82

32.43

1.4

1.3

2.81

2.95

g/l

1.04

340

1517

Mood disorders

814

3365

1.60

32.36

1.4

2.92

2.97

g/l

0.41

574

2319

Other disorders of teeth and supporting structures

185

715

2.62

32.22

1.7

1.3

2.76

2.98

g/l

0.93

143

468

Benign neoplasm of other and ill-defined parts of digestive system

162

586

2.81

32.18

1.5

1.4

2.79

2.82

g/l

0.08

117

406

Urticaria

279

1295

2.18

32.09

1.5

1.4

2.79

2.90

g/l

0.54

209

905

Mood [affective] disorders

811

3363

1.59

32.03

1.4

2.92

2.98

g/l

0.39

572

2317

Ulcerative colitis (strict) with PSC

13.74

32.00

1.3

3.51

2.50

g/l

1.55

Pulmonary eosinophilia, not elsewhere classified

13.29

31.83

1.8

1.3

3.38

2.86

g/l

0.53

All influenza (not pneumonia)

139

465

3.03

31.80

1.3

2.56

3.09

g/l

2.90

324

Inflammatory bowel disease, strict (require KELA)

229

984

2.35

31.75

1.2

1.3

3.23

2.95

g/l

1.25

139

692

Acute suppurative otitis media

265

1124

2.22

31.75

1.4

1.3

2.57

2.96

g/l

3.78

193

782

Spondylosis

379

1676

1.95

31.74

1.5

1.4

2.70

3.04

g/l

3.25

243

1139

Disorders of sclera, cornea, iris and ciliary body

435

2368

1.85

31.71

1.4

3.07

2.94

g/l

0.82

302

1656

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

288

1360

2.14

31.69

1.6

1.3

2.79

2.85

g/l

0.22

163

955

Migraine with aura and triptan purchases

163

597

2.77

31.64

1.4

3.01

2.94

g/l

0.21

121

418

Migraine without aura

190

755

2.55

31.26

1.4

3.00

2.99

g/l

0.04

139

545

Other reaction to severe stress, and adjustment disorders

325

1614

2.03

31.21

1.5

1.3

2.86

2.98

g/l

0.60

231

1115

Temporomandibular joint disorders, including avohilmo

361

1857

1.96

31.21

1.4

3.01

2.94

g/l

0.33

243

1309

Other diseases of lip and oral mucosa

147

516

2.89

30.89

1.4

1.3

2.79

2.93

g/l

0.30

111

354

Pneumococcal septicemia

6.25

30.82

1.5

1.3

2.32

2.82

g/l

0.86

Other bacterial intestinal infections

156

566

2.79

30.80

1.4

1.3

2.74

2.86

g/l

0.34

112

399

Care involving use of rehabilitation procedures

502

2725

1.76

30.78

1.4

2.78

2.99

g/l

1.87

353

1903

Abnormal serum enzyme levels

226

965

2.33

30.75

1.5

1.3

3.03

3.06

g/l

0.07

170

665

Polypectomy (DHB20)

204

4.17

30.59

2.0

1.3

3.14

2.96

g/l

0.38

139

Nonsuppurative otitis media

223

822

2.37

30.52

1.5

1.3

2.77

2.91

g/l

0.64

160

582

Herpesviral [herpes simplex] infections

125

406

3.13

30.20

1.4

2.94

2.93

g/l

0.02

290

COPD, hospital admissions 1, only main diagnosis

240

908

2.27

29.79

1.3

1.4

2.46

2.97

g/l

4.51

170

623

Erysipelas

364

1737

1.92

29.59

1.5

1.4

2.87

3.07

g/l

1.10

264

1195

COPD related to multimorbidity

259

1002

2.19

29.54

1.4

2.53

2.97

g/l

3.65

183

677

Cholecystitis

109

330

3.34

29.49

1.8

1.2

3.20

2.94

g/l

0.57

234

Factors influencing health status and contact with health services

236

493

2.42

29.40

1.3

2.93

3.20

g/l

1.17

167

314

Congenital malformations of the respiratory system

7.33

29.21

1.5

1.4

2.49

2.39

g/l

0.10

Enterocolitis due to Clostridium difficile

256

3.69

29.16

1.5

1.4

2.55

2.90

g/l

0.97

182

Thrombocytopenia, unspecified

194

4.17

29.15

1.6

1.4

2.76

2.91

g/l

0.29

136

Seropositive rheumatoid arthritis, wide

220

965

2.30

29.10

1.5

1.4

2.68

2.86

g/l

0.84

164

666

DVT of lower extremities and pulmonary embolism

294

1440

2.05

29.07

1.4

1.3

2.81

2.93

g/l

0.53

212

1005

Bacterial intestinal infections, IBD co-morbidities

155

578

2.71

29.06

1.4

1.3

2.72

2.86

g/l

0.39

112

406

Other disorders of urethra and urinary system

516

2243

1.73

28.90

1.4

1.3

2.82

2.98

g/l

1.21

355

1576

Suppurative and unspecified otitis media

330

1491

1.98

28.87

1.4

1.3

2.71

2.94

g/l

1.67

238

1039

Other specified/unspecified inflammatory spondylopathies

138

4.83

28.85

1.6

1.4

2.92

2.87

g/l

0.08

Polyarteritis nodosa and related conditions

10.30

28.83

1.7

1.3

2.80

2.48

g/l

0.37

Systemic lupus erythematosus

5.83

28.80

1.6

1.3

2.69

2.61

g/l

0.10

Deposits [accretions] on teeth

235

3.78

28.79

1.7

1.3

2.43

2.71

g/l

0.63

178

Psychiatric diseases

863

2798

1.55

28.76

1.4

2.83

3.00

g/l

1.81

619

1923

Weight loss

278

3.56

28.69

1.4

1.3

3.02

2.89

g/l

0.28

200

Venous thromboembolism

380

1984

1.87

28.69

1.5

1.4

2.74

2.98

g/l

1.70

270

1364

Any mental disorder

871

2832

1.55

28.65

1.4

2.83

3.00

g/l

1.83

626

1946

Abnormal weight loss

246

3.73

28.58

1.4

1.3

3.17

2.87

g/l

0.77

174

Gout

174

625

2.56

28.56

1.4

2.62

3.06

g/l

2.28

112

432

Postviral fatigue syndrome

13.35

28.51

2.0

1.2

3.03

2.90

g/l

0.08

Anxiety (asthma-related co-morbidities)

495

2253

1.74

28.50

1.4

2.93

2.98

g/l

0.30

374

1560

Zoster [herpes zoster]

145

530

2.77

28.27

1.5

1.3

2.36

2.89

g/l

3.48

113

361

Non-follicular lymphoma, hilmo, excluding all cancers

262

3.62

28.24

1.5

1.4

2.09

3.00

g/l

4.51

186

Pollen allergy

201

851

2.37

28.18

1.4

1.3

3.00

2.85

g/l

0.64

171

601

Cystitis

640

2397

1.64

28.08

1.4

1.3

2.83

2.97

g/l

1.15

467

1694

Other diseases of urinary system

774

2783

1.57

28.04

1.4

2.87

2.99

g/l

1.02

540

1955

Unknown and unspecified causes of morbidity

174

4.27

27.97

1.3

2.52

3.04

g/l

2.14

129

Non-follicular lymphoma

264

3.59

27.92

1.5

1.4

2.09

2.96

g/l

4.05

184

Alcohol-induced chronic pancreatitis

205

4.00

27.90

1.2

3.13

3.01

g/l

0.17

143

Visual disturbances and blindness

385

2108

1.84

27.64

1.6

1.4

2.97

2.92

g/l

0.23

289

1459

Hypothyroidism, drug reimbursement

124

286

3.13

27.63

1.7

1.3

3.21

3.20

g/l

0.02

207

Mucosal proctocolitis

132

467

2.87

27.43

1.4

1.3

2.96

3.00

g/l

0.09

332

Atopic dermatitis, strict definition with reimbursement

271

1280

2.07

27.38

1.4

1.3

2.81

2.90

g/l

0.41

205

894

Transplanted organ and tissue status

109

348

3.19

27.19

1.5

1.4

2.46

2.98

g/l

1.64

262

Other/unspecified dorsalgia

278

1366

2.04

27.14

1.2

1.4

2.92

2.96

g/l

0.15

190

934

Other and unspecified tonsillitis

273

1126

2.07

27.02

1.4

2.79

3.06

g/l

1.84

197

744

Other Crohn's disease

238

3.69

26.87

1.2

1.3

3.41

2.98

g/l

1.04

167

Disturbances of skin sensation

239

1122

2.15

26.81

1.3

2.89

2.99

g/l

0.35

177

757

Heart failure, strict

368

1418

1.88

26.73

1.4

2.61

3.00

g/l

3.37

251

965

Other symptoms and signs involving the digestive system and abdomen

129

457

2.85

26.69

1.4

1.3

2.63

2.90

g/l

0.89

331

Other/unspecified seropositive rheumatoid arthritis

213

957

2.25

26.66

1.5

1.4

2.67

2.86

g/l

0.88

160

661

COPD-related respiratory insufficiency

259

3.52

26.44

1.4

1.3

2.11

3.08

g/l

5.84

183

Thyroiditis, ILD-related definition

111

364

3.10

26.42

1.5

1.3

2.80

2.84

g/l

0.07

257

Deviated nasal septum

237

1114

2.14

26.41

1.2

1.3

3.01

3.07

g/l

0.19

156

728

Alcohol-induced acute pancreatitis

106

5.27

26.33

1.3

3.42

3.03

g/l

0.45

Non-invasive ventilation

165

622

2.51

26.31

1.3

2.22

3.06

g/l

4.24

422

Hypokalaemia

104

329

3.21

26.30

1.3

2.71

2.99

g/l

0.67

224

Symptoms and signs involving cognition, perception, emotional state and behaviour

717

3237

1.56

26.26

1.3

1.4

2.95

2.98

g/l

0.16

502

2248

Encephalitis

6.12

26.22

1.3

2.92

2.69

g/l

0.19

All anxiety disorders

499

2382

1.70

26.21

1.4

1.3

2.93

2.97

g/l

0.22

378

1651

Spinal stenosis

330

1353

1.92

26.15

1.4

2.73

3.05

g/l

2.24

243

911

Temporal arteritis

6.65

26.12

1.2

1.3

2.77

2.71

g/l

0.06

Other encephalitis

6.35

25.99

1.3

2.98

2.76

g/l

0.17

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

210

949

2.23

25.94

1.5

1.4

2.63

2.87

g/l

1.40

157

654

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

429

2434

1.74

25.72

1.6

1.3

2.85

2.94

g/l

0.53

333

1690

Other ulcerative colitis

186

4.02

25.69

1.3

3.20

2.99

g/l

0.34

130

Continuous positive airway pressure

150

498

2.62

25.60

1.4

2.46

2.99

g/l

2.93

134

342

Visual disturbances

361

1986

1.83

25.59

1.6

1.4

3.00

2.91

g/l

0.43

270

1367

Other nutritional deficiencies

493

2891

1.68

25.58

1.4

2.82

2.98

g/l

1.30

353

2041

Polyneuropathies and other disorders of the peripheral nervous system

170

708

2.43

25.41

1.4

1.3

2.72

2.92

g/l

0.73

124

500

Tumor necrosis factor alpha inhibitors

152

602

2.56

25.37

1.3

1.4

3.33

2.89

g/l

1.81

418

Cirrhosis of liver, NAS

121

4.84

25.34

1.2

1.3

3.03

2.74

g/l

0.55

Other symptoms and signs involving the circulatory and respiratory systems

145

4.42

25.29

1.4

1.3

2.85

3.03

g/l

0.31

100

Missing teeth due to accident, extraction or parodontitis

112

379

3.00

25.27

1.5

1.4

2.69

2.93

g/l

0.79

259

Atrial fibrillation and flutter with reimbursement

193

522

2.39

25.26

1.4

2.68

3.09

g/l

2.31

136

358

Viral pneumonia (unknown virus, not influenza)

193

3.91

25.19

1.2

1.3

2.68

3.06

g/l

0.71

134

Other complications of surgical and medical care, not elsewhere classified

303

3.26

25.10

1.4

2.76

2.98

g/l

0.52

216

Lymphoid leukaemia

138

4.52

25.08

1.4

1.2

1.82

2.74

g/l

3.78

Glomerulonephritis

103

334

3.14

25.05

1.7

1.4

2.54

2.97

g/l

1.31

239

Benzodiazepine use

740

3455

1.53

25.04

1.3

1.4

2.90

2.99

g/l

0.63

503

2402

Giant cell arteritis with polymyalgia rheumatica

6.36

25.01

1.2

1.3

2.77

2.82

g/l

0.05

All-cause Heart Failure

357

1396

1.85

24.91

1.4

2.63

3.00

g/l

3.01

245

948

Lymphoid leukaemia

139

4.49

24.85

1.4

1.3

1.82

2.86

g/l

4.74

102

Other and unspecified polyneuropathies, also in other diseases

150

596

2.55

24.83

1.4

1.3

2.69

2.93

g/l

0.86

109

420

Shoulder lesions

540

2007

1.65

24.67

1.4

1.3

2.91

3.03

g/l

0.81

395

1353

Ulcerative colitis (strict definition, require KELA)

165

688

2.43

24.65

1.2

1.4

2.96

2.98

g/l

0.05

488

Pain in thoracic spine

131

489

2.71

24.60

1.4

1.3

2.81

3.00

g/l

0.57

100

336

Non-rheumatic valve diseases

317

1216

1.91

24.49

1.4

2.86

2.93

g/l

0.22

215

841

Diseases of oral cavity, salivary glands and jaws

672

2192

1.58

24.46

1.4

1.3

2.84

3.01

g/l

1.61

486

1495

Agranulocytosis

106

355

3.04

24.38

1.3

1.4

2.40

2.88

g/l

1.96

248

Suppurative and necrotic conditions of lower respiratory tract

133

4.54

24.37

1.4

1.3

2.65

2.97

g/l

0.61

Other overlap syndromes

9.19

24.34

1.5

1.4

2.42

2.65

g/l

0.20

Valvular heart disease excluding rheumatic fever

320

1236

1.90

24.30

1.4

2.84

2.91

g/l

0.21

217

857

Papulosquamous disorders

300

1585

1.91

24.21

1.4

3.14

2.89

g/l

1.36

215

1084

Concussion

356

1704

1.82

24.19

1.5

1.4

2.88

3.00

g/l

0.62

248

1194

Cervicobrachial syndrome

177

767

2.33

24.19

1.6

1.3

3.14

3.01

g/l

0.45

138

519

Intracranial trauma

411

1762

1.75

24.02

1.5

1.4

2.93

3.01

g/l

0.39

286

1235

Follow-up examination after treatment for conditions other than malignant neoplasms

295

991

1.96

23.90

1.4

1.3

2.88

3.05

g/l

0.85

219

594

Insulin, combination of fast acting with intermediate-acting or long-acting

433

2354

1.70

23.80

1.5

1.3

2.81

2.98

g/l

1.14

279

1657

Non-selective monoamine reuptake inhibitors

284

1436

1.93

23.74

1.4

2.73

2.95

g/l

1.57

201

1000

Disorders of lens

475

1782

1.69

23.63

1.4

2.79

2.94

g/l

0.98

327

1272

Secondary hypertension

195

3.76

23.60

1.3

1.2

2.74

2.97

g/l

0.37

133

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

159

666

2.42

23.54

1.2

1.4

2.95

2.97

g/l

0.05

471

Congenital malformations, deformations and chromosomal abnormalities

468

2713

1.66

23.49

1.5

1.4

2.83

2.94

g/l

0.74

322

1892

Cervical disc disorders

258

1311

1.98

23.37

1.4

2.77

3.06

g/l

2.08

176

891

Adalimumab

102

343

3.03

23.35

1.3

1.4

3.45

2.88

g/l

1.82

244

Allergic conjunctivitis

444

2616

1.68

23.34

1.6

1.3

2.85

2.92

g/l

0.46

346

1816

Paralytic ileus and intestinal obstruction

173

754

2.31

23.30

1.3

2.79

2.96

g/l

0.56

113

517

Hypoparathyroidism

5.38

23.08

2.5

1.3

2.49

2.67

g/l

0.21

Stomatitis and related lesions

258

3.35

23.07

1.4

2.92

2.96

g/l

0.08

172

Presence of other functional implants

373

1488

1.78

23.02

1.4

2.69

2.95

g/l

1.81

204

1054

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

406

2385

1.71

22.92

1.4

2.85

2.96

g/l

0.61

289

1659

Disorders of orbit

120

4.62

22.75

1.7

1.4

3.04

2.92

g/l

0.15

Other (seronegative) rheumatoid arthritis, wide

154

646

2.41

22.72

1.5

1.4

2.55

2.87

g/l

1.41

115

446

Disorders of parathyroid gland

147

597

2.45

22.56

1.8

1.3

2.54

2.84

g/l

1.14

105

407

Asthma mixed form (mode), excluding more controls

5.52

22.43

1.7

1.3

2.54

2.89

g/l

0.77

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

120

450

2.70

22.41

1.3

1.4

3.18

2.98

g/l

0.50

316

Use of hypnotics and sedatives

788

3078

1.49

22.40

1.3

1.4

2.83

3.03

g/l

2.52

568

2121

Disorders of the thyroid gland

689

2983

1.52

22.05

1.4

1.3

2.97

2.96

g/l

0.03

454

2116

Iridocyclitis

189

878

2.17

21.91

1.5

1.3

3.01

2.91

g/l

0.33

136

615

Systemic sclerosis (FG)

6.71

21.87

1.2

1.3

2.98

2.70

g/l

0.33

Disorders of skin appendages

369

2141

1.73

21.85

1.3

1.4

3.05

2.93

g/l

0.64

267

1480

Lung diseases due to external agents

100

345

2.93

21.81

1.3

2.76

3.00

g/l

0.59

251

Correction of physiology of bite - demanding therapy visit

243

3.36

21.75

1.4

3.39

2.91

g/l

1.70

168

Recurring oral aphthae, including avohilmo

123

475

2.62

21.69

1.3

1.4

2.93

2.79

g/l

0.42

328

GI-bleeding

211

1026

2.07

21.65

1.4

1.3

2.97

2.95

g/l

0.06

144

720

Hypo-osmolality and hyponatraemia

125

486

2.59

21.54

1.4

1.3

2.69

2.92

g/l

0.81

337

Atopic dermatitis

423

2167

1.67

21.54

1.3

2.87

2.95

g/l

0.47

316

1523

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

169

759

2.25

21.33

1.2

1.4

2.96

2.97

g/l

0.01

101

527

123

479

2.60

21.32

1.6

1.3

2.92

2.94

g/l

0.02

330

Gout, FINNGEN

174

791

2.22

21.26

1.4

2.62

3.11

g/l

2.82

112

543

Migraine without aura and triptan purchases

151

649

2.35

21.14

1.3

1.4

3.04

2.94

g/l

0.28

113

456

Other anxiety disorders

355

1816

1.74

21.11

1.3

2.92

2.99

g/l

0.35

275

1248

Extracorporeal dialysis

176

3.78

21.06

1.5

1.3

2.01

2.81

g/l

3.01

125

Insulin medication

433

2255

1.65

20.90

1.5

1.3

2.81

2.97

g/l

1.03

279

1565

Triptan medication for migraine, single purchase ok

601

2655

1.54

20.82

1.4

1.3

2.97

2.92

g/l

0.26

417

1844

Migraine, single triptan purchase ok & required. ICD-code if available is included

601

2655

1.54

20.82

1.4

1.3

2.97

2.92

g/l

0.26

417

1844

Coxibs

214

536

2.14

20.78

1.3

2.96

3.16

g/l

0.72

151

364

Hypothyreosis and Thyroxine purchase for inclusion criteria

659

2894

1.51

20.73

1.4

1.3

3.02

2.95

g/l

0.41

436

2051

Other metabolic disorders

118

457

2.62

20.70

1.7

1.3

2.92

2.98

g/l

0.10

316

Other pulmonary heart/vessel disease

4.94

20.67

1.3

2.39

2.78

g/l

0.70

Disorders of synovium and tendon

371

1966

1.71

20.59

1.5

1.3

2.93

3.01

g/l

0.46

258

1342

Hypothyroidism, other/unspecified

637

2784

1.52

20.53

1.4

1.3

3.02

2.96

g/l

0.33

419

1978

Other skin changes

130

530

2.48

20.48

1.8

1.3

2.73

2.86

g/l

0.37

101

374

Pain and other conditions associated with female genital organs and menstrual cycle

171

750

2.21

20.47

1.4

2.88

2.90

g/l

0.04

121

521

Asthma mixed form (mode)

5.07

20.45

1.7

1.3

2.54

2.94

g/l

0.95

Vasculitis limited to skin, not elsewhere classified

6.23

20.42

1.4

1.2

2.71

2.76

g/l

0.04

Other diseases of intestine

331

2.91

20.41

1.4

1.3

2.80

2.89

g/l

0.17

226

Personal history of allergy to drugs, medicaments and biological substances

8.90

20.35

1.6

1.1

2.90

3.01

g/l

0.08

Secondary right heart disease

5.18

20.31

1.2

1.3

2.35

2.77

g/l

0.73

Nonalcoholic fatty liver disease

333

2.90

20.25

1.3

1.4

3.13

2.97

g/l

0.46

229

Disorders of oesophagus in diseases classified elsewhere

8.21

20.14

1.4

1.1

3.50

2.53

g/l

1.15

Diseases of spleen

7.56

20.08

1.8

1.3

2.82

2.67

g/l

0.13

Recurring oral aphthae

142

4.04

19.93

1.5

1.3

2.95

2.66

g/l

0.58

Selective serotonin reuptake inhibitors

735

2631

1.48

19.90

1.3

1.4

2.89

3.04

g/l

1.51

510

1824

Somatoform disorder

143

617

2.34

19.88

1.4

1.3

3.00

2.89

g/l

0.29

421

Rotator cuff syndrome

405

1814

1.67

19.85

1.4

1.3

2.95

3.02

g/l

0.33

302

1223

Otitis media, unspecified

111

389

2.66

19.83

1.4

1.3

2.55

2.82

g/l

0.97

290

Acute laryngitis and tracheitis

106

392

2.69

19.69

1.3

2.95

2.96

g/l

0.02

258

Myocarditis

113

4.41

19.68

1.4

1.2

2.60

3.00

g/l

0.94

Obesity and other hyperalimentation

453

2820

1.60

19.65

1.4

2.83

2.97

g/l

0.96

324

1990

Dermatitis due to substances taken internally

139

4.03

19.62

1.5

2.23

2.96

g/l

1.82

Care involving dialysis

244

3.21

19.57

1.5

1.3

2.25

2.93

g/l

2.17

171

Lung cancer and mesothelioma

247

3.03

19.56

1.2

1.3

2.65

2.98

g/l

0.85

161

Gastroduodenal ulcer

159

720

2.22

19.52

1.3

3.05

2.92

g/l

0.33

105

485

Other and unspecified vasculitis limited to skin

6.32

19.51

1.4

1.2

2.79

2.80

g/l

0.00

Other specified/unspecified soft tissue disorders

102

4.59

19.42

1.5

1.3

2.94

2.90

g/l

0.05

Acute and subacute iridocyclitis

160

731

2.21

19.41

1.4

1.3

3.04

2.93

g/l

0.31

110

517

Triptan medication for migraine, min. 3 purchases

433

2115

1.62

19.41

1.4

1.3

2.94

2.96

g/l

0.11

317

1478

Other diseases of the digestive system

207

1043

2.00

19.32

1.3

3.00

2.93

g/l

0.19

143

731

Total colectomy operation

111

4.43

19.28

1.6

1.3

3.02

2.74

g/l

0.37

Total colectomy

111

4.43

19.28

1.6

1.3

3.02

2.74

g/l

0.37

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

187

3.53

19.23

1.6

1.4

3.15

3.03

g/l

0.24

130

Other or unspecified ileus, impaction or obstruction

124

509

2.46

19.22

1.3

2.62

2.94

g/l

1.17

353

Direct fill therapy

131

553

2.40

19.18

1.4

2.38

2.86

g/l

2.21

403

Other viral diseases, not elsewhere classified

169

791

2.15

19.17

1.5

1.4

2.59

2.88

g/l

1.49

129

568

Idiopathic thrombocytopenic purpura

5.15

19.14

1.3

2.78

2.63

g/l

0.18

Obesity

449

2810

1.59

19.12

1.4

2.83

2.97

g/l

0.91

320

1983

Systemic sclerosis

5.84

19.11

1.2

2.99

2.56

g/l

0.62

Sequelae with surgical and medical care as external cause

152

685

2.24

19.08

1.5

1.3

2.89

2.88

g/l

0.03

113

471

Other inflammation of eyelid

110

429

2.60

19.07

1.5

1.3

3.00

2.89

g/l

0.25

299

Glomerular disorders in diseases classified elsewhere

361

2.75

19.03

1.4

2.30

3.06

g/l

3.80

254

Cerebrovascular diseases (FINNGEN)

220

797

1.99

19.01

1.3

2.79

3.08

g/l

1.60

157

550

Dizziness and giddiness

509

2675

1.55

18.90

1.4

3.00

2.95

g/l

0.27

358

1860

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

4.84

18.78

1.5

1.3

2.80

2.79

g/l

0.01

Other viral diseases

249

1345

1.86

18.76

1.6

1.3

2.64

2.90

g/l

1.73

182

953

Cutaneous abscess, furuncle and carbuncle

202

1022

1.99

18.70

1.3

2.88

2.95

g/l

0.25

150

705

Sequelae of external causes of morbidity and mortality

185

908

2.06

18.64

1.5

1.3

2.83

2.89

g/l

0.18

137

627

Arthrosis

475

1642

1.60

18.58

1.3

1.4

2.87

3.03

g/l

1.09

333

1120

Nonorganic sleeping disorders, excluding more controls

148

670

2.23

18.38

1.3

2.98

3.02

g/l

0.12

447

Cervicalgia

145

652

2.24

18.29

1.8

1.3

3.08

2.98

g/l

0.24

106

441

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

270

3.01

18.27

1.5

1.4

2.46

2.97

g/l

1.68

189

Acetic acid derivatives and related substances

208

530

2.06

18.27

1.5

1.3

2.91

3.17

g/l

1.20

144

361

Anterior Iridocyclitis

166

789

2.12

18.25

1.5

1.3

3.01

2.91

g/l

0.28

115

550

Diseases of arteries, arterioles and capillaries

408

1887

1.62

18.03

1.4

2.76

2.99

g/l

1.65

286

1292

Emphysema

121

4.10

18.02

1.2

1.3

2.44

2.91

g/l

0.86

Adverse effects, not elsewhere classified

167

800

2.11

18.00

1.6

1.3

2.69

2.89

g/l

0.81

120

561

Chronic gastritis

171

826

2.08

17.97

1.3

1.4

2.88

2.90

g/l

0.04

136

563

Other abnormal immunological findings in serum

6.35

17.78

1.7

1.2

3.77

2.71

g/l

1.55

Drug-induced osteoporosis

8.65

17.68

2.1

1.4

2.23

2.67

g/l

0.50

Seronegative rheumatoid arthritis

319

2.79

17.63

1.4

1.3

2.67

2.84

g/l

0.30

209

Other and unspecified urticaria

166

800

2.10

17.62

1.4

1.3

2.66

2.88

g/l

1.03

118

561

Volume depletion

208

3.26

17.60

1.4

1.3

2.39

2.94

g/l

1.71

144

Other arthrosis

332

1402

1.70

17.59

1.3

1.4

2.91

3.02

g/l

0.49

237

964

Endocarditis

5.18

17.47

1.4

1.2

3.13

2.99

g/l

0.10

Paroxysmal tachycardia

162

648

2.13

17.45

1.4

1.3

3.07

3.03

g/l

0.10

110

443

Psoriatic and enteropathic arthropathies

378

2.62

17.41

1.3

3.04

2.97

g/l

0.14

253

SLE, strict definition

112

4.22

17.35

1.6

1.4

2.62

2.66

g/l

0.04

SLE, ICD10

112

4.22

17.35

1.6

1.4

2.62

2.66

g/l

0.04

Hernia

659

3095

1.45

17.19

1.4

2.90

2.96

g/l

0.39

460

2127

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.55

17.19

1.4

1.3

1.66

2.83

g/l

1.09

Multiple myeloma

6.55

17.19

1.4

1.3

1.66

2.83

g/l

1.09

Acute tubulo-interstitial nephritis

404

2261

1.59

17.09

1.4

2.62

2.99

g/l

3.74

290

1590

Intestinal stricture

204

1070

1.92

17.02

1.3

1.4

2.95

2.88

g/l

0.17

137

743

Chronic ulcer of skin, not elsewhere classified

154

3.63

16.99

1.9

1.3

3.11

2.98

g/l

0.16

110

Benign neoplasm: Colon, unspecified

155

734

2.12

16.98

1.4

1.5

2.71

3.02

g/l

1.39

108

509

Crohn's disease of small intestine

234

3.09

16.95

1.3

1.4

3.34

2.89

g/l

0.93

167

Non-ischemic cardiomyopathy

183

751

2.01

16.93

1.4

1.3

2.84

2.96

g/l

0.31

124

513

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

4.43

16.92

1.7

1.4

2.50

2.94

g/l

0.61

Gingivitis and periodontal diseases

619

2170

1.48

16.92

1.4

1.3

2.89

3.03

g/l

1.10

450

1474

Internal derangement of knee

254

1427

1.78

16.85

1.5

1.4

2.93

3.04

g/l

0.47

171

984

Other diseases of stomach and duodenum

146

3.69

16.78

1.3

3.06

2.94

g/l

0.14

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.38

16.70

1.7

1.3

2.50

2.80

g/l

0.36

Exposure to unspecified factor

684

3737

1.42

16.66

1.4

2.81

2.96

g/l

1.30

433

2644

Other disorders of ear

634

2920

1.45

16.65

1.5

1.3

2.80

2.96

g/l

1.36

447

2041

Bronchitis, not specified as acute or chronic

222

3.10

16.46

1.5

1.3

2.90

3.01

g/l

0.25

148

Other arrhythmias

426

2094

1.56

16.37

1.4

2.94

2.96

g/l

0.08

280

1465

Keratitis

251

1423

1.78

16.34

1.4

2.97

2.94

g/l

0.06

168

983

Chronic iridocyclitis

149

3.63

16.33

1.5

1.3

3.08

2.87

g/l

0.29

107

Seropositive rheumatoid arthritis, strict definition

119

518

2.32

16.31

1.4

1.3

2.64

2.87

g/l

0.89

355

Insulin, fast-acting

257

1467

1.76

16.29

1.5

1.3

2.79

2.96

g/l

0.77

168

1033

Dermatographic urticaria

219

3.11

16.24

1.8

1.4

2.81

2.91

g/l

0.22

149

Ulcerative enterocolitis

4.54

16.20

1.4

1.3

2.95

2.88

g/l

0.08

Persons with potential health hazards related to communicable diseases

306

1822

1.68

16.16

1.4

1.3

2.62

2.94

g/l

2.22

184

1313

Other infectious diseases

216

3.10

15.95

1.5

1.3

3.04

2.94

g/l

0.14

153

Gonarthrosis [arthrosis of knee](FG)

446

1694

1.55

15.95

1.3

2.92

3.04

g/l

0.73

320

1153

Benign neoplasm: Colon, unspecified

155

757

2.06

15.91

1.4

1.3

2.71

2.99

g/l

1.17

108

530

Deforming dorsopathies

192

1011

1.91

15.87

1.4

2.73

2.97

g/l

1.17

148

687

Viral infections of the central nervous system

238

2.99

15.85

1.4

2.58

2.93

g/l

0.83

160

6-mercaptopurine

5.27

15.85

2.3

1.2

2.41

2.73

g/l

0.38

Cerebral cysts

157

3.50

15.81

1.7

1.3

2.87

2.84

g/l

0.04

110

Heart failure and bmi 25plus

196

701

1.94

15.78

1.3

1.4

2.68

2.93

g/l

0.92

124

440

Diabetes mellitus

737

3146

1.40

15.74

1.4

2.91

2.97

g/l

0.39

495

2215

Crohn's disease NAS

218

3.08

15.73

1.2

1.3

3.16

2.92

g/l

0.40

153

Hepatic failure, not elsewhere classified

4.72

15.70

1.4

1.3

2.90

2.68

g/l

0.25

Gastric ulcer

106

446

2.39

15.67

1.3

1.4

3.00

2.91

g/l

0.16

306

Invasive ventilation

208

3.13

15.67

1.3

1.79

2.80

g/l

6.25

148

Diabetes, varying definitions

733

3133

1.40

15.66

1.4

2.90

2.97

g/l

0.46

489

2208

Other and unspecified effects of external causes

215

1180

1.84

15.64

1.5

1.3

2.82

2.94

g/l

0.47

152

824

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

447

2.40

15.63

1.7

1.3

2.80

2.91

g/l

0.22

317

Convulsions, not elsewhere classified

154

745

2.05

15.62

1.4

1.3

2.73

3.06

g/l

1.26

113

513

Excessive, frequent and irregular menstruation

292

945

1.73

15.56

1.3

1.4

2.82

2.86

g/l

0.13

199

650

Benign neoplasm: Transverse colon

279

2.80

15.52

1.6

1.4

2.75

3.00

g/l

0.71

194

Systemic sclerosis, icd10

4.82

15.52

1.2

1.3

2.98

2.59

g/l

0.60

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

658

3021

1.42

15.50

1.4

2.99

2.98

g/l

0.07

444

2113

Oxicams

169

468

2.07

15.49

1.3

2.96

3.17

g/l

0.85

125

318

Algoneurodystrophy

100

4.20

15.44

1.4

1.3

2.80

2.67

g/l

0.20

Benign neoplasm: Transverse colon

280

2.79

15.42

1.6

1.4

2.75

3.02

g/l

0.81

199

Genitourinary diseases

462

1508

1.54

15.38

1.4

2.88

2.98

g/l

0.54

322

1039

Personality disorders, excluding more controls

189

1001

1.90

15.37

1.3

2.73

3.07

g/l

2.10

130

671

Other disorders of eye and adnexa

116

513

2.29

15.36

1.3

1.4

2.81

2.92

g/l

0.29

358

Other/unspecified rheumatoid arthritis

355

2.56

15.33

1.5

1.3

2.47

2.83

g/l

1.11

245

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.72

15.24

1.9

1.2

1.89

2.69

g/l

1.68

Pruritus

333

2.61

15.23

1.6

1.3

2.83

2.86

g/l

0.04

237

Misadventures to patients during surgical and medical care

107

459

2.36

15.20

1.4

1.3

3.01

2.93

g/l

0.15

329

Radiculopathy

109

471

2.33

15.20

1.4

1.3

2.85

2.95

g/l

0.24

330

Symptoms and signs involving the urinary system

502

2625

1.48

15.17

1.5

1.4

2.96

2.94

g/l

0.08

357

1812

Congenital malformations and deformations of the musculoskeletal system

373

2.52

15.17

1.6

1.3

2.72

2.61

g/l

0.29

282

Ascites

152

3.47

15.09

1.3

1.2

2.76

3.00

g/l

0.33

108

Postprocedural disorders of nervous system

245

2.90

15.07

1.5

1.4

2.83

2.91

g/l

0.13

176

Unspecified kidney failure

218

3.02

15.06

1.4

1.2

2.42

3.00

g/l

2.00

155

Conjunctivitis (acute, non atopic)

207

1133

1.83

15.03

1.4

1.3

2.81

2.89

g/l

0.26

155

792

Chorioretinal inflammation

4.91

15.03

1.4

3.25

2.67

g/l

0.72

Psoriasis

205

1123

1.84

15.02

1.2

1.4

3.31

2.96

g/l

1.69

144

778

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

284

2.75

15.02

1.3

1.4

2.78

2.99

g/l

0.45

200

Ocular pain

273

2.79

15.02

1.4

1.5

2.97

2.92

g/l

0.08

190

Combined immunodeficiencies

8.37

15.02

1.4

1.2

1.78

2.79

g/l

1.24

Disorders of ocular muscles, binocular movement, accommodation and refraction

338

2103

1.60

15.00

1.5

1.4

3.10

2.88

g/l

1.29

245

1477

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.74

14.92

1.3

1.2

2.43

2.68

g/l

0.33

Other enthesopathies

205

1125

1.83

14.92

1.6

1.3

2.85

2.96

g/l

0.44

149

757

Vascular disorders of the intestines

116

3.84

14.84

1.3

2.81

2.90

g/l

0.11

Acute pharyngitis

111

486

2.29

14.77

1.3

2.68

2.91

g/l

0.88

324

Obesity due to excess calories

327

2045

1.61

14.75

1.3

1.4

2.83

2.96

g/l

0.69

230

1417

Insulin, intermediate and long-acting

352

2195

1.58

14.73

1.4

2.83

2.98

g/l

0.82

232

1540

Fissure and fistula of anal and rectal regions

165

848

1.96

14.71

1.2

1.3

3.02

2.99

g/l

0.06

109

569

Hepatomegaly and splenomegaly, not elsewhere classified

8.10

14.57

1.4

1.2

3.10

2.69

g/l

0.29

Insulin, fast-acting or short human

258

1523

1.70

14.56

1.5

1.3

2.79

2.95

g/l

0.68

169

1066

Rare circulating lymphoid malignancy

4.54

14.55

1.9

1.2

1.89

2.58

g/l

1.30

Other CVD (FINNGEN)

199

2.87

14.51

1.3

3.05

3.07

g/l

0.03

134

Pyogenic arthritis

161

3.34

14.50

1.3

2.56

3.08

g/l

1.17

112

Other diseases of jaws

213

3.00

14.44

1.6

1.5

2.56

2.94

g/l

0.93

136

Senile cataract

391

1560

1.56

14.41

1.4

2.76

2.94

g/l

1.03

266

1113

TMD related pain

110

3.91

14.39

1.4

3.21

2.80

g/l

0.61

Nephrotic syndrome

4.13

14.34

1.9

1.3

2.07

2.32

g/l

0.39

Other cataract

268

1231

1.69

14.29

1.5

1.3

2.93

2.91

g/l

0.07

185

883

Reactive arthropathies, FINNGEN

209

3.01

14.28

1.4

1.3

3.29

2.97

g/l

0.60

144

Heartburn

269

2.74

14.26

1.4

1.3

2.65

2.96

g/l

0.89

190

Chronic nephritic syndrome

111

3.86

14.19

2.0

1.3

2.83

2.82

g/l

0.01

Pyothorax

102

4.00

14.19

1.5

1.3

2.78

2.97

g/l

0.22

Cluster headache, strict

4.24

14.18

1.3

1.2

2.98

3.20

g/l

0.32

Postprocedural endocrine and metabolic disorders, not elsewhere classified

424

2.36

14.16

1.8

1.3

2.97

2.92

g/l

0.08

294

Demyelinating diseases of the central nervous system

323

2.57

14.08

1.4

2.85

2.99

g/l

0.24

225

Cluster headache, wide

4.12

14.04

1.3

2.93

3.16

g/l

0.34

Ulcerative ileocolitis

131

3.58

13.96

1.2

1.3

3.19

3.05

g/l

0.19

Pneumothorax

155

3.33

13.96

1.3

1.2

2.53

3.09

g/l

1.49

113

Acute lymphadenitis

207

3.00

13.92

1.9

1.3

2.84

2.88

g/l

0.06

147

Dental operations

430

1450

1.53

13.86

1.4

1.3

3.00

2.98

g/l

0.08

298

1014

Diseases of pulp and periapical tissues, including avohilmo

775

2956

1.37

13.83

1.4

2.94

2.97

g/l

0.18

528

2068

Dental pulpitis 4

776

2962

1.36

13.78

1.4

2.94

2.98

g/l

0.18

532

2071

Atopic dermatitis, strict definition

241

1392

1.71

13.74

1.4

2.82

2.89

g/l

0.28

184

977

Polyarthritis, unspecified

4.22

13.72

1.8

1.4

2.57

2.93

g/l

0.57

Cardiac murmurs and other cardiac sounds

249

2.77

13.70

1.1

1.4

2.71

2.80

g/l

0.16

186

Exposure to other specified factors

512

3347

1.44

13.68

1.5

1.4

2.83

2.98

g/l

1.25

364

2321

Meniscus derangement

348

1517

1.58

13.67

1.3

1.4

2.96

3.02

g/l

0.26

218

1035

Disorders of mineral metabolism

231

2.85

13.64

1.4

2.53

3.01

g/l

1.42

159

Abscess of lung

6.08

13.64

1.4

1.3

2.65

2.63

g/l

0.02

Soft tissue disorders related to use, overuse and pressure

171

913

1.88

13.64

1.4

1.3

2.86

2.96

g/l

0.34

129

613

Adenocarcinoma and ductal carcinoma of pancreas

5.02

13.62

1.1

1.3

3.46

2.68

g/l

1.50

Dental pulpitis 1

775

2964

1.36

13.62

1.4

2.95

2.97

g/l

0.16

530

2074

Type 2 diabetes

671

2878

1.39

13.61

1.5

1.4

2.89

3.00

g/l

0.73

455

2013

Haemorrhoids and perianal venous thrombosis

174

934

1.87

13.60

1.2

1.4

2.84

2.96

g/l

0.43

115

635

Benign neoplasm: Stomach

282

2.66

13.59

1.8

1.4

2.84

2.83

g/l

0.01

195

Exclusions for E4_PCOS_CONSORTIUM

525

2282

1.45

13.55

1.4

2.81

2.92

g/l

0.64

319

1649

Dental caries 1 and operation codes

593

2142

1.42

13.53

1.4

1.3

2.95

2.94

g/l

0.04

405

1515

Benign neoplasm: Caecum

277

2.67

13.52

1.6

1.4

2.65

2.96

g/l

0.83

194

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

5.78

13.48

1.5

1.3

1.87

2.56

g/l

0.88

Secondary and unspecified malignant neoplasm of lymph nodes

233

2.83

13.43

1.4

2.32

2.97

g/l

1.59

162

Disorders of optic nerve and visual pathways

325

2.52

13.40

1.5

1.4

2.77

2.83

g/l

0.09

228

Other disorders of bone

152

787

1.95

13.34

1.4

1.3

2.90

2.89

g/l

0.01

110

553

Diseases of tongue

170

3.16

13.32

1.5

2.84

2.85

g/l

0.02

116

Rash and other nonspecific skin eruption

320

2.53

13.32

1.4

2.85

2.87

g/l

0.02

231

Diseases of the myoneural junction and muscle

362

2.43

13.30

1.5

1.4

2.93

2.92

g/l

0.01

259

Localized swelling, mass and lump of skin and subcutaneous tissue

210

1205

1.75

13.23

1.7

1.3

2.93

g/l

0.00

174

815

Chronic lymphocytic leukaemia

5.03

13.16

1.3

1.52

2.81

g/l

3.22

Type 2 diabetes, wide definition

474

2116

1.46

13.15

1.5

1.3

2.77

2.99

g/l

1.66

345

1537

Abnormal findings on diagnostic imaging of central nervous system

127

3.53

13.10

1.6

1.3

2.87

2.93

g/l

0.07

Behavioural syndromes associated with physiological disturbances and physical factors

240

1432

1.68

13.09

1.3

1.4

2.89

2.97

g/l

0.32

166

1014

Ulcerative colitis (strict definition, all Crohn cases excluded)

118

562

2.12

13.07

1.2

1.4

2.95

g/l

0.00

400

Tonsillectomy and adenotomy

439

2072

1.48

13.05

1.4

1.3

2.72

2.98

g/l

2.80

328

1429

Ankylosing spondylitis

288

2.60

13.04

1.3

1.4

3.49

3.05

g/l

1.07

202

Benign neoplasm: Caecum

283

2.61

12.97

1.6

1.4

2.65

2.93

g/l

0.77

199

Crohn's disease of large intestine

173

3.12

12.96

1.3

2.82

2.98

g/l

0.25

124

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

4.94

12.91

1.3

1.2

1.52

2.86

g/l

3.90

Chronic lymphocytic leukaemia, helper endpoint

4.94

12.91

1.3

1.2

1.52

2.86

g/l

3.90

Gout, idiopatic and unspecified

140

713

1.98

12.89

1.4

1.3

2.61

3.03

g/l

2.00

499

TMD related operations

137

695

1.99

12.79

1.4

3.25

2.94

g/l

1.19

483

Benign neoplasm: Stomach

291

2.57

12.78

1.8

1.4

2.84

2.82

g/l

0.02

197

Other and unspecified drugs and medicaments

251

2.70

12.75

1.4

2.60

2.94

g/l

0.75

172

Other noninfective disorders of lymphatic vessels and lymph nodes

4.26

12.75

1.4

1.3

2.98

2.72

g/l

0.31

Inflammatory diseases of female pelvic organs

414

2106

1.49

12.72

1.4

2.79

2.91

g/l

0.78

295

1482

Hypersensitivity pneumonitis due to organic dust

6.14

12.68

1.1

1.4

3.21

2.73

g/l

0.46

Other demyelinating diseases of the central nervous system

130

3.46

12.67

1.5

1.4

3.01

2.99

g/l

0.02

Pleural plaque

191

2.96

12.66

1.3

1.2

2.97

3.03

g/l

0.08

140

Sleep disorders

165

894

1.86

12.63

1.3

1.4

2.96

2.95

g/l

0.03

112

623

Bullous disorders

135

3.38

12.62

1.4

1.3

2.89

2.71

g/l

0.28

Scleritis and episcleritis

192

2.96

12.59

1.4

1.5

3.36

2.92

g/l

1.04

137

Diffuse large B-cell lymphoma

102

3.79

12.58

1.4

1.3

1.85

2.85

g/l

2.21

Subjective visual disturbances

170

931

1.84

12.57

1.4

1.3

2.95

2.88

g/l

0.20

126

631

Persons encountering health services for specific procedures, not carried out

236

2.75

12.56

1.4

1.3

2.96

2.99

g/l

0.04

161

Disorders of muscles

318

2.48

12.49

1.3

3.06

2.93

g/l

0.25

222

Gonarthrosis

389

1477

1.52

12.48

1.3

1.4

2.91

3.02

g/l

0.66

277

1018

Non-Hodgkin lymphoma, all

4.28

12.48

1.4

1.2

2.58

2.61

g/l

0.02

Sacroiliitis, not elsewhere classified

136

3.36

12.48

1.4

3.04

2.82

g/l

0.31

Other diseases of oesophagus

231

2.75

12.48

1.2

1.3

3.11

2.90

g/l

0.48

160

Ischemic heart diseases

489

2130

1.44

12.47

1.4

2.83

2.96

g/l

0.90

345

1460

Brachial plexus disorders

349

2.41

12.44

1.5

1.4

3.16

2.98

g/l

0.37

238

Other meningitis

5.52

12.38

1.6

1.2

2.56

2.65

g/l

0.09

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

240

930

1.68

12.20

1.2

1.4

3.07

3.05

g/l

0.06

172

660

Panic disorder

119

585

2.05

12.15

1.4

1.3

2.94

2.99

g/l

0.10

400

Coeliac disease

428

2.24

12.14

1.7

1.4

2.78

g/l

0.01

301

Nonorganic sleeping disorders

148

785

1.90

12.13

1.3

1.4

2.98

2.94

g/l

0.10

548

Failure and rejection of transplanted organs and tissues

5.87

12.06

1.3

2.62

2.60

g/l

0.02

Other bursopathies

392

2.29

11.99

1.6

1.2

2.97

2.93

g/l

0.07

266

Lichen simplex chronicus and prurigo

160

3.10

11.98

1.1

1.5

2.70

3.07

g/l

0.80

112

Special screening examination for other diseases and disorders

208

2.81

11.98

1.3

3.17

2.94

g/l

0.29

129

Postmenopausal osteoporosis with pathological fracture

120

3.47

11.95

1.3

2.04

2.74

g/l

2.22

Other peripheral vascular diseases

231

2.72

11.95

1.3

1.4

2.84

2.94

g/l

0.21

161

Hyperlipidaemia, other/unspecified

217

1223

1.69

11.89

1.5

1.4

2.64

3.04

g/l

3.19

162

828

Ovarian cyst

259

913

1.65

11.88

1.3

1.4

2.78

2.87

g/l

0.35

178

623

Aortic aneurysm

127

632

1.99

11.88

1.4

1.3

2.90

3.10

g/l

0.55

444

Chronic tubulo-interstitial nephritis

3.93

11.84

1.3

1.5

3.34

2.83

g/l

0.97

External causes of morbidity and mortality

506

1780

1.43

11.76

1.4

1.3

2.84

3.03

g/l

1.42

354

1234

Obesity, other/unspecified

237

1453

1.64

11.73

1.5

1.3

2.85

2.98

g/l

0.57

188

1007

Viral pneumonia (known virus, not influenza)

4.70

11.72

1.4

1.2

2.71

2.95

g/l

0.17

Erythema nodosum

4.09

11.71

1.6

1.4

2.84

2.69

g/l

0.17

Psoriatic arthropathies

329

2.40

11.63

1.3

3.17

3.03

g/l

0.27

226

Ulcerative rectosigmoiditis

281

2.52

11.63

1.3

2.76

3.04

g/l

0.54

196

Other disorders of conjunctiva

423

2.22

11.62

1.5

1.3

2.79

2.86

g/l

0.15

295

Cardiomyopathy

108

521

2.09

11.60

1.4

1.3

2.90

3.04

g/l

0.33

365

Other neurological diseases

438

2454

1.44

11.58

1.4

2.77

2.96

g/l

1.49

306

1698

Psoriasis vulgaris

133

692

1.94

11.58

1.2

1.3

3.23

2.94

g/l

1.04

479

Oter anti-inflammatory and antirheumatic agents, non-steroids

146

417

1.95

11.57

1.2

1.3

2.99

3.18

g/l

0.53

106

287

Hypothyroidism, strict autoimmune, 3 medication purchases required

551

2715

1.39

11.55

1.3

2.99

2.94

g/l

0.27

380

1925

Carpal tunnel syndrome

383

2358

1.47

11.54

1.4

2.93

2.98

g/l

0.24

281

1631

Chronic periodontitis

101

477

2.14

11.49

1.4

1.3

2.58

3.01

g/l

1.57

325

Ischaemic heart disease, wide definition

475

2090

1.43

11.48

1.4

2.84

2.97

g/l

0.86

328

1440

Erythema multiforme

4.76

11.48

1.3

2.58

2.70

g/l

0.09

Crohn disease (strict definition, require KELA, min 2 HDR)

225

2.71

11.46

1.2

1.3

3.97

2.97

g/l

2.65

158

Subacute thyroiditis

3.75

11.44

1.5

1.4

2.83

2.89

g/l

0.07

Fenamates

104

325

2.17

11.42

1.5

1.3

3.08

3.22

g/l

0.33

226

373

2330

1.48

11.42

1.3

1.4

2.95

3.00

g/l

0.21

224

1608

L04AC Interleukin inhibitors

165

3.02

11.41

1.3

1.4

2.95

2.99

g/l

0.04

115

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

5.51

11.41

1.5

1.2

3.42

2.71

g/l

0.66

Alcohol use disorder, Swedish definition

353

2207

1.49

11.38

1.2

1.4

2.97

3.02

g/l

0.16

212

1524

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.29

11.32

1.1

1.2

3.46

2.87

g/l

1.18

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

110

3.52

11.30

1.4

1.2

1.85

2.88

g/l

2.46

Diffuse large B-cell lymphoma, helper endpoint

110

3.52

11.30

1.4

1.2

1.85

2.88

g/l

2.46

Colectomy operation

107

520

2.07

11.30

1.4

1.3

3.25

2.83

g/l

1.26

362

Systemic lupus erythematosus, unspecified

3.73

11.29

1.4

2.87

2.70

g/l

0.15

Other external causes of accidental injury

624

2292

1.37

11.28

1.4

1.3

2.82

3.02

g/l

1.85

433

1605

Abnormal findings on examination of urine, without diagnosis

115

3.45

11.27

1.4

1.3

2.75

2.70

g/l

0.08

Crohn disease (strict definition, require KELA)

227

2.68

11.27

1.2

1.3

3.97

2.97

g/l

2.64

160

Other obstetric conditions, not elsewhere classified

241

957

1.64

11.24

1.2

1.4

3.03

3.04

g/l

0.02

174

679

Hernia of abdominal wall

279

1797

1.56

11.23

1.5

1.4

2.82

2.99

g/l

0.82

195

1254

Gout, unspecified

116

582

2.01

11.22

1.3

2.59

3.00

g/l

1.72

412

Meningitis

156

3.06

11.22

1.6

1.3

2.45

2.91

g/l

1.69

109

Faecal incontinence

199

2.79

11.22

1.4

1.2

2.56

2.77

g/l

0.30

131

Enthesopathies of lower limb, excluding foot

142

763

1.87

11.21

1.5

1.3

2.77

3.05

g/l

1.14

102

510

Acute generalized exanthematous pustulosis

131

3.26

11.13

1.5

1.3

2.04

2.75

g/l

1.78

Coxarthrosis [arthrosis of hip](FG)

280

1293

1.57

11.12

1.3

2.92

2.99

g/l

0.28

217

872

Reactive arthropathies

282

2.47

11.05

1.4

3.27

3.01

g/l

0.51

190

Hodgkin lymphoma

4.09

10.99

1.6

1.2

2.29

2.76

g/l

0.59

Substance abuse, excluding more controls

349

2064

1.48

10.99

1.3

1.4

2.81

3.08

g/l

1.84

236

1397

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

641

2914

1.35

10.95

1.4

2.85

2.95

g/l

0.66

432

2052

Viral and other specified intestinal infections

153

829

1.81

10.87

1.6

1.3

2.75

2.88

g/l

0.49

105

581

Paracetamol of NSAID medication

128

321

2.02

10.86

1.4

1.3

2.77

3.21

g/l

1.92

235

Haemolytic anaemias

3.69

10.84

1.7

1.3

2.56

2.54

g/l

0.02

Retention of urine

189

937

1.71

10.82

1.4

2.95

2.99

g/l

0.10

131

642

Injuries to the abdomen, lower back, lumbar spine and pelvis

236

1465

1.61

10.82

1.2

1.4

2.89

2.93

g/l

0.14

171

1011

Tongue abnormality

165

2.95

10.79

1.5

2.80

2.87

g/l

0.08

113

Disorders of vestibular function (Vertigo)

280

1810

1.54

10.77

1.3

1.4

2.72

2.91

g/l

1.13

186

1264

392

2439

1.44

10.75

1.3

1.4

2.99

3.00

g/l

0.05

237

1685

Extreme obesity with alveolar hypoventilation

104

3.52

10.75

1.4

1.3

2.24

2.92

g/l

0.79

Cluster headache, strict, including avohilmo

155

3.02

10.72

1.3

2.84

3.01

g/l

0.30

106

Rosacea

412

2.18

10.71

1.3

1.4

3.18

2.91

g/l

0.60

287

Trochanteric bursitis

386

2.22

10.70

1.5

1.4

2.84

2.80

g/l

0.06

267

Phlebitis and thrombophlebitis (not including DVT)

146

804

1.83

10.69

1.3

2.63

2.89

g/l

1.07

571

Disorders of plasma-protein metabolism, not elsewhere classified

7.92

10.68

1.3

2.30

2.91

g/l

—

Dental caries, including avohilmo

521

1916

1.39

10.66

1.4

1.3

2.84

2.94

g/l

0.61

352

1351

Hodgkin lymphoma, hilmo

3.98

10.62

1.6

1.3

2.29

2.93

g/l

0.86

Other abnormalities of plasma proteins

5.94

10.61

1.9

1.2

2.67

2.94

g/l

0.18

Hyperparathyroidism

104

507

2.04

10.55

1.4

1.3

2.47

2.84

g/l

1.53

350

Substance use, excluding alcohol

146

808

1.82

10.53

1.4

1.3

2.54

2.99

g/l

2.56

101

557

Dental caries 1

521

1920

1.39

10.53

1.4

1.3

2.84

2.94

g/l

0.63

352

1355

Other CVD

103

507

2.04

10.52

1.4

1.3

2.86

2.89

g/l

0.04

352

Other and unspecified rosacea

277

2.45

10.50

1.3

1.5

3.17

2.87

g/l

0.59

196

Thyroiditis

236

2.58

10.45

1.5

2.83

2.92

g/l

0.17

166

Amyloidosis

5.53

10.45

1.5

1.4

1.62

3.13

g/l

2.84

Generalized skin eruption due to drugs and medicaments

111

3.39

10.44

1.5

1.3

1.95

2.65

g/l

1.59

Cluster headache, wide,, including avohilmo

163

2.93

10.42

1.3

2.80

3.09

g/l

0.59

110

Benign neoplasm: Pancreas

4.36

10.36

1.5

1.3

2.72

g/l

—

Secondary uncertain malignant neoplasm

353

2.26

10.36

1.5

1.4

2.60

2.95

g/l

0.58

249

Disorders of calcium metabolism

169

2.88

10.34

1.3

1.4

2.57

2.95

g/l

0.77

117

Dental operations, only avohilmo

453

1639

1.42

10.32

1.4

2.96

2.94

g/l

0.09

306

1145

Menorrhagia

243

835

1.62

10.32

1.4

2.81

2.84

g/l

0.10

163

574

Optic neuritis

148

3.03

10.31

1.6

1.4

2.67

2.90

g/l

0.36

103

Isolated proteinuria

3.72

10.31

1.3

2.73

2.74

g/l

0.01

Other or ill-defined heart diseases

132

3.14

10.30

1.4

1.2

2.82

3.05

g/l

0.36

Dental caries 3 and operation codes

606

2307

1.35

10.27

1.4

2.88

2.97

g/l

0.59

414

1638

Hyperhidrosis

4.60

10.27

1.4

1.2

2.55

3.14

g/l

0.74

Spondylolisthesis/Spondylolysis

112

574

1.96

10.24

1.6

1.3

2.66

2.99

g/l

1.34

393

Chronic hepatitis NAS

5.45

10.20

1.2

3.08

2.61

g/l

—

Cytomegalovirus infection, IBD co-morbidity

4.30

10.16

1.4

1.2

2.12

2.64

g/l

0.62

Neuromuscular dysfunction of bladder

257

2.48

10.16

1.3

2.64

2.87

g/l

0.34

182

Benign neoplasm: Pancreas

4.29

10.15

1.5

1.6

2.72

g/l

—

Cerebral palsy and other paralytic syndromes

395

2.17

10.14

1.3

1.4

2.76

2.91

g/l

0.33

280

Irregular menses

323

1771

1.49

10.12

1.5

1.4

2.70

2.96

g/l

2.41

229

1267

Otalgia

270

2.44

10.10

1.7

1.3

2.48

2.85

g/l

1.19

197

Carrier of infectious disease

4.04

10.10

1.6

1.3

2.97

2.76

g/l

0.14

Other bullous disorders

4.03

10.09

1.2

1.4

2.68

2.72

g/l

0.04

Vitamin deficiency

124

3.19

10.03

1.2

1.4

2.45

2.79

g/l

0.61

Vitamin deficiency, wide

124

3.19

10.03

1.2

1.4

2.45

2.79

g/l

0.61

Synovial cyst of popliteal space [Baker]

183

2.76

10.03

1.3

3.10

2.80

g/l

0.38

129

Exophthalmic conditions

6.30

10.01

1.6

1.3

3.00

2.78

g/l

0.19

Accidents

613

2292

1.34

9.96

1.4

1.3

2.84

3.02

g/l

1.69

429

1605

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

242

2.51

9.94

1.2

1.3

3.97

2.98

g/l

2.63

169

Dystonia

173

2.82

9.93

1.4

1.5

3.05

2.86

g/l

0.25

116

Cardiomyopathy, other and unspecified

201

2.66

9.93

1.4

1.2

2.95

3.04

g/l

0.11

147

Acquired haemolytic anaemia

4.34

9.89

1.7

1.4

2.20

2.82

g/l

0.74

Hypotension

394

2.15

9.78

1.3

3.03

2.90

g/l

0.24

276

Other medical care

233

1454

1.57

9.75

1.3

1.4

2.64

2.99

g/l

1.82

164

1003

Episcleritis

164

2.85

9.72

1.5

1.4

3.51

2.96

g/l

1.19

117

Other/unspecified reactive arthropathies

221

2.57

9.72

1.4

1.3

3.33

2.96

g/l

0.67

155

Coronary atherosclerosis

394

1785

1.43

9.71

1.4

2.83

2.98

g/l

0.97

277

1215

Tuberculosis, IBD comorbidity

153

2.90

9.70

2.1

1.4

2.63

2.82

g/l

0.29

110

Achalasia of cardia

5.40

9.68

1.3

1.4

2.49

2.58

g/l

—

Neuralgia and neuritis, unspecified

132

3.07

9.68

1.4

2.47

2.77

g/l

0.69

Covid-19 suspected case

156

904

1.74

9.66

1.4

1.3

3.09

3.00

g/l

0.28

136

619

Insomnia

120

643

1.88

9.65

1.4

2.94

2.99

g/l

0.12

454

Acute bronchiolitis

224

2.48

9.65

1.4

1.3

2.53

2.48

g/l

0.08

181

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

179

1078

1.67

9.59

1.2

1.3

2.74

3.06

g/l

1.59

121

734

Cytomegaloviral disease

4.10

9.57

1.4

1.3

2.12

2.73

g/l

0.78

Viral meningitis

113

3.24

9.49

1.4

1.3

2.92

2.90

g/l

0.03

Other congenital malformations

341

2.22

9.48

1.3

1.4

3.04

2.70

g/l

0.95

250

Disorders of refraction and accommodation

190

1162

1.64

9.47

1.4

1.3

3.10

2.84

g/l

1.19

141

818

Injury, poisoning and certain other consequences of external causes

402

1415

1.43

9.45

1.5

1.3

2.81

3.00

g/l

1.47

291

948

Abnormality of white blood cells, not elsewhere classified

6.83

9.45

1.3

1.2

2.01

2.81

g/l

—

Diseases of inner ear

318

2140

1.46

9.42

1.3

1.4

2.72

2.94

g/l

1.67

207

1493

Type 2 diabetes, definitions combined

605

2727

1.33

9.42

1.4

2.87

2.99

g/l

0.86

411

1908

Mouth breathing

271

1805

1.51

9.41

1.4

2.81

2.94

g/l

0.61

181

1267

Special screening examination for infectious and parasitic diseases

149

633

1.77

9.39

1.4

1.3

2.93

3.12

g/l

0.66

111

369

Procreative management

239

1302

1.56

9.38

1.5

1.4

2.59

2.85

g/l

1.66

162

902

Falls/tendency to fall

791

3091

1.28

9.36

1.4

2.87

2.98

g/l

0.82

549

2146

Umbilical hernia

168

1004

1.68

9.30

1.5

1.4

2.97

2.99

g/l

0.04

114

702

Endometriosis

233

879

1.58

9.30

1.3

1.4

2.84

2.86

g/l

0.05

169

601

Hyperkinetic disorders, excluding more controls

385

2.12

9.28

1.3

2.79

2.94

g/l

0.39

262

conjunctival haemorrhage

191

2.65

9.27

1.6

1.3

2.95

2.93

g/l

0.02

134

Dental pulpitis 4, only avohilmo

756

3070

1.29

9.26

1.4

2.94

2.96

g/l

0.15

506

2153

Fentanyl

214

2.54

9.26

1.4

1.2

2.42

3.02

g/l

1.51

155

Benign paroxysmal vertigo

168

1006

1.68

9.24

1.3

1.4

2.63

2.87

g/l

1.22

109

699

Disorders of lipoprotein metabolism and other lipidaemias

485

2238

1.37

9.22

1.4

2.75

3.05

g/l

3.64

351

1532

Small fibre neuropathy

3.77

9.21

1.6

1.3

2.50

2.88

g/l

0.44

Other and unspecified visual disturbances

290

2.30

9.07

1.8

1.3

3.20

2.85

g/l

0.89

201

Benign neoplasm: Small intestine

106

3.26

9.07

1.2

1.5

3.00

2.72

g/l

0.35

Erosion of teeth

4.19

9.06

1.3

2.43

2.97

g/l

0.70

Etanercept

217

2.52

9.05

1.5

1.3

3.28

2.82

g/l

1.04

155

Chronic suppurative otitis media, including avohilmo

266

2.36

9.01

1.8

1.4

2.92

2.78

g/l

0.29

191

Disorders of vitreous body and globe

286

1896

1.48

9.00

1.4

2.85

2.91

g/l

0.23

209

1315

Allergic purpura

3.60

8.99

1.3

2.52

2.70

g/l

0.27

Other hearing loss

143

811

1.74

8.98

1.5

1.3

2.72

2.96

g/l

0.93

557

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

138

2.93

8.98

1.4

1.2

3.42

2.99

g/l

0.40

101

Benign neoplasm: Small intestine

107

3.23

8.94

1.2

1.4

3.00

2.82

g/l

0.21

Conductive and sensorineural hearing loss

468

2385

1.36

8.93

1.5

1.3

2.86

2.94

g/l

0.43

323

1658

Diplopia

430

2.04

8.89

1.9

1.3

2.92

2.94

g/l

0.02

304

Diabetes insipidus

5.96

8.89

1.9

1.2

2.91

g/l

—

Nummular dermatitis

219

2.49

8.87

1.4

3.12

3.10

g/l

0.02

156

Type 2 diabetes, strict (exclude DM1)

606

2760

1.31

8.83

1.4

2.87

2.99

g/l

0.83

412

1922

Injuries to the knee and lower leg

787

3553

1.27

8.81

1.5

1.4

2.77

2.99

g/l

2.88

566

2451

Other bacterial agents as the cause of diseases classified to other chapters

6.22

8.72

1.2

2.38

2.62

g/l

—

Dental caries 3

546

2093

1.34

8.72

1.4

2.87

2.97

g/l

0.61

367

1486

Unspecified/other endometriosis

347

2.15

8.70

1.5

1.4

2.67

3.02

g/l

1.08

239

Ankylosing spondylitis, ICD10

328

2.19

8.68

1.3

3.49

2.98

g/l

1.38

229

Sensorineural hearing loss

436

2234

1.37

8.63

1.5

1.3

2.83

2.95

g/l

0.70

297

1547

Haemorrhage, not elsewhere classified

3.99

8.62

1.2

1.3

2.61

3.01

g/l

0.43

Disorders of vitreous body

277

1849

1.47

8.61

1.4

2.89

2.91

g/l

0.07

200

1283

Other diseases of anus and rectum

159

956

1.67

8.60

1.2

1.4

2.76

2.99

g/l

0.92

121

664

Coxarthrosis

260

1174

1.51

8.58

1.3

1.4

2.88

3.00

g/l

0.55

200

814

Allergic urticaria

272

2.30

8.58

1.3

1.5

3.01

2.83

g/l

0.45

191

Cellulitis

137

793

1.74

8.58

1.4

1.3

2.54

2.92

g/l

1.83

109

552

Lupus erythematosus

4.12

8.56

1.2

3.10

2.69

g/l

0.44

Benign neoplasm of major salivary glands

285

2.27

8.55

1.6

1.4

2.71

2.93

g/l

0.49

197

Diabetes, insulin treatment (Kela reimbursement)

652

3090

1.29

8.53

1.4

2.86

2.96

g/l

0.70

440

2167

Benign neoplasm: salivary glands, exclude unknown (D119)

254

2.35

8.53

1.6

1.4

2.81

2.93

g/l

0.22

177

Oesophagitis

121

3.01

8.47

1.3

1.2

2.89

2.96

g/l

0.06

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.72

8.47

1.3

1.4

2.89

2.88

g/l

0.01

Benign neoplasm: Duodenum

3.95

8.46

1.2

1.5

2.92

2.65

g/l

0.29

Benign neoplasm: Ascending colon

371

2.09

8.45

1.4

1.3

2.85

g/l

0.00

258

Diabetes medication

682

3234

1.28

8.45

1.4

2.89

2.97

g/l

0.48

464

2271

Dental pulpitis 1, only avohilmo

752

3092

1.27

8.41

1.4

2.96

g/l

0.01

500

2172

Unspecified misadventure during surgical and medical care

149

2.79

8.41

1.3

1.4

3.33

2.85

g/l

0.77

103

Childhood allergy (age < 16)

115

519

1.84

8.40

1.3

2.61

2.74

g/l

0.41

369

Adenocarcinoma of pancreas

4.52

8.39

1.1

1.2

3.52

2.78

g/l

1.14

Viral encephalitis, not elsewhere classified/unspecified

4.06

8.39

1.3

2.08

2.89

g/l

1.13

Tuberculosis, wide

166

2.67

8.38

2.1

1.4

2.63

2.91

g/l

0.47

120

Supplementary factors related to causes of morbidity and mortality classified elsewhere

196

1252

1.57

8.35

1.6

1.3

3.01

2.93

g/l

0.28

143

862

Gout, strict definition

496

1.93

8.33

1.4

1.3

2.56

3.03

g/l

2.05

355

Vasomotor rhinitis (mode)

214

2.46

8.31

1.7

1.4

2.94

2.86

g/l

0.15

148

Other abnormal findings of blood chemistry

112

3.08

8.30

1.6

1.3

2.70

2.83

g/l

0.14

Other obstructive and reflux uropathy

112

3.07

8.29

1.2

1.3

3.31

2.79

g/l

0.82

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

152

829

1.68

8.28

1.3

2.64

2.90

g/l

1.33

113

590

Ulcer of oesophagus

156

2.72

8.25

1.3

1.2

3.06

3.07

g/l

0.01

105

Symptoms and signs involving emotional state

3.32

8.24

1.1

1.3

2.75

2.69

g/l

0.07

Complications of internal orthopaedic prosthetic devices, implants and grafts

119

670

1.79

8.21

1.3

1.4

2.86

2.92

g/l

0.11

463

CR(E)ST syndrome

4.65

8.18

1.4

1.3

2.62

2.58

g/l

0.04

Malignant neoplasm of pancreas

129

2.90

8.18

1.2

1.3

3.42

2.85

g/l

1.59

Other noninflammatory disorders of vulva and perineum

310

2.18

8.17

1.4

1.3

2.97

2.84

g/l

0.22

214

Benign neoplasm: Duodenum

3.83

8.11

1.2

1.3

2.92

2.86

g/l

0.05

Lesion of ulnar nerve

515

1.90

8.11

1.5

1.3

2.99

2.98

g/l

0.02

361

Juvenile arthritis (FINNGEN)

158

2.69

8.08

1.3

2.66

2.64

g/l

0.02

113

Colonic or urogenital fistula

170

1059

1.61

8.07

1.2

1.3

3.07

2.94

g/l

0.31

113

734

Duodenal ulcer

229

2.37

8.07

1.2

1.3

3.78

2.94

g/l

1.07

159

Endometriosis of pelvic peritoneum

114

629

1.80

8.06

1.4

2.95

2.89

g/l

0.12

434

Type 2 diabetes, definitions combined, including avohilmo

605

2768

1.30

8.05

1.4

2.89

2.99

g/l

0.64

407

1930

Iron deficiency anaemia secondary to blood loss (chronic)

467

1.94

8.05

1.5

1.3

2.69

2.93

g/l

0.62

326

Ulcer of lower limb, not elsewhere classified

365

2.07

8.03

1.3

2.70

2.94

g/l

0.36

254

Benign neoplasm: Ascending colon

379

2.05

8.01

1.4

2.85

2.92

g/l

0.14

264

Filling of root of tooth

3.32

7.97

1.9

1.3

2.58

2.66

g/l

0.10

STROKE

347

1721

1.40

7.97

1.3

1.4

2.77

3.02

g/l

1.87

248

1177

Acute epiglottitis

5.28

7.97

1.6

1.4

3.50

2.53

g/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.33

7.96

1.1

1.2

3.52

2.77

g/l

1.25

Fall on same level

781

3481

1.26

7.96

1.3

1.4

2.88

2.97

g/l

0.67

549

2420

Other diseases of arteries and capillaries

237

2.34

7.95

1.7

1.4

2.65

2.95

g/l

0.62

167

Heart failure and coronary heart disease

150

669

1.68

7.95

1.4

2.60

3.04

g/l

2.52

106

457

Other and unspecified disorders of vitreous body

230

1530

1.50

7.95

1.4

2.88

2.87

g/l

0.03

171

1059

Injuries to the ankle and foot

458

3138

1.33

7.94

1.4

1.3

2.97

2.95

g/l

0.09

336

2171

Vitamin D deficiency

4.03

7.94

1.1

1.4

2.42

2.44

g/l

0.02

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

225

2.38

7.93

1.5

1.4

2.64

2.89

g/l

0.43

161

Viral warts

347

2.09

7.93

1.5

1.4

2.69

2.96

g/l

0.77

238

Fibroblastic disorders

126

729

1.74

7.93

1.4

1.3

2.89

2.99

g/l

0.29

503

Other specified/unspecified bacterial intestinal infections

177

2.57

7.92

1.2

1.5

2.76

2.83

g/l

0.08

123

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.99

7.91

1.2

3.27

2.62

g/l

0.72

Hordeolum and other deep inflammation of eyelid

160

2.66

7.89

1.5

1.2

2.88

2.99

g/l

0.15

108

Acute nasopharyngitis (common cold)

399

2.01

7.88

1.3

2.79

3.03

g/l

0.62

254

Superficial injury of lower leg

155

951

1.64

7.84

1.3

2.86

2.96

g/l

0.32

120

655

Olecranon bursitis

178

2.56

7.84

1.4

1.2

2.77

2.99

g/l

0.35

122

Nonspecific lymphadenitis

208

2.43

7.84

1.5

1.3

2.98

2.87

g/l

0.17

151

Diseases of external ear

204

1336

1.53

7.80

1.3

1.4

2.84

2.91

g/l

0.23

152

928

Benign neoplasm: Descending colon

167

2.60

7.77

1.3

1.4

2.81

2.96

g/l

0.25

122

Polycystic ovarian syndrome, consortium definition

457

2061

1.34

7.77

1.4

2.70

2.94

g/l

2.59

320

1458

TMD muscular pain linked with fibromyalgia

5.21

7.74

1.9

1.4

4.11

2.78

g/l

—

Arthropathic psoriasis

398

2.00

7.73

1.3

1.4

3.08

2.94

g/l

0.30

281

Post-traumatic stress disorder

285

2.20

7.71

1.3

3.18

2.97

g/l

0.44

191

Other specified and unspecified disorders of eyelid

5.14

7.71

1.9

1.3

2.04

2.87

g/l

—

Type of accident

178

1134

1.58

7.71

1.6

1.3

3.04

2.90

g/l

0.53

130

785

Dental caries 1, only avohilmo

518

2011

1.32

7.68

1.4

1.3

2.89

2.92

g/l

0.11

349

1422

Hyperkalaemia

112

2.98

7.66

1.7

1.3

2.33

2.91

g/l

1.50

Glaucoma

296

1832

1.42

7.65

1.3

1.4

2.76

2.94

g/l

0.93

197

1285

Excessive attrition of teeth

269

996

1.47

7.63

1.5

1.4

2.95

3.04

g/l

0.30

191

674

Chronic suppurative otitis media

200

2.42

7.50

1.8

1.3

2.93

2.85

g/l

0.10

140

Stenosis and insufficiency of lacrimal passages

269

2.21

7.50

1.3

2.92

2.79

g/l

0.21

189

Other/unspecified cytomegaloviral diseases

3.99

7.48

1.4

1.2

2.10

2.73

g/l

0.74

Other coagulation defects

238

2.29

7.45

1.5

1.4

2.59

2.86

g/l

0.59

163

MS-disease / Multiple Sclerosis

270

2.21

7.45

1.4

2.58

2.97

g/l

0.96

190

Appendectomy

419

3030

1.34

7.44

1.3

1.4

2.84

2.98

g/l

0.95

281

2117

Benign neoplasm of major salivary glands

303

2.13

7.41

1.6

1.4

2.71

2.93

g/l

0.50

210

Other/unspecified synovitis and tenosynovitis

363

2.03

7.41

1.5

1.3

2.72

2.90

g/l

0.50

256

Postprocedural disorders of digestive system, not elsewhere classified

3.39

7.40

2.2

1.2

3.40

2.47

g/l

1.11

Personality disorders

189

1233

1.54

7.39

1.3

2.73

2.99

g/l

1.44

130

846

Hypertensive heart and/or renal disease

127

576

1.72

7.39

1.4

2.87

2.97

g/l

0.19

386

Fracture of lumbar spine and pelvis

110

625

1.77

7.38

1.2

1.3

2.92

2.88

g/l

0.06

431

Adhesive capsulitis of shoulder

101

561

1.81

7.35

1.3

3.03

2.91

g/l

0.31

384

Disorders of choroid and retina

462

2553

1.32

7.33

1.4

2.89

2.96

g/l

0.31

314

1775

Pneumonitis due to solids and liquids

172

2.52

7.33

1.3

1.2

2.68

2.85

g/l

0.22

125

Other follicular disorders

259

2.22

7.33

1.4

3.67

2.96

g/l

1.63

179

Thoracic aortic aneurysm

406

1.96

7.32

1.5

1.3

2.98

3.06

g/l

0.11

287

Hallux valgus (acquired)

188

879

1.55

7.30

1.5

1.4

2.96

2.93

g/l

0.08

139

609

Other and unspecified follicular disorders

110

2.95

7.30

1.5

1.3

3.78

2.96

g/l

1.06

Spondylopathies in diseases classified elsewhere

5.54

7.30

1.2

2.52

2.22

g/l

—

Adult respiratory distress syndrome

5.53

7.29

1.1

1.2

2.90

2.36

g/l

—

Cervicocranial syndrome

305

2.11

7.28

1.5

1.3

2.96

2.88

g/l

0.12

216

Benign neoplasm: Descending colon

173

2.51

7.26

1.3

1.4

2.81

2.97

g/l

0.28

119

Other retinal disorders

341

1994

1.38

7.24

1.4

2.88

2.97

g/l

0.33

227

1382

Infective dermatitis

380

1.99

7.24

1.4

1.3

3.00

2.98

g/l

0.03

274

Other embolism and thrombosis

415

1.94

7.22

1.8

1.3

3.09

2.83

g/l

0.53

293

Abnormal involuntary movements

436

1.92

7.22

1.4

1.3

2.83

2.90

g/l

0.12

306

Unspecified haematuria

224

1299

1.48

7.19

1.6

1.4

3.01

2.92

g/l

0.26

166

890

Peritonsillar abscess

118

691

1.72

7.16

1.3

2.85

3.05

g/l

0.69

449

Later onset COPD

116

525

1.74

7.16

1.1

1.4

2.74

3.00

g/l

0.95

369

Cramp and spasm

145

2.66

7.15

1.4

2.62

2.99

g/l

0.65

101

Other juvenile arthritis

145

2.66

7.15

1.3

1.4

2.68

2.73

g/l

0.06

102

Other symptoms and signs involving cognitive functions and awareness

234

1504

1.46

7.15

1.3

1.4

2.84

2.94

g/l

0.39

166

1032

Lichen planus

403

1.95

7.13

1.9

1.3

2.94

2.82

g/l

0.21

282

Other keratitis

383

1.97

7.09

1.4

2.57

2.95

g/l

0.96

270

Noninflammatory disorders of female genital tract

278

972

1.44

7.09

1.4

2.79

2.88

g/l

0.43

194

672

Cardiomyopathies, Primary/intrinsic

349

2.02

7.07

1.4

1.3

2.90

3.13

g/l

0.64

244

Ulcerative proctitis

206

2.36

7.06

1.4

1.3

2.98

3.02

g/l

0.07

147

Metatarsalgia

276

2.15

7.06

1.6

1.3

2.73

2.86

g/l

0.26

194

Disorders of adult personality and behaviour

198

1319

1.51

7.05

1.3

1.4

2.73

2.99

g/l

1.61

140

913

Other disorders of kidney and ureter

398

1.95

7.03

1.4

2.63

2.93

g/l

0.83

280

Conduction disorders

148

763

1.62

7.01

1.3

2.94

g/l

0.00

536

Excessive vomiting in pregnancy

317

2.07

7.00

1.4

1.5

2.94

2.93

g/l

0.02

219

Vascular diseases of the intestine

3.42

6.98

1.1

1.3

2.48

2.71

g/l

0.24

Other localized connective tissue disorders

4.04

6.93

1.6

1.2

2.29

2.62

g/l

—

Preparation and fitting of bite rail to mouth

102

580

1.77

6.91

1.5

1.4

3.27

2.94

g/l

1.04

405

Other endocrine disorders

212

2.30

6.89

1.3

2.42

2.40

g/l

0.03

169

Juvenile rheumatoid arthirtis

3.49

6.87

1.3

1.4

2.52

3.10

g/l

0.99

Other contact dermatitis

253

2.19

6.87

1.5

1.4

3.11

2.95

g/l

0.34

182

Phobic anxiety disorders

516

1.81

6.83

1.5

1.3

3.00

3.02

g/l

0.05

351

Non-allergic asthma

280

2.12

6.82

1.9

1.5

2.47

2.77

g/l

0.63

199

Restless leg syndrome

396

1.93

6.80

1.7

1.4

2.70

2.83

g/l

0.29

276

Other and unspecified nerve root and plexus disorders, also in other diseases

118

702

1.69

6.80

1.3

3.04

3.02

g/l

0.02

490

Decubitus ulcer and pressure area

109

2.87

6.80

1.5

1.2

2.79

2.73

g/l

0.06

Superficial injury of abdomen, lower back and pelvis

539

1.79

6.79

1.2

1.4

2.69

2.94

g/l

0.90

381

Seborrhoeic keratosis

119

710

1.68

6.78

1.6

1.3

2.83

2.79

g/l

0.09

491

Disorders of continuity of bone

321

2.04

6.77

1.5

1.3

3.11

2.90

g/l

0.31

220

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

5.13

6.74

1.3

1.2

2.98

2.37

g/l

—

Injuries to the wrist and hand

634

3674

1.25

6.71

1.3

1.4

2.82

2.98

g/l

1.58

456

2539

Eustachian salpingitis and obstruction

323

2.03

6.67

1.6

1.3

3.08

3.12

g/l

0.05

223

Calcific aortic valvular stenosis, diagnosis (helper)

130

779

1.64

6.67

1.4

2.78

2.95

g/l

0.44

548

Operations 2 for CAVS

130

779

1.64

6.67

1.4

2.78

2.95

g/l

0.44

548

Psoriatic arthropathies, ICD10

399

1.92

6.66

1.3

1.4

3.19

2.92

g/l

0.62

277

Inflammation of lacrimal passages (acute and unspecified)

4.09

6.66

1.7

1.2

3.07

2.75

g/l

0.32

Other diseases of blood and blood-forming organs

187

2.38

6.63

1.3

1.4

2.86

2.83

g/l

0.02

129

Hypertensive Heart Disease

110

524

1.72

6.62

1.5

1.3

2.93

3.00

g/l

0.10

354

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

197

1314

1.49

6.62

1.4

2.81

2.95

g/l

0.59

153

928

Vulvovaginal ulceration/inflammation in other diseases

206

2.31

6.62

1.5

1.4

3.14

3.00

g/l

0.21

146

Cardiomyopathy (excluding other)

358

1.97

6.61

1.4

1.3

2.90

3.17

g/l

0.77

249

Osteonecrosis

157

2.51

6.61

1.5

1.4

2.35

2.87

g/l

0.76

107

Dental caries 3, only avohilmo

544

2175

1.28

6.56

1.4

2.89

2.95

g/l

0.29

366

1545

Calcific aortic valvular stenosis, including rheumatic fever

130

782

1.63

6.56

1.4

2.78

2.96

g/l

0.45

551

Other enthesopathy of foot (+metatarsalgia)

305

2.05

6.53

1.5

1.3

2.75

2.88

g/l

0.25

211

Unspecified fall

281

2012

1.39

6.53

1.5

1.4

2.81

2.90

g/l

0.36

188

1405

Calcific aortic valvular stenosis, operated

130

784

1.63

6.52

1.4

2.78

2.95

g/l

0.42

553

Calcific aortic valvular stenosis

130

784

1.63

6.52

1.4

2.78

2.95

g/l

0.42

553

Artrosis, including avohilmo

539

2316

1.28

6.51

1.3

1.4

2.91

3.01

g/l

0.61

382

1579

Glaucoma suspect

190

1279

1.49

6.47

1.4

2.67

2.90

g/l

1.24

128

891

Nail disorders

273

2.11

6.46

1.2

1.4

2.78

2.97

g/l

0.41

192

Adjustment and management of implanted device

504

1.79

6.43

1.1

1.3

2.68

3.03

g/l

1.09

357

Dental pulpitis 2

442

1727

1.31

6.42

1.4

1.3

2.86

2.95

g/l

0.49

298

1219

Glucagon-like peptide-1 (GLP-1) analogues

298

1785

1.38

6.41

1.3

1.4

2.88

2.96

g/l

0.32

208

1223

Fracture of rib(s), sternum and thoracic spine

157

1017

1.55

6.41

1.2

1.3

2.76

2.95

g/l

0.75

116

700

Presence of cardiac and vascular implants and grafts

217

1130

1.46

6.35

1.4

2.80

3.03

g/l

1.22

165

785

Cardiodefibrillation

179

1194

1.50

6.33

1.3

1.4

2.73

2.96

g/l

0.84

108

830

Kidney transplant status

179

2.38

6.32

1.7

1.3

2.28

2.77

g/l

0.68

129

Injuries to the thorax

243

1723

1.41

6.29

1.3

1.4

2.88

2.99

g/l

0.42

179

1180

Dental pulpitis 2, only avohilmo

451

1772

1.31

6.28

1.4

1.3

2.86

2.94

g/l

0.45

303

1257

Complications following infusion, transfusion and therapeutic injection

4.51

6.27

1.5

1.3

2.70

2.78

g/l

—

Acne

386

1.90

6.27

1.3

3.22

2.82

g/l

1.22

266

Anogenital herpesviral [herpes simplex] infection

224

2.21

6.26

1.5

1.4

2.89

2.93

g/l

0.07

153

Hard cardiovascular diseases

454

2252

1.30

6.26

1.3

1.4

2.74

2.97

g/l

2.08

329

1523

Pure hypercholesterolaemia

396

2018

1.32

6.25

1.4

2.77

3.05

g/l

2.44

284

1376

Disorder of the sleep-wake schedule

3.73

6.24

1.3

2.81

2.57

g/l

0.19

Other specified and unspecified retinal disorders

3.09

6.21

1.6

1.2

2.70

2.74

g/l

0.03

Other protozoal intestinal diseases

4.05

6.21

1.5

1.3

2.45

2.71

g/l

0.24

Tuberculosis

132

2.60

6.21

1.9

1.3

2.68

2.89

g/l

0.25

Other disorders of eyelid

223

1508

1.43

6.18

1.5

1.3

2.69

2.88

g/l

0.95

163

1056

Perforation of tympanic membrane

305

2.02

6.18

1.3

1.4

2.97

2.96

g/l

0.02

215

Disorders resulting from impaired renal tubular function

2.87

6.12

1.3

2.03

2.68

g/l

1.25

Lesion of lateral popliteal nerve

139

2.55

6.12

1.4

1.3

3.13

2.96

g/l

0.19

Prurigo nodularis

3.81

6.11

1.1

1.4

2.30

2.94

g/l

1.11

Abnormal blood-pressure reading, without diagnosis

2.86

6.11

1.5

1.4

2.48

3.07

g/l

1.04

Use of pramipexole

120

739

1.63

6.10

1.4

2.74

2.86

g/l

0.26

515

Substance abuse

349

2517

1.33

6.08

1.3

1.4

2.81

3.02

g/l

1.31

236

1717

Mental and behavioural disorders due to tobacco

280

2.05

6.07

1.3

1.4

2.27

2.98

g/l

2.63

190

Autoimmune thyroiditis

3.66

6.07

1.3

1.2

2.74

2.85

g/l

0.10

Acute peritonitis

164

2.40

6.05

1.5

1.3

3.27

2.90

g/l

0.29

116

Lateral epicondylitis

463

1.80

6.05

1.5

1.3

2.66

2.93

g/l

0.91

315

Other sleep disorders

342

1.94

6.04

1.4

2.76

2.89

g/l

0.27

250

Other aneurysm

123

2.63

5.98

1.6

1.3

2.89

2.88

g/l

0.01

Other and unspecified psoriasis

190

2.28

5.97

1.2

1.5

3.00

2.94

g/l

0.06

133

Smoking dependency

282

2.04

5.96

1.3

1.4

2.27

2.99

g/l

2.69

191

Atypical facial pain

147

2.48

5.96

1.6

1.4

2.85

2.99

g/l

0.20

102

Sudden idiopathic hearing loss

297

2.00

5.88

1.8

1.3

2.96

2.98

g/l

0.03

209

Barrett oesophagus

107

2.74

5.87

1.5

1.2

3.18

3.01

g/l

0.23

Polyuria

123

770

1.61

5.86

1.4

1.3

3.08

2.94

g/l

0.35

541

Crohn disease (strict definition, all UC cases excluded)

173

2.34

5.85

1.2

1.3

3.98

2.82

g/l

2.03

121

Corneal ulcer

114

702

1.63

5.82

1.6

1.3

2.87

2.95

g/l

0.20

492

Mental and behavioural disorders due to psychoactive substance use

359

2584

1.31

5.82

1.3

1.4

2.80

3.01

g/l

1.29

239

1771

Peripheral artery disease

199

1107

1.45

5.79

1.4

2.64

2.96

g/l

1.60

150

756

Elevated blood glucose level

245

2.10

5.78

2.1

1.3

2.84

2.86

g/l

0.04

165

Trigeminal neuralgia

174

2.32

5.77

1.7

1.4

2.50

2.91

g/l

1.00

123

Idiopathic gout

232

2.13

5.76

1.4

1.3

2.72

3.00

g/l

0.53

162

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

144

2.46

5.72

1.3

1.4

2.12

2.58

g/l

0.78

108

Other and unspecified myopathies

213

2.18

5.72

1.5

1.4

2.88

2.94

g/l

0.07

149

Other diseases of gallbladder

2.99

5.69

1.2

1.3

2.51

2.94

g/l

0.73

Other disorders of optic [2nd] nerve and visual pathways

188

2.26

5.68

1.5

1.3

2.79

g/l

0.00

134

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

566

2687

1.25

5.67

1.3

1.4

2.74

3.03

g/l

3.01

380

1888

Drug-induced neutropenia

214

2.17

5.67

1.4

1.5

2.51

2.89

g/l

0.52

147

Malignant neoplasm, wide definition for exclusion

566

2688

1.25

5.66

1.3

1.4

2.74

3.03

g/l

3.01

380

1888

Heterophoria

295

1.98

5.64

1.6

1.5

3.15

2.78

g/l

0.61

203

Ganglion

122

770

1.59

5.64

1.5

1.3

2.91

2.95

g/l

0.10

526

Atherosclerosis, excluding cerebral and coronary sclerosis

183

1000

1.47

5.64

1.4

2.66

2.97

g/l

1.39

134

692

Iron deficiency

3.34

5.61

1.2

3.01

2.80

g/l

0.20

Other and unspecified diseases of blood and blood-forming organs

3.33

5.61

1.4

1.3

3.12

2.61

g/l

0.30

Intestinal adhesions without obstruction

202

2.19

5.59

1.7

1.4

2.71

3.01

g/l

0.47

144

Open wound of lower leg

490

1.74

5.57

1.6

1.3

2.28

3.01

g/l

4.40

345

Disturbance of activity and attention

440

1.79

5.57

1.4

2.75

2.81

g/l

0.13

316

Infections with a predominantly sexual mode of transmission

199

1394

1.43

5.56

1.3

1.4

2.89

3.03

g/l

0.56

141

952

Appendicitis, broad definition

463

3355

1.26

5.56

1.4

2.90

3.00

g/l

0.66

303

2334

Other and unspecified glaucoma

152

2.39

5.55

1.6

1.3

2.53

2.80

g/l

0.38

106

Correction of physiology of bite - very demanding therapy visit

2.88

5.54

1.4

3.11

2.82

g/l

0.28

Other psoriatic arthropathies

389

1.84

5.53

1.3

1.4

3.22

2.91

g/l

0.69

271

Other extrapyramidal and movement disorders in other diseases

124

790

1.58

5.52

1.5

1.3

2.84

2.85

g/l

0.02

551

Otitis externa

136

885

1.54

5.52

1.3

2.89

g/l

0.00

110

618

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

564

2687

1.24

5.50

1.3

1.4

2.74

3.03

g/l

2.89

378

1887

Impetigo

153

2.38

5.49

1.4

1.2

2.30

2.72

g/l

0.84

112

Desensitization to allergens

217

2.14

5.49

1.3

1.4

2.56

2.75

g/l

0.41

148

Artificial joint operation, meniscal resection

528

2817

1.25

5.49

1.4

2.89

2.97

g/l

0.45

354

1956

Dislocation, sprain and strain of joints and ligaments of knee

382

2752

1.29

5.49

1.4

1.3

2.86

3.04

g/l

1.36

265

1888

Oesophageal varices

2.80

5.48

1.8

1.3

3.11

2.74

g/l

0.31

Diseases of appendix

465

3366

1.26

5.48

1.4

2.89

3.00

g/l

0.79

305

2342

Superficial injury of hip and thigh

405

1.81

5.44

1.3

2.88

2.92

g/l

0.06

282

Abrasion of teeth

171

853

1.48

5.44

1.3

1.4

2.98

3.10

g/l

0.34

122

569

Acute appendicitis, no complications

351

2692

1.30

5.43

1.4

2.91

3.01

g/l

0.54

230

1872

Benign neoplasm of mouth and pharynx

356

1.87

5.41

1.4

1.3

2.50

2.91

g/l

1.36

244

Localized scleroderma [morphea]

4.20

5.39

1.5

1.2

2.48

2.57

g/l

—

Contact with and exposure to communicable diseases

215

1532

1.40

5.37

1.4

2.80

2.94

g/l

0.45

111

1091

Haemorrhage in early pregnancy

180

1217

1.45

5.36

1.2

1.4

2.70

2.93

g/l

0.96

132

865

Familial hypercholesterolemia

459

1.75

5.35

1.6

1.4

2.50

2.93

g/l

1.65

316

Injuries to the head

690

3717

1.21

5.33

1.5

1.3

2.83

2.97

g/l

1.26

479

2592

Myeloid leukaemia

3.32

5.32

1.5

1.3

2.55

2.76

g/l

0.13

Benign neoplasm of mouth and pharynx

358

1.86

5.32

1.4

2.50

2.91

g/l

1.34

247

Erosion of teeth, including avohilmo

125

777

1.56

5.32

1.3

1.4

2.74

3.05

g/l

1.11

525

Type 1 diabetes

159

1077

1.48

5.31

1.4

1.3

2.85

2.93

g/l

0.20

108

761

Generalized anxiety disorder

589

1.66

5.28

1.3

2.92

3.00

g/l

0.20

396

Other maternal disorders predominantly related to pregnancy

364

1761

1.30

5.27

1.2

1.4

3.00

2.89

g/l

0.50

259

1252

Specific personality disorders

157

1064

1.48

5.27

1.3

1.4

2.73

2.99

g/l

1.30

113

733

Acne vulgaris

289

1.95

5.25

1.2

1.3

3.28

2.85

g/l

0.98

199

Benign neoplasm: Rectum, anus and anal canal

101

621

1.63

5.23

1.5

1.4

2.72

2.99

g/l

1.03

437

Neovascular glaucoma

2.78

5.21

1.4

1.3

2.87

2.59

g/l

0.31

Mature T/NK-cell lymphomas, hilmo

4.09

5.20

1.3

1.2

2.98

2.27

g/l

—

Papilloedema, unspecified

3.27

5.19

1.4

3.07

2.48

g/l

0.57

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

263

1.99

5.17

1.3

2.53

3.07

g/l

1.00

179

Chronic Coagulation defects

2.98

5.17

1.7

1.3

2.69

2.52

g/l

0.15

Dermatophytosis

420

1.77

5.16

1.6

1.4

3.22

2.90

g/l

0.68

295

Gonarthrosis,primary

499

2520

1.25

5.12

1.3

1.4

2.90

2.97

g/l

0.38

350

1751

Normotensive glaucoma

184

2.19

5.09

1.5

1.3

2.70

2.83

g/l

0.17

133

3.13

5.09

1.2

1.3

3.24

2.83

g/l

0.36

Atrophic disorders of skin

504

1.70

5.08

1.5

1.4

2.66

2.79

g/l

0.32

351

Other hammer toe(s) (acquired)

464

1.70

5.08

1.5

3.05

2.87

g/l

0.45

318

Dialysis

128

2.45

5.06

1.4

1.3

2.43

2.69

g/l

0.28

Oral lichen ruber planus, including avohilmo

185

2.18

5.04

1.5

2.98

2.87

g/l

0.14

130

Pacemaker

141

917

1.50

5.03

1.2

1.4

2.78

2.94

g/l

0.42

649

Squamous cell neoplasms and carcinomas of the skin

245

2.01

5.02

1.1

1.3

2.58

2.89

g/l

0.57

179

Plantar fascial fibromatosis

294

1.92

5.01

1.4

1.3

2.75

2.89

g/l

0.30

205

Lichen simplex chronicus

2.84

4.99

1.2

1.3

3.09

3.10

g/l

0.01

Myocardial infarction

250

1323

1.36

4.99

1.3

1.4

2.82

2.98

g/l

0.76

178

876

Testicular hypofunction

105

2.61

4.99

1.4

1.2

2.90

3.11

g/l

0.16

Benign neoplasm: Parotid gland

226

2.05

4.96

1.5

1.4

2.95

2.99

g/l

0.06

155

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

171

1194

1.44

4.94

1.2

1.3

2.96

3.01

g/l

0.14

121

819

Myeloid leukaemia

3.16

4.93

1.5

1.3

2.55

2.65

g/l

0.06

Hyperkinetic disorders

487

1.69

4.92

1.3

1.4

2.79

2.76

g/l

0.05

353

Diseases of peritoneum

310

1.88

4.92

1.5

1.4

3.27

2.94

g/l

0.38

215

Extrapyramidal and movement disorders

187

1328

1.41

4.92

1.5

1.4

2.81

2.90

g/l

0.27

126

916

Female infertility

184

794

1.44

4.91

1.4

2.95

2.89

g/l

0.17

133

548

Other and unspecified coagulation defects

155

2.28

4.90

1.5

1.4

2.42

2.88

g/l

0.99

109

Malignant neoplasm of breast

155

1613

0.69

4.90

1.2

1.4

2.73

2.82

g/l

0.28

100

1147

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

12.25

4.87

2.3

1.3

1.95

2.09

g/l

—

Superficial injury of wrist and hand

127

839

1.52

4.87

1.4

2.61

2.95

g/l

1.87

585

Allergic contact dermatitis

503

1.68

4.86

1.3

1.4

2.90

2.87

g/l

0.06

353

Benign neoplasm: Parotid gland

228

2.03

4.86

1.5

1.4

2.95

2.94

g/l

0.01

156

Arthropathies in other diseases classified elsewhere

2.73

4.86

1.4

1.3

2.66

3.01

g/l

0.31

Disorder of lipoprotein metabolism, unspecified

391

1.77

4.85

1.3

1.4

3.00

g/l

0.01

268

Paralytic strabismus

188

2.14

4.85

1.7

1.4

3.30

2.92

g/l

0.51

130

Other abnormal uterine and vaginal bleeding

134

632

1.52

4.85

1.2

1.4

3.00

2.79

g/l

0.64

432

AV-block

380

1.75

4.85

1.2

1.3

3.29

3.11

g/l

0.23

275

Visual impairment including blindness (binocular or monocular)

162

2.24

4.85

1.1

1.3

2.92

2.67

g/l

0.35

119

Benign neoplasm: Rectum

557

1.64

4.84

1.5

1.4

2.72

2.98

g/l

0.84

389

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

209

1329

1.39

4.83

1.3

1.4

2.70

3.01

g/l

1.31

135

930

Glaucoma secondary to other eye disorders

2.66

4.83

1.4

1.3

2.87

2.78

g/l

0.09

Anti-inflammatory and antirheumatic products, non-steroids

175

606

1.46

4.83

1.3

2.71

3.09

g/l

2.28

128

423

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

249

1.98

4.81

1.1

1.4

2.58

3.06

g/l

1.06

180

Other epidermal thickening

119

2.46

4.81

1.4

1.3

2.44

2.75

g/l

0.65

Other disorders of bladder

327

1.85

4.80

1.3

1.2

3.64

2.91

g/l

1.42

231

Respiratory tuberculosis

119

2.46

4.80

2.1

1.3

2.57

2.79

g/l

0.27

Respiratory tuberculosis, confirmed and not-confirmed

119

2.46

4.80

2.1

1.3

2.57

2.79

g/l

0.27

Injuries to the shoulder and upper arm

489

3326

1.23

4.79

1.4

3.03

2.93

g/l

0.57

352

2295

Other superficial mycoses

3.21

4.79

1.6

1.3

2.94

2.63

g/l

0.29

Abdominal aortic aneurysm (AAA)

207

2.07

4.78

1.3

1.2

2.62

3.08

g/l

1.29

149

Injury of muscle and tendon at forearm level

3.33

4.77

1.3

3.62

2.68

g/l

0.65

Benign neoplasm: Pituitary gland, craniopharyngeal duct

157

2.25

4.76

1.4

1.3

2.96

2.88

g/l

0.07

110

Otitis externa, unspecified

394

1.76

4.75

1.4

2.92

2.90

g/l

0.03

276

Lichen ruber planus, wide definition including periferal and oral lichen planus

117

764

1.54

4.74

1.7

1.4

3.08

2.84

g/l

0.62

522

Hypertrophic disorders of skin

190

2.12

4.73

1.3

1.4

2.96

g/l

0.01

134

Opening and dilatation of root channel of tooth

217

2.05

4.72

1.8

1.3

2.31

3.05

g/l

2.68

150

Impingement syndrome of shoulder

130

869

1.50

4.72

1.4

1.3

2.85

2.95

g/l

0.25

599

Unspecific neurodegenerative disorder

759

0.57

4.72

1.2

1.4

2.71

2.92

g/l

0.51

531

Other disorders of patella

101

639

1.59

4.70

1.2

1.4

3.14

3.00

g/l

0.45

430

Unspecified nephritic syndrome

3.06

4.69

1.5

1.3

2.77

2.69

g/l

0.09

Chronic mastoiditis

3.06

4.69

1.9

1.3

2.88

2.70

g/l

0.18

Heart failure and hypertrophic cardiomyopathy

3.75

4.67

1.4

1.1

2.16

2.51

g/l

—

Other disorders starting during childhood or adolecense, excluding more controls

184

2.12

4.66

1.3

2.19

2.57

g/l

0.94

140

Convalescence

165

2.20

4.66

1.5

1.4

2.86

2.93

g/l

0.08

116

Striking against or struck by other objects

199

1443

1.38

4.65

1.4

1.3

2.66

2.96

g/l

1.66

133

1002

Other/unspecified enthesopathies, not elsewhere classified

253

1.95

4.63

1.8

1.3

3.13

2.86

g/l

0.54

180

Valvular operations

397

1.75

4.62

1.5

1.3

2.88

3.01

g/l

0.22

283

Fracture at wrist and hand level

204

1489

1.37

4.58

1.3

1.4

2.86

2.98

g/l

0.40

137

1015

Speech and linguistic disorders, excluding more controls

272

1.88

4.56

1.2

1.3

2.64

2.72

g/l

0.17

194

Sleep disorders, other/unspecified

110

2.49

4.56

1.2

1.3

3.24

2.68

g/l

0.86

Benign neoplasm: Rectum

566

1.62

4.56

1.5

1.3

2.72

2.90

g/l

0.52

390

Convergence insufficiency and excess

3.89

4.56

1.2

1.4

3.11

2.72

g/l

—

Acute gastritis

193

2.09

4.55

1.5

1.4

2.67

2.78

g/l

0.19

134

Congenital malformations of the urinary system

200

2.07

4.55

1.2

1.3

3.26

2.77

g/l

0.69

147

Arterial embolism and thrombosis

116

2.43

4.54

1.3

1.2

2.05

2.89

g/l

1.91

Maternal care for other conditions predominantly related to pregnancy

137

921

1.47

4.54

1.2

1.4

2.85

3.01

g/l

0.55

659

Osteomyelitis

167

2.17

4.53

1.6

1.2

2.74

2.92

g/l

0.23

119

Pure hyperglyceridaemia

3.19

4.50

1.5

2.81

2.95

g/l

—

Hyperfunction of pituitary gland

161

2.19

4.50

1.3

2.23

2.91

g/l

2.76

109

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

105

678

1.56

4.50

1.4

2.75

2.89

g/l

0.31

468

Recurrent dislocation of patella

161

2.19

4.50

1.1

1.4

2.90

2.97

g/l

0.08

106

Panniculitis affecting regions of neck and back

2.67

4.50

1.6

1.4

2.96

2.86

g/l

0.11

Endometriosis ASRM stages 1,2

116

766

1.52

4.49

1.4

2.95

2.89

g/l

0.13

534

Injuries to the neck

137

936

1.47

4.49

1.4

1.3

2.76

2.97

g/l

0.82

102

644

Bell's palsy

401

1.73

4.48

1.4

1.3

2.17

2.93

g/l

4.58

281

Other disorders of gingiva or/and edentulous alveolar ridge

142

2.27

4.48

1.2

1.4

2.58

2.86

g/l

0.35

101

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

214

1226

1.36

4.48

1.4

3.00

3.03

g/l

0.08

139

859

Benign neoplasm: Rectum, anus and anal canal

101

647

1.57

4.48

1.5

1.3

2.72

2.95

g/l

0.81

451

Other and unspecified epidermal thickening

2.80

4.47

1.4

1.3

2.37

2.76

g/l

0.72

Myocardial infarction, without ST-elevation

173

1137

1.41

4.46

1.3

1.4

2.88

2.96

g/l

0.26

133

777

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

4.08

4.46

2.1

1.2

2.34

2.79

g/l

—

Other specified/unspecified dorsopathies

2.79

4.46

1.6

1.7

3.05

2.90

g/l

0.12

Malignant neoplasm of breast, HER2-negative

152

1586

0.70

4.45

1.2

1.4

2.72

2.82

g/l

0.29

1131

Female infertility, cervigal, vaginal, other or unspecified origin

166

780

1.43

4.44

1.4

2.92

2.89

g/l

0.09

121

538

Autoimmune hyperthyroidism

162

2.18

4.43

1.3

1.4

2.81

2.92

g/l

0.15

118

Trigger finger

463

1.67

4.42

1.3

3.14

2.90

g/l

0.53

319

Acute appendicitis

424

3233

1.24

4.41

1.4

2.88

3.01

g/l

0.87

280

2258

Presbycusis

270

1.89

4.41

1.5

1.2

2.30

3.00

g/l

2.27

189

Follicular lymphoma

112

2.44

4.40

1.7

1.4

2.13

2.85

g/l

1.24

Oral leukoplakia and related diseases, including avohilmo

265

1.90

4.40

1.3

1.4

2.45

2.94

g/l

1.42

182

Right bundle-branch block

2.84

4.40

1.1

1.2

2.43

2.95

g/l

0.83

Benign neoplasm: Pituitary gland, craniopharyngeal duct

163

2.17

4.38

1.4

2.96

2.92

g/l

0.03

113

Tubulo-interstitial nephritis, not specified as acute or chronic

163

2.16

4.37

1.2

1.3

2.96

2.78

g/l

0.19

114

Cholesteatoma of middle ear

131

2.31

4.36

1.9

1.3

2.76

2.87

g/l

0.09

Urethritis and urethral syndrome

3.24

4.35

1.4

1.3

2.52

2.66

g/l

—

Psychotic depression

170

2.13

4.34

1.2

1.5

3.25

3.03

g/l

0.22

113

Scar conditions and fibrosis of skin

119

2.38

4.33

1.2

1.4

2.56

2.96

g/l

0.63

Ptosis of eyelid

295

1.84

4.33

1.8

1.4

2.47

2.82

g/l

0.99

205

Other disorders of the musculoskeletal system and connective tissue

505

1.63

4.31

1.5

1.4

2.57

2.87

g/l

0.86

360

Contusion of toe(s) without damage to nail

2.82

4.30

1.1

1.2

2.73

2.66

g/l

0.05

Intracranial injury

323

2456

1.27

4.27

1.6

1.4

2.83

2.96

g/l

0.70

226

1696

Amenorrhoea

268

1.88

4.26

1.8

1.4

2.50

3.03

g/l

1.74

183

Follicular lymphoma, hilmo

114

2.39

4.24

1.7

1.4

2.13

2.75

g/l

0.97

Primary open-angle glaucoma, strict

113

750

1.51

4.24

1.3

1.4

2.86

g/l

0.00

524

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

276

1862

1.30

4.24

1.5

1.4

3.10

2.89

g/l

1.14

203

1324

Acute posthaemorrhagic anaemia

2.86

4.23

1.3

1.2

3.22

2.60

g/l

—

Gluteal tendinitis

2.58

4.23

1.4

1.7

2.20

2.92

g/l

1.71

Bruxism

2.79

4.21

1.3

1.4

3.87

2.81

g/l

—

Other disorders of nervous system

186

2.06

4.20

1.4

1.5

2.49

2.92

g/l

1.02

133

Other specified disorders of muscle

2.93

4.18

1.6

1.2

3.52

2.75

g/l

1.07

Primary open-angle glaucoma

137

925

1.45

4.18

1.3

1.4

2.87

2.85

g/l

0.04

640

Schizophrenia

681

0.50

4.17

1.1

1.4

2.42

3.04

g/l

1.56

464

Benign neoplasm of other and unspecified endocrine glands

448

1.66

4.17

1.4

2.89

2.92

g/l

0.04

314

Endometriosis of rectovaginal septum and vagina

256

1.89

4.16

1.5

1.3

2.58

2.87

g/l

0.65

176

Thyrotoxicosis

137

952

1.44

4.14

1.5

1.4

2.94

2.84

g/l

0.29

651

Other erythematous conditions

2.50

4.14

1.3

1.4

2.48

2.75

g/l

0.36

Left ventricular outflow tract obstruction (LVOTO), broad definition

396

1.70

4.14

1.6

1.3

2.85

2.90

g/l

0.05

281

DVT of lower extremities

613

1.56

4.12

1.4

1.3

3.03

2.82

g/l

0.42

429

Persistent mood disorders

111

741

1.50

4.12

1.3

2.81

2.90

g/l

0.22

502

Other and unspecified aplastic anaemias

3.84

4.11

1.4

1.3

3.58

2.19

g/l

—

Other local infections of skin and subcutaneous tissue

315

1.79

4.10

1.4

1.3

2.65

2.98

g/l

0.68

221

Propionic acid derivatives

170

606

1.41

4.09

1.3

2.73

3.09

g/l

2.08

123

423

Viral hepatitis, IBD co-morbidity

110

2.38

4.07

1.0

1.2

3.15

3.34

g/l

0.15

Other symptoms and signs involving general sensations and perceptions

2.58

4.06

1.2

1.3

2.98

2.58

g/l

0.38

Benign neoplasm: Sigmoid colon

568

1.57

4.05

1.4

2.63

2.98

g/l

1.41

400

Injuries to the hip and thigh

228

1580

1.32

4.04

1.3

1.4

2.86

2.92

g/l

0.23

172

1087

Poisoning by medicine

134

933

1.44

4.03

1.2

1.4

2.74

2.97

g/l

0.74

635

Alcohol abuse, main dg, excluding more controls

522

1.60

4.03

1.3

3.01

3.07

g/l

0.10

350

Scoliosis

259

1.86

4.02

1.3

1.4

2.63

2.87

g/l

0.44

183

Other (not insulin) diabetes medications

567

2856

1.20

4.02

1.3

1.4

2.91

2.98

g/l

0.45

397

1986

Angina pectoris

295

1554

1.28

4.01

1.5

1.4

2.85

2.96

g/l

0.53

198

1042

Spontaneous rupture of synovium and tendon

217

1.95

4.01

1.9

1.3

2.74

2.85

g/l

0.13

151

Other acquired deformities of musculoskeletal system and connective tissue

143

2.19

4.00

2.0

1.3

2.55

2.96

g/l

0.58

Mixed and other personality disorders

318

1.77

3.99

1.5

1.4

2.89

3.02

g/l

0.17

227

Other and unspecified local infections of skin and subcutaneous tissue

296

1.80

3.99

1.4

1.3

2.69

2.98

g/l

0.51

207

Testicular dysfunction

124

2.29

3.98

1.4

1.2

2.82

3.16

g/l

0.28

Radial styloid tenosynovitis [de Quervain]

163

2.10

3.98

1.7

1.3

3.04

2.93

g/l

0.19

114

Vitamin B12 deficiency anaemia

260

1.85

3.97

1.1

1.4

3.51

2.90

g/l

1.12

181

Open wound of ankle and foot

348

1.73

3.97

1.3

3.04

2.94

g/l

0.12

243

Nonpyogenic thrombosis of intracranial venous system

3.74

3.96

1.2

1.3

3.76

2.76

g/l

—

Alcoholic liver disease

290

1.80

3.94

1.2

1.3

3.22

2.95

g/l

0.35

201

2.53

3.93

1.3

1.2

2.99

2.71

g/l

0.37

Mixed conductive and sensorineural hearing loss

349

1.73

3.93

1.3

2.95

2.90

g/l

0.08

244

Melanocytic naevi

163

1180

1.39

3.93

1.4

2.65

2.99

g/l

1.75

131

835

Alzheimer disease, including avohilmo

607

0.56

3.92

1.2

1.3

2.61

2.89

g/l

0.80

430

Benign neoplasm of other and unspecified endocrine glands

456

1.63

3.92

1.4

1.3

2.89

2.87

g/l

0.04

322

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

139

1280

0.71

3.92

1.1

1.4

2.72

2.93

g/l

0.74

917

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

139

1280

0.71

3.92

1.1

1.4

2.72

2.93

g/l

0.74

917

Hypertrophic cardiomyopathy

106

2.38

3.91

1.4

1.3

2.17

2.72

g/l

1.12

Herpesviral keratitis and keratoconjunctivitis

106

2.38

3.91

1.6

1.3

3.37

2.86

g/l

0.43

Occupational exposure to risk-factors

2.53

3.89

1.7

1.3

3.66

2.93

g/l

0.75

Respiratory tuberculosis, not confirmed

2.58

3.89

2.3

1.3

2.54

2.73

g/l

0.21

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

488

1.61

3.88

1.4

2.27

2.94

g/l

2.29

343

Hydronephrosis

306

1.77

3.88

1.5

1.4

2.84

2.98

g/l

0.27

220

Poisoning by drugs, medicaments and biological substances

147

1049

1.41

3.87

1.3

1.4

2.74

2.99

g/l

0.83

103

726

Hemiplegia

132

2.21

3.86

1.3

2.74

2.88

g/l

0.13

Type 1 diabetes, wide definition, subgroup 1

121

833

1.46

3.85

1.4

1.3

2.84

2.93

g/l

0.20

617

Other diseases of spinal cord

2.70

3.83

1.3

2.60

2.64

g/l

0.02

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

101

2.40

3.82

2.1

1.3

3.40

2.76

g/l

0.77

Other/unspecified enthesopathies of lower limb, excluding foot

214

1.93

3.82

1.2

1.4

3.25

2.90

g/l

0.46

152

Lichen planus, including avohilmo

657

1.51

3.81

1.7

1.4

3.10

2.83

g/l

0.64

446

Chronic periodontitis, complicated

309

1.76

3.77

1.4

2.59

2.99

g/l

1.20

215

Other disorders of glucose regulation and pancreatic internal secretion

265

1.82

3.77

1.7

1.3

2.93

2.92

g/l

0.02

182

Campylobacter enteritis

2.67

3.74

1.3

1.4

3.03

2.58

g/l

0.47

Dental caries 2 and operation codes

474

3130

1.20

3.74

1.4

1.3

3.04

2.91

g/l

0.79

360

2177

Sequelae of injuries, of poisoning and of other consequences of external causes

136

964

1.42

3.74

1.4

1.3

2.89

2.94

g/l

0.10

666

Speech therapy

144

1031

1.40

3.73

1.5

1.3

2.71

2.90

g/l

0.72

133

708

Flat foot [pes planus] (acquired)

266

1.81

3.73

1.3

1.4

2.95

2.94

g/l

0.02

185

Problems related to lifestyle

355

1.70

3.72

1.4

1.3

2.94

3.00

g/l

0.08

241

Other problems related to primary support group, including family circumstances

504

1.58

3.71

1.4

2.69

2.78

g/l

0.24

368

Ventral hernia

122

849

1.44

3.71

1.4

1.3

2.72

2.87

g/l

0.42

589

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

179

1330

1.35

3.70

1.2

1.4

2.74

3.00

g/l

1.19

121

932

Myocardial infarction, strict

222

1234

1.32

3.69

1.3

1.4

2.86

2.98

g/l

0.51

159

817

Hyperaldosteronism

2.72

3.67

1.4

1.2

2.79

2.82

g/l

0.03

Hidradenitis suppurativa

129

2.19

3.65

1.3

3.68

2.84

g/l

1.29

D07AA Corticosteroids, weak (group I)

655

1.50

3.65

1.4

2.80

g/l

0.01

476

174

1212

1.35

3.64

1.5

1.4

2.68

2.96

g/l

1.28

125

825

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.44

3.64

1.5

1.2

3.08

2.85

g/l

0.13

Visual field defects

232

1.86

3.64

1.5

1.3

2.92

2.88

g/l

0.06

162

Impotence

149

2.10

3.63

1.4

1.3

2.84

3.25

g/l

0.72

Disorders of tooth development and eruption

192

1.94

3.60

1.3

2.23

2.69

g/l

0.85

144

Chromosomal abnormalities, not elsewhere classified

104

2.34

3.60

1.4

1.3

2.21

2.38

g/l

0.17

Thyrotoxicosis, other and/or unspecified

107

731

1.47

3.60

1.4

2.90

2.84

g/l

0.14

511

Abnormalities of gait and mobility

329

1.71

3.58

1.4

1.3

2.26

2.91

g/l

1.85

239

Oesophageal obstruction

2.67

3.57

1.2

3.43

2.88

g/l

0.53

Other condition

523

1.56

3.56

1.8

1.3

3.14

2.96

g/l

0.48

364

Benign neoplasm: Sigmoid colon

587

1.52

3.55

1.4

1.3

2.63

2.91

g/l

0.97

412

Artificial joint re-operation

164

2.03

3.55

1.3

1.5

3.53

2.92

g/l

0.87

118

KRA_PSY_EATING, excluding more controls

277

1.77

3.54

1.2

1.3

2.86

3.01

g/l

0.28

189

Epilepsy

159

1165

1.36

3.54

1.3

1.4

2.69

2.87

g/l

0.57

123

830

435

1.59

3.54

1.3

2.92

2.86

g/l

0.10

317

Tinnitus

123

866

1.43

3.53

1.4

1.3

2.82

2.95

g/l

0.45

598

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

105

2.31

3.53

2.1

1.2

3.40

2.82

g/l

0.69

Skin changes due to chronic exposure to nonionizing radiation

159

1105

1.36

3.52

1.5

1.3

2.68

2.94

g/l

1.02

112

749

Deep endometriosis

346

1.69

3.52

1.5

1.4

2.56

2.85

g/l

0.82

244

Other specified and unspecified personality disorders

346

1.69

3.52

1.3

1.4

2.83

3.00

g/l

0.28

240

Cysts of oral region, not elsewhere classified

118

2.22

3.51

1.8

1.4

3.14

3.08

g/l

0.05

Actinic keratosis

153

1061

1.37

3.51

1.5

1.3

2.67

2.92

g/l

0.94

109

715

Nonischemic cardiomyopathy

158

2.04

3.51

1.3

3.28

2.93

g/l

0.52

113

Leisure time condition

672

1.48

3.46

1.5

1.3

2.94

2.89

g/l

0.10

478

Malignant neoplasm of breast, HER-positive

1357

0.68

3.44

1.2

1.4

2.76

2.81

g/l

0.09

957

Benign neoplasm of eye and adnexa

296

1.73

3.42

1.7

1.4

2.63

2.89

g/l

0.36

207

Tuberculosis of other organs, strict

3.01

3.42

2.1

1.3

2.60

2.82

g/l

—

Strabismus

157

1157

1.36

3.41

1.7

1.3

3.03

2.83

g/l

0.60

108

814

Other peripheral vertigo

274

1.76

3.41

1.5

1.4

2.87

2.86

g/l

0.01

194

Statin medication

453

2113

1.20

3.41

1.4

2.91

3.02

g/l

0.58

324

1428

Ankylosing spondylitis, strict definition

160

2.02

3.40

1.2

1.3

3.73

3.03

g/l

0.85

113

Delirium, not induced by alcohol and other psychoactive substances

245

1.80

3.38

1.2

1.3

2.72

2.92

g/l

0.34

173

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

554

1.52

3.38

1.3

1.4

2.89

2.94

g/l

0.08

387

Left hemicolectomy

2.86

3.37

1.3

1.2

2.67

2.68

g/l

—

Superficial injury of ankle and foot

467

1.57

3.37

1.5

1.3

2.70

2.88

g/l

0.36

326

Early lumbar disc prolapse, operated

366

1.65

3.36

1.2

1.3

3.08

3.06

g/l

0.02

242

Thyroiditis, unspecified

3.29

3.36

1.7

1.2

2.95

2.66

g/l

0.24

Benign lipomatous neoplasm of other sites/unspecified

246

1.80

3.35

1.2

1.4

2.88

2.89

g/l

0.01

171

Other and unspecified injuries of lower leg

254

1.78

3.33

1.5

1.3

2.51

2.99

g/l

1.26

172

Myopia

508

1.54

3.33

1.3

1.4

3.11

2.94

g/l

0.39

351

Benign neoplasm of middle ear and respiratory system

225

1.83

3.32

1.8

1.3

3.26

2.98

g/l

0.43

153

Event of undetermined intent

218

1.85

3.32

1.2

1.3

3.22

2.93

g/l

0.35

152

Benign lipomatous neoplasm of other sites/unspecified

247

1.79

3.31

1.2

1.4

2.88

2.89

g/l

0.00

173

Dissection of aorta

2.56

3.30

1.8

1.3

2.67

2.75

g/l

0.06

Muscle strain

2.56

3.30

1.2

3.08

2.94

g/l

—

Disorders of psychological development

456

1.55

3.29

1.3

1.4

2.58

2.74

g/l

0.38

323

Other and unspecified disorders of skin and subcutaneous tissue

176

1.94

3.29

1.5

1.4

2.56

2.97

g/l

0.78

123

Chondrocostal junction syndrome [Tietze]

2.31

3.27

1.5

1.3

2.72

2.64

g/l

0.11

Other dialysis

2.36

3.26

1.3

2.67

2.63

g/l

0.03

Dental caries 2

477

3163

1.19

3.24

1.4

1.3

3.03

2.91

g/l

0.75

364

2200

Sequelae of injuries of neck and trunk

2.41

3.24

1.6

1.3

2.80

2.76

g/l

0.03

Suppurative otitis media, unspecified

2.69

3.23

1.8

1.4

2.78

2.87

g/l

0.04

Hypertrophy of breast in women and men

115

815

1.42

3.22

1.4

1.3

2.91

g/l

0.01

566

Bacterial, viral and other infectious agents

332

1.67

3.22

1.3

2.89

3.00

g/l

0.20

229

Cardiac arrest

116

2.09

3.22

1.1

1.2

2.67

3.09

g/l

0.46

Spirochaetal infections, other/unspecified

257

1.76

3.21

1.2

1.4

2.86

2.92

g/l

0.08

174

Degenerative diseases of the nervous system

633

0.61

3.21

1.2

1.3

2.84

2.87

g/l

0.03

449

Benign neoplasm of eye and adnexa

302

1.70

3.21

1.7

1.4

2.63

2.92

g/l

0.41

216

Seborrhoeic dermatitis

302

1.70

3.21

1.4

1.3

3.02

3.10

g/l

0.10

223

Other shoulder lesions

302

1.70

3.21

1.4

1.3

2.37

2.91

g/l

1.50

211

Chondropathies

626

1.48

3.20

1.5

1.4

2.87

2.90

g/l

0.05

430

Melanocytic naevi

163

1224

1.34

3.20

1.4

1.3

2.65

2.95

g/l

1.44

131

851

Oligomenorrhoea

110

2.20

3.19

1.6

1.4

2.55

2.89

g/l

0.62

Monoamine oxidase A inhibitors

411

1.59

3.17

1.2

1.3

2.72

2.99

g/l

0.68

279

Alzheimer disease

508

0.56

3.17

1.2

1.3

2.66

2.86

g/l

0.38

361

Amiodarone users

266

1.74

3.15

1.2

1.3

2.89

3.02

g/l

0.19

188

Embedded teeth, including avohilmo

342

1.65

3.14

1.4

2.90

2.86

g/l

0.06

235

Other degenerative diseases of the nervous system

119

642

1.41

3.14

1.4

1.3

2.80

2.99

g/l

0.47

438

Aortic valve malfunction, age under 60 years

350

1.64

3.14

1.6

1.3

3.05

2.92

g/l

0.14

246

Golimumab

111

2.18

3.14

1.0

1.3

3.04

2.87

g/l

0.20

Unspecified privation

350

1.64

3.13

1.7

1.3

2.77

2.93

g/l

0.21

245

Pilonidal cyst

335

1.65

3.12

1.4

1.3

3.45

3.08

g/l

0.74

226

Persons encountering health services in circumstances related to reproduction

366

2048

1.21

3.11

1.3

1.4

2.81

2.88

g/l

0.35

254

1433

Respiratory conditions due to other external agents

3.11

3.10

1.5

1.2

2.22

2.86

g/l

—

Fracture of foot, except ankle

137

1008

1.36

3.09

1.4

1.3

2.75

2.91

g/l

0.67

102

689

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

283

1.71

3.08

1.7

1.4

2.64

2.80

g/l

0.19

197

Gonarthrosis, primary, with knee surgery

267

1750

1.25

3.06

1.4

2.89

2.92

g/l

0.11

184

1215

Calculus of kidney and ureter

148

1104

1.34

3.05

1.4

1.3

3.20

3.00

g/l

0.55

100

772

Other disorders of binocular movement

2.53

3.05

1.5

1.3

2.95

2.64

g/l

0.45

Major coronary heart disease event

352

1935

1.22

3.05

1.4

2.81

2.99

g/l

1.24

258

1308

Social phobias

299

1.68

3.05

1.6

1.3

2.97

3.03

g/l

0.10

202

Pain associated with micturition

376

1.60

3.05

1.3

2.75

2.87

g/l

0.19

264

Abscess of anal and rectal regions

284

1.70

3.05

1.3

3.36

3.06

g/l

0.49

191

Use of antiglaucoma preparations and miotics

167

1.93

3.04

1.3

2.98

2.81

g/l

0.15

119

Routine general health check-up of defined subpopulation

2.92

3.03

1.2

1.4

2.81

2.75

g/l

0.04

Injuries to unspecified part of trunk, limb or body region

315

1.66

3.02

1.6

1.4

2.54

2.98

g/l

1.21

221

Artificial opening status

147

1.99

3.00

1.4

2.88

2.99

g/l

0.16

109

Benign neoplasm of middle ear and respiratory system

233

1.77

3.00

1.8

1.4

3.26

2.97

g/l

0.46

168

Gestational [pregnancy-induced] hypertension

150

1124

1.34

2.97

1.6

1.4

3.16

2.98

g/l

0.60

108

788

Other menopausal disorders

152

651

1.35

2.97

1.7

1.4

3.14

2.80

g/l

1.28

106

449

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

2.49

2.97

1.1

1.2

2.65

2.78

g/l

—

Other benign neoplasms of skin

179

1352

1.30

2.96

1.7

1.4

2.96

3.00

g/l

0.10

126

937

Other female pelvic inflammatory diseases

621

1.46

2.95

1.2

1.4

2.70

2.81

g/l

0.22

431

Contusion of other and unspecified parts of foot

162

1.93

2.95

1.2

1.3

2.76

2.80

g/l

0.06

109

Malignant neoplasm

531

2697

1.17

2.95

1.3

1.4

2.73

3.03

g/l

3.06

356

1900

Use of anticholinesterases

634

0.61

2.94

1.2

1.3

2.62

2.90

g/l

0.72

445

N06DA Anticholinesterases

634

0.61

2.94

1.2

1.3

2.62

2.90

g/l

0.72

445

Tooth eruption problems

599

1.46

2.94

1.4

1.3

2.94

2.84

g/l

0.25

431

2.34

2.92

1.8

1.3

3.48

2.87

g/l

0.81

Melanocytic naevi, other sites/unspecified

258

1.72

2.90

1.7

1.4

2.83

2.94

g/l

0.15

185

Medicines for HER+ breast cancer

105

1419

0.72

2.90

1.2

1.4

2.70

2.81

g/l

0.27

999

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

251

1.72

2.88

1.7

1.4

2.65

2.86

g/l

0.24

173

Dislocation, sprain and strain of joints and ligaments at neck level

616

1.45

2.88

1.5

1.4

2.88

2.94

g/l

0.14

415

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

101

692

1.42

2.88

1.3

1.4

2.83

2.79

g/l

0.08

507

Ingrowing nail

178

1.87

2.87

1.2

1.3

3.02

2.89

g/l

0.18

125

Melanocytic naevi, other sites/unspecified

259

1.71

2.87

1.7

1.4

2.83

2.94

g/l

0.15

179

Urolithiasis

155

1178

1.32

2.84

1.4

1.3

3.19

3.02

g/l

0.46

102

824

Other specified/unspecified hearing loss

215

1.78

2.84

1.6

1.3

2.75

3.09

g/l

0.70

150

Other facial nerve disorders

2.36

2.83

1.5

1.3

2.37

2.62

g/l

—

Degeneration of macula and posterior pole

195

1257

1.28

2.82

1.4

2.87

2.92

g/l

0.13

134

873

Speech and linguistic disorders

361

1.58

2.81

1.4

1.3

2.50

2.64

g/l

0.30

267

Salpingitis and oophoritis

102

728

1.41

2.80

1.4

2.41

2.84

g/l

2.46

506

Other appendicitis

299

1.65

2.80

1.2

1.4

3.03

2.92

g/l

0.14

204

Use of donepezil

384

0.47

2.80

1.2

2.76

2.85

g/l

0.10

276

Cerebrovascular diseases

371

2225

1.20

2.79

1.3

1.4

2.81

2.94

g/l

0.72

270

1515

Chalazion

393

1.56

2.79

1.7

1.4

3.00

2.99

g/l

0.01

272

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

217

1724

1.26

2.79

1.4

1.3

3.07

2.94

g/l

0.50

164

1190

Disorders of breast

269

2030

1.23

2.79

1.5

1.4

2.84

2.89

g/l

0.19

193

1426

Crossbite

277

1.65

2.78

1.2

1.4

2.45

2.67

g/l

0.47

214

Benign neoplasm: Skin, unspecified

117

2.07

2.78

1.2

1.4

3.01

2.89

g/l

0.10

Dissociative [conversion] disorders

124

2.03

2.76

1.2

1.3

3.06

2.90

g/l

0.21

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

217

1.76

2.76

1.8

1.4

2.72

2.79

g/l

0.06

145

Other and unspecified trigeminal disorders

2.90

2.76

1.2

1.5

3.37

2.57

g/l

—

L01XX Other antineoplastic agents

124

2.03

2.76

1.2

1.4

2.13

2.79

g/l

0.88

Major coronary heart disease event excluding revascularizations

312

1775

1.22

2.76

1.3

1.4

2.81

2.98

g/l

0.89

223

1191

Dislocation, sprain and strain of joints and ligaments of head

145

1.95

2.75

1.5

1.3

2.96

2.69

g/l

0.26

100

L02BG Aromatase inhibitors

1127

0.69

2.75

1.2

1.4

2.58

2.77

g/l

0.46

789

Hypoglycaemia, other or unspecified

203

1.78

2.73

1.9

1.3

2.92

2.85

g/l

0.11

138

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

252

1.69

2.72

1.3

2.26

2.50

g/l

0.53

192

Other predominantly sexually transmitted diseases, not elsewhere classified

106

766

1.39

2.72

1.2

1.4

3.00

2.99

g/l

0.01

528

Biomechanical lesions, not elsewhere classified

125

2.01

2.71

1.2

1.4

2.57

2.79

g/l

0.22

Other disorders of bone density and structure

2.52

2.71

1.3

2.73

2.48

g/l

—

Oral leukoplakia and related diseases

146

1.93

2.70

1.4

2.56

2.96

g/l

0.64

100

Drug-induced systemic lupus erythematosus

3.85

2.70

1.4

1.3

3.36

2.77

g/l

—

Other chondrocalcinosis

3.81

2.69

2.0

1.2

2.40

2.76

g/l

—

Speech disturbances, not elsewhere classified

219

1.74

2.68

1.3

1.4

2.49

2.88

g/l

0.97

150

Sub-endpoint used in defining T1D endpoints

160

1212

1.30

2.68

1.4

1.3

2.79

2.91

g/l

0.32

111

856

Obsessive-compulsive disorder

212

1.75

2.67

1.4

1.3

2.84

2.88

g/l

0.06

142

Benign neoplasm: Skin, unspecified

119

2.03

2.67

1.2

1.4

3.01

2.73

g/l

0.28

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.23

2.64

1.2

1.3

3.64

2.64

g/l

1.65

IgA nephropathy (IgA glomerulonephritis)

2.41

2.64

1.4

2.53

2.91

g/l

—

Mental and behavioural disorders due to alcohol

271

2165

1.22

2.63

1.2

1.4

2.95

3.02

g/l

0.25

174

1470

Idiopathic urticaria

2.49

2.63

1.3

2.83

2.57

g/l

0.38

Malignant neoplasm of endocrine gland

228

1.72

2.63

1.8

1.5

2.73

2.85

g/l

0.10

160

Dronedarone medication

2.48

2.62

1.3

1.1

2.71

2.75

g/l

—

Retinal vascular occlusion

289

1.63

2.62

1.2

1.3

2.83

2.91

g/l

0.11

206

Tobacco use

162

1.87

2.62

1.4

1.3

2.63

2.97

g/l

0.49

109

Hyperprolactinaemia

113

2.05

2.62

1.3

1.2

2.46

2.92

g/l

1.23

Suicide or other Intentional self-harm

140

1063

1.32

2.62

1.3

1.4

2.86

2.96

g/l

0.26

739

L01XE Protein kinase inhibitors

148

1.90

2.61

1.4

2.57

2.82

g/l

0.32

103

Urethral stricture

127

1.98

2.60

1.2

3.23

2.89

g/l

0.34

Dysplasia of cervi uteri

127

733

1.34

2.59

1.3

1.4

2.66

2.92

g/l

1.27

511

Diseases of male genital organs

299

1244

1.22

2.58

1.3

1.4

3.02

3.03

g/l

0.03

205

843

Coxarthrosis, primary

274

1956

1.22

2.58

1.3

1.4

2.87

2.92

g/l

0.18

219

1343

Other specified disorders of kidney and ureter

2.20

2.58

1.5

1.3

3.07

2.77

g/l

0.38

Other puerperal infections

314

1.60

2.58

1.4

3.03

2.95

g/l

0.13

219

Congenital malformations of ovaries, fallopian tubes and broad ligaments

207

1.75

2.58

1.2

1.4

2.73

2.94

g/l

0.32

144

Malignant neoplasm of thyroid gland

207

1.75

2.58

1.8

1.5

2.73

2.83

g/l

0.09

148

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

100

604

1.39

2.57

1.2

1.4

2.55

2.99

g/l

1.61

421

Type 1 diabetes, wide definition

127

953

1.33

2.57

1.4

1.3

2.80

2.93

g/l

0.32

682

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1055

0.72

2.56

1.2

1.4

2.76

2.94

g/l

0.39

753

Other secondary gonarthrosis

142

1.91

2.56

1.2

1.5

3.72

2.98

g/l

0.42

Benign neoplasm: Skin of eyelid, including canthus

483

1.48

2.55

1.7

1.4

3.21

2.87

g/l

0.64

340

Acute nephritic syndrome

2.63

2.54

1.2

2.39

2.90

g/l

—

Impacted teeth

109

745

1.37

2.53

1.3

3.00

2.93

g/l

0.15

519

Other/unspecified disorders of vestibular function

101

2.10

2.53

1.1

1.5

2.91

2.83

g/l

0.07

Embedded and impacted teeth

157

1032

1.30

2.53

1.4

1.3

2.97

2.93

g/l

0.13

123

714

Benign neoplasm of meninges

300

1.61

2.53

1.6

1.4

2.59

2.79

g/l

0.36

213

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

231

1.70

2.52

1.4

1.3

2.48

2.95

g/l

1.12

161

Use of other anti-dementia drugs

459

0.57

2.52

1.1

1.3

2.67

2.86

g/l

0.24

325

Use of memantine

459

0.57

2.52

1.1

1.3

2.67

2.86

g/l

0.24

325

Open wound of wrist and hand

242

1955

1.23

2.52

1.3

1.4

2.84

3.03

g/l

1.22

179

1334

Disturbances of smell and taste

108

2.05

2.52

1.3

1.6

3.24

2.96

g/l

0.22

Sequelae of other external causes

150

1.88

2.52

1.6

1.3

2.73

2.80

g/l

0.08

104

Pustular psoriasis

143

1.90

2.51

1.2

1.5

4.12

2.88

g/l

1.38

Achilles tendinitis

324

1.58

2.51

1.8

1.3

2.74

2.98

g/l

0.60

229

Other congenital malformations of skin

136

1.93

2.51

1.3

3.28

2.68

g/l

1.32

Benign neoplasm: Skin of trunk

122

1.98

2.51

2.2

1.3

3.14

2.83

g/l

0.32

Pregnancy hypertension

237

1739

1.23

2.50

1.5

1.4

3.10

2.92

g/l

0.90

173

1239

Follicular cysts of skin and subcutaneous tissue

702

1.39

2.50

1.4

1.3

2.84

2.92

g/l

0.17

490

Cystic kidney disease

2.12

2.49

1.3

3.23

2.63

g/l

0.57

Family history of other conditions

2.86

2.49

1.1

1.4

2.75

2.67

g/l

—

Papillary adenocarcinoma of thyroid gland

158

1.85

2.48

2.0

1.5

2.81

2.84

g/l

0.02

111

Retinal vascular disorders

294

1.60

2.47

1.2

1.3

2.83

2.91

g/l

0.09

209

Other disorders of veins

199

1593

1.25

2.46

1.3

1.4

2.97

2.91

g/l

0.15

132

1125

Somnolence, stupor and coma

109

2.03

2.46

1.3

1.4

1.90

2.85

g/l

3.15

Arthropod-borne viral fevers and viral haemorrhagic fevers

318

1.58

2.46

1.4

1.3

2.63

3.01

g/l

1.13

223

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

123

1.97

2.46

1.3

2.57

2.79

g/l

0.31

Secondary polycythaemia

2.48

2.46

1.4

2.22

2.80

g/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

159

1241

1.28

2.45

1.2

1.3

3.03

2.98

g/l

0.12

117

857

Benign neoplasm of bone and articular cartilage

295

1.60

2.44

2.1

1.4

2.67

2.97

g/l

0.61

209

Hallux rigidus

407

1.50

2.42

1.3

1.5

3.26

2.93

g/l

1.03

284

Status epilepticus

2.18

2.41

1.3

2.27

2.79

g/l

0.66

Contraceptive management

255

1472

1.22

2.41

1.3

1.4

2.96

2.94

g/l

0.08

176

1032

Other symptoms and signs involving the urinary system

304

1.59

2.41

1.5

1.3

2.78

3.08

g/l

0.54

209

Certain conditions originating in the perinatal period

346

1.52

2.41

1.3

2.32

2.66

g/l

0.98

256

Discitis, unspecified

2.78

2.38

1.5

1.3

3.53

2.68

g/l

—

Benign neoplasm: Choroid

153

1.84

2.38

1.2

1.5

2.74

2.91

g/l

0.18

106

Hypertrophic scar

175

1.78

2.38

1.4

1.3

2.72

2.92

g/l

0.25

124

Personal history of other diseases and conditions

464

1.47

2.38

1.5

1.4

2.47

2.75

g/l

0.77

347

Inflammatory disease of uterus

574

1.42

2.38

1.4

1.3

2.62

2.95

g/l

0.94

398

Foreign body in respiratory tract

161

1.81

2.35

1.5

1.4

3.07

2.72

g/l

0.31

114

Unspecified event, undetermined intent

2.28

2.35

1.5

1.3

3.37

2.64

g/l

—

102

665

1.36

2.35

1.2

1.4

2.92

g/l

0.01

471

Other disorders starting during childhood or adolescence

242

1.65

2.34

1.3

1.4

2.19

2.43

g/l

0.53

185

Astigmatism

229

1.67

2.32

1.2

1.3

2.71

2.61

g/l

0.14

164

Benign neoplasm of meninges

307

1.57

2.32

1.6

1.4

2.59

2.86

g/l

0.55

213

Contact with other hot fluids

2.06

2.32

1.5

1.2

2.48

2.60

g/l

0.15

Autism spe, excluding more controls

2.33

2.32

1.3

1.4

2.34

2.94

g/l

—

Thyrotoxicosis with diffuse goitre

510

1.44

2.32

1.5

1.3

2.82

2.87

g/l

0.09

360

Other otitis externa (chronic)

199

1.72

2.32

1.2

1.4

2.51

2.83

g/l

0.58

143

Benign neoplasm: Cerebral meninges

268

1.61

2.32

1.7

1.4

2.60

2.80

g/l

0.34

186

Other and unspecified mood [affective] disorders

245

1.64

2.31

1.2

1.4

2.87

2.84

g/l

0.04

165

Malignant neoplasm of eye, brain and central nervous system

112

1.98

2.31

1.6

1.2

2.16

2.89

g/l

1.04

Use of glatiramer acetate

2.40

2.30

1.4

3.45

2.79

g/l

—

Glaucoma-related operations

119

1.94

2.30

1.5

1.4

2.74

2.84

g/l

0.12

Emotionally unstable personality disorder

511

1.43

2.30

1.3

1.4

2.58

2.99

g/l

1.43

350

Benign neoplasm: Choroid

155

1.82

2.30

1.2

1.5

2.74

2.91

g/l

0.18

109

Superficial injury of forearm

356

1.52

2.29

1.4

1.3

2.92

2.89

g/l

0.04

244

Exposure to other and unspecified inanimate mechanical forces

246

1.64

2.28

1.4

1.3

2.93

2.87

g/l

0.11

176

Acidosis

2.58

2.28

1.2

1.3

2.31

3.04

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

148

1.83

2.27

1.5

1.3

3.44

2.84

g/l

0.93

105

Pustulosis palmaris et plantaris

127

1.90

2.26

1.1

1.5

4.07

2.92

g/l

1.15

Malignant neoplasm of oesophagus

0.00

2.25

0.0

1.3

—

2.87

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

126

968

1.31

2.23

1.2

1.4

2.79

2.97

g/l

0.72

657

Hypertrophy of breast

726

1.35

2.23

1.4

1.3

2.88

2.89

g/l

0.01

503

Mental and behavioural disorders due to sedatives or hypnotics

240

1.63

2.22

1.3

1.4

2.58

3.11

g/l

1.30

169

malignant neoplasm of male genital organs

107

902

0.75

2.22

1.3

1.4

3.46

3.07

g/l

0.98

629

Dementia

853

0.74

2.22

1.2

1.4

2.76

2.93

g/l

0.48

588

Benign neoplasm: Skin of trunk

128

1.89

2.22

2.2

1.3

3.14

2.90

g/l

0.24

Viral haemorrhagic fevers, not elsewhere classified/unspecified

248

1.62

2.21

1.4

1.3

2.60

3.05

g/l

1.34

169

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

2.05

2.21

1.4

3.78

2.86

g/l

0.48

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

736

1.35

2.20

1.3

1.4

2.97

g/l

0.01

498

Dementia, including avohilmo

101

930

0.75

2.20

1.2

1.4

2.92

2.94

g/l

0.03

638

Background retinopathy and retinal vascular changes

2.52

2.19

1.3

1.4

2.81

2.80

g/l

—

Palmar fascial fibromatosis [Dupuytren]

425

1.46

2.19

1.4

1.2

3.12

2.97

g/l

0.24

292

Diabetic retinopathy, excluding more controls

129

555

1.31

2.19

1.5

1.4

3.01

2.96

g/l

0.09

358

Psoriasis (vulgaris), strict definition

2.14

2.19

1.1

1.3

3.09

2.92

g/l

0.17

Corns and callosities

195

1.70

2.19

1.2

1.4

3.35

2.99

g/l

0.29

139

Benign neoplasm of bone and articular cartilage

304

1.55

2.19

2.1

1.4

2.67

2.93

g/l

0.52

213

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

317

2195

1.18

2.17

1.4

2.83

2.96

g/l

0.73

214

1568

Major anomalies of jaw size

2.04

2.17

1.4

1.3

2.99

2.65

g/l

0.44

Benign neoplasm: Long bones of lower limb

101

2.00

2.16

1.9

1.3

2.40

2.61

g/l

—

Presence of other devices

661

1.36

2.16

1.3

2.76

3.01

g/l

0.93

482

Transport accidents

257

1902

1.20

2.15

1.5

1.3

2.95

3.06

g/l

0.47

177

1328

Alzheimer’s disease, wide definition

410

0.59

2.15

1.1

1.3

2.76

2.89

g/l

0.18

295

Prolonged pregnancy

625

0.65

2.15

1.2

1.4

3.18

3.06

g/l

0.22

444

Benign neoplasm: Cerebral meninges

274

1.58

2.14

1.7

1.4

2.60

2.77

g/l

0.26

195

Congenital malformations of eye, ear, face and neck

251

1.60

2.12

1.3

2.89

2.80

g/l

0.14

177

Disorders of synovium and tendon in diseases classified elsewhere

2.47

2.11

1.4

1.3

2.80

2.72

g/l

—

Dental caries 2, only avohilmo

454

3131

1.14

2.10

1.4

3.05

2.92

g/l

0.89

345

2181

Emotional disorders and disorders of social functioning with onset specific to childhood

195

1.68

2.09

1.4

2.10

2.72

g/l

2.30

145

Injury of muscle and tendon at shoulder and upper arm level

169

1359

1.25

2.09

1.4

3.01

2.98

g/l

0.07

117

932

Dental pulpitis 3

427

1.39

2.08

1.2

1.3

2.49

2.76

g/l

0.78

307

Mental and behavioural disorders due to opioids

131

1.85

2.08

1.4

1.3

2.64

2.89

g/l

0.21

Other benign neoplasms of connective and other soft tissue

332

1.51

2.08

1.5

1.4

2.57

2.96

g/l

0.92

233

Female genital prolapse

153

696

1.27

2.08

1.5

1.4

2.83

2.80

g/l

0.08

109

479

Bicipital tendinitis

124

1.87

2.07

1.3

2.56

3.04

g/l

1.06

Superficial injury of head

110

839

1.31

2.07

1.6

1.3

2.57

2.83

g/l

1.17

577

Medical abortion

362

1689

1.17

2.05

1.3

1.4

2.83

2.89

g/l

0.24

252

1195

Arterial embolism and thrombosis of lower extremity artery

2.19

2.04

1.1

1.2

2.38

2.87

g/l

—

UC patients in KELA-register (code 208), prior to 1994

132

1.83

2.04

1.6

1.3

2.84

2.91

g/l

0.06

Alzheimer’s disease, wide definition, excluding more controls

269

0.55

2.04

1.1

1.5

2.80

2.88

g/l

0.09

173

Emotional disorders starting during childhood or adolecense, excluding more controls

158

1.74

2.04

1.4

1.3

2.06

2.85

g/l

2.70

111

Left bundle-branch block

154

1.76

2.04

1.4

1.3

3.11

3.07

g/l

0.04

105

Carbimazole or st.post thyroidectomy, condition for graves disease

107

816

1.31

2.03

1.8

1.4

2.76

2.87

g/l

0.31

562

Congenital malformations of genital organs

422

1.44

2.02

1.2

1.4

2.52

2.76

g/l

0.64

313

Benign neoplasm: Skin of eyelid, including canthus

508

1.40

2.02

1.7

1.4

3.21

2.81

g/l

0.81

350

Degenerative macular diseases

294

1.54

2.02

1.4

1.3

2.63

2.87

g/l

0.49

204

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.24

2.01

1.5

1.4

3.27

2.65

g/l

—

Varicella [chickenpox]

185

1.69

2.01

1.2

1.3

2.66

2.83

g/l

0.21

129

Sixth [abducent] nerve palsy

2.02

2.01

1.6

1.3

2.97

2.79

g/l

0.13

Benign neoplasm: Long bones of lower limb

104

1.94

2.01

1.9

1.3

2.39

2.74

g/l

—

Unspecified urinary incontinence

247

1.59

2.01

1.4

2.54

2.70

g/l

0.21

170

Coronary angioplasty

155

949

1.26

2.00

1.3

1.4

2.79

2.95

g/l

0.64

121

638

Any dementia

709

0.72

2.00

1.2

1.4

2.75

2.88

g/l

0.30

502

Alcohol abuse, main dg

611

1.36

2.00

1.3

3.01

2.92

g/l

0.18

415

Congenital malformations of the circulatory system

600

1.36

1.99

1.6

1.4

2.60

2.76

g/l

0.41

440

Primary gonarthrosis, bilateral

232

1693

1.20

1.99

1.3

1.4

2.95

2.93

g/l

0.06

172

1181

Blepharochalasis

123

960

1.28

1.97

1.5

1.4

2.91

2.83

g/l

0.20

665

Fall on same level involving ice and snow

297

2538

1.17

1.96

1.6

1.4

2.85

2.95

g/l

0.45

212

1769

Complications of other internal prosthetic devices, implants and grafts

2.04

1.96

1.1

1.2

2.78

2.77

g/l

0.00

Meralgia paraesthetica

1.99

1.95

1.2

1.4

3.02

2.91

g/l

0.08

Lesion of sciatic nerve

1.99

1.95

1.3

3.35

2.71

g/l

0.47

Allergic contact dermatitis due to drugs in contact with skin

2.21

1.95

1.3

3.17

2.48

g/l

—

Other noninflammatory disorders of vagina

249

1.57

1.95

1.3

3.04

2.85

g/l

0.29

172

Disorders of porphyrin and bilirubin metabolism

2.76

1.94

2.0

1.3

2.83

2.70

g/l

—

Laparoscopic right hemicolectomy

127

1.82

1.94

1.1

1.4

3.52

2.76

g/l

1.07

Glucosamine medication

224

1489

1.20

1.94

1.3

1.4

2.83

2.89

g/l

0.15

154

1041

Other benign neoplasms of connective and other soft tissue

338

1.49

1.93

1.5

1.4

2.57

2.95

g/l

0.88

243

Malignant neoplasm of small intestine

2.47

1.93

1.1

1.2

2.13

2.92

g/l

—

Parkinson's disease

398

0.58

1.92

1.3

2.07

2.96

g/l

2.35

275

Hypermetropia

266

1.55

1.92

1.5

1.4

2.87

2.64

g/l

0.36

192

Other benign neoplasms of skin

179

1465

1.22

1.91

1.7

1.3

2.96

2.89

g/l

0.19

126

1016

Residual foreign body in soft tissue

150

1.74

1.91

1.4

1.3

2.66

3.00

g/l

0.76

False labour

181

926

1.23

1.90

1.3

3.14

3.01

g/l

0.45

123

662

Injury of unspecified body region

227

1.59

1.90

1.6

1.3

2.57

2.87

g/l

0.51

159

Lesion of femoral nerve

3.24

1.89

1.1

1.4

4.30

2.82

g/l

—

Fracture of femur

641

1.33

1.89

1.3

2.68

2.89

g/l

0.57

452

Postmenopausal bleeding

129

554

1.28

1.88

1.3

2.85

2.72

g/l

0.34

379

Presbyopia

228

1.59

1.87

1.4

3.57

3.00

g/l

0.82

157

Myeloproliferative diseases

228

1.59

1.87

1.1

1.4

2.40

2.95

g/l

1.12

158

Other disorders of cornea

284

1.52

1.87

1.1

1.4

2.84

2.88

g/l

0.05

205

Malignant neoplasm of prostate

106

865

0.77

1.86

1.3

1.4

3.44

3.06

g/l

0.90

602

Coxarthrosis, primary, with hip surgery

199

1564

1.21

1.86

1.3

1.4

2.82

2.90

g/l

0.27

159

1061

Essential (haemorrhagic) thrombocythaemia

1.95

1.85

1.1

1.4

2.50

2.78

g/l

—

Other conjunctival vascular disorders and cysts

2.22

1.85

1.7

1.3

2.92

2.62

g/l

—

Endometriosis of ovary

644

1.34

1.85

1.3

1.4

3.01

2.85

g/l

0.35

447

Other strabismus

123

967

1.27

1.84

1.6

1.3

3.04

2.83

g/l

0.51

678

Stroke, excluding SAH

272

1720

1.18

1.84

1.3

1.4

2.87

2.92

g/l

0.16

196

1171

Peripheral artery operations in Hilmo

301

1.50

1.84

1.3

2.63

3.00

g/l

0.50

209

Implicit parasitic Sepsis

4.26

1.83

1.6

1.2

2.16

2.26

g/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.14

1.82

1.5

1.3

3.27

2.70

g/l

—

Infective bursitis

2.14

1.82

1.3

1.4

2.45

3.17

g/l

—

Varicose veins

309

2010

1.16

1.82

1.5

1.4

2.86

2.92

g/l

0.22

206

1423

Benign lipomatous neoplasm

137

1096

1.25

1.82

1.2

1.4

2.92

3.01

g/l

0.17

765

Cerebral aneurysm, nonruptured

286

1.51

1.82

1.4

2.66

2.84

g/l

0.26

195

Familial hypercholesterolemia, with ischemic heart disease

222

1.58

1.81

1.3

2.73

3.06

g/l

0.63

155

Alzheimer disease, excluding more controls

304

0.61

1.80

1.3

1.4

2.60

2.86

g/l

0.38

198

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

263

1.53

1.78

1.3

1.4

2.57

2.91

g/l

0.72

183

Endometriosis ASRM stages 3,4

120

948

1.27

1.78

1.3

1.4

2.81

2.87

g/l

0.13

656

Parkinson's disease, strict definition

351

0.57

1.78

1.4

1.3

1.95

2.97

g/l

2.65

246

Unstable angina pectoris

155

1043

1.23

1.77

1.3

1.4

2.96

2.97

g/l

0.01

121

699

Other and unspecified injuries of ankle and foot

124

1.78

1.76

1.9

1.2

3.10

2.81

g/l

0.48

Other noninflammatory disorders of uterus, except cervix

104

548

1.30

1.75

1.5

1.4

3.01

2.69

g/l

0.99

376

Disorder of external ear, unspecified

1.99

1.75

1.6

1.3

3.54

2.75

g/l

—

Dementia in Alzheimer disease

288

0.56

1.74

1.1

1.3

2.62

2.79

g/l

0.19

214

Diabetic nephropathy, excluding more controls

407

1.38

1.73

1.4

1.5

2.82

2.96

g/l

0.21

259

Haemangioma and lymphangioma, any site

306

1.48

1.72

1.6

1.4

3.01

2.88

g/l

0.18

215

Outcome of delivery

493

0.71

1.72

1.2

1.4

2.99

2.93

g/l

0.11

354

Effects of foreign body entering through natural orifice

127

1015

1.25

1.72

1.3

1.4

2.83

2.95

g/l

0.30

698

Brain meningioma, excluding all cancers (controls excluding all cancers)

140

1.72

1.5

2.23

2.77

g/l

1.02

Other vitreous opacities

103

1.86

1.72

1.4

1.3

2.58

2.72

g/l

0.17

Behavioural disorders, excluding more controls

2.14

1.71

1.3

1.4

2.86

2.74

g/l

—

Additional codes for the location of defect, injury or illness

163

1.66

1.71

1.2

1.3

2.87

2.84

g/l

0.03

111

Melanoma in situ

1.89

1.71

1.6

1.4

2.71

2.95

g/l

—

Amputation

226

1.55

1.70

1.3

1.2

2.83

3.03

g/l

0.18

157

Other eating disorders

187

1.61

1.69

1.2

1.4

3.00

2.65

g/l

0.60

123

Alcohol use disorder, ICD-based

210

1770

1.19

1.69

1.2

1.4

2.93

3.04

g/l

0.37

134

1219

Lichen sclerosus et atrophicus

308

1.47

1.68

1.6

1.4

2.87

2.78

g/l

0.12

219

Eating disorders

425

1.39

1.66

1.2

1.4

2.89

g/l

0.01

294

Maltreatment syndromes

188

1.60

1.66

1.2

1.3

3.20

2.91

g/l

0.34

134

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

268

1.50

1.66

1.3

1.4

2.57

2.89

g/l

0.68

191

Myeloproliferative diseases (CML excluded)

196

1.59

1.65

1.1

1.4

2.57

2.88

g/l

0.48

134

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

150

1.68

1.64

1.6

1.3

3.15

3.06

g/l

0.07

112

Single spontaneous delivery

153

994

0.82

1.63

1.4

2.76

2.71

g/l

0.15

733

Oral lichen ruber planus wide, hypothyreosis or thyroxin

150

1.68

1.63

2.4

1.5

2.18

2.85

g/l

1.75

106

Haemangioma and lymphangioma, any site

310

1.46

1.63

1.6

1.3

3.01

2.91

g/l

0.13

221

Conductive hearing loss, unspecified

261

1.50

1.63

1.3

3.12

3.01

g/l

0.13

187

Fracture of neck

135

1.71

1.62

1.0

1.3

1.83

2.88

g/l

2.62

Melanoma in situ

1.85

1.62

1.6

1.3

2.71

2.79

g/l

—

Myocardial infarction, with ST-elevation

496

1.35

1.61

1.2

1.4

2.57

3.08

g/l

2.22

350

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

219

1271

1.18

1.61

1.6

1.4

2.64

3.01

g/l

2.73

155

888

Preterm labour and delivery

138

1123

1.23

1.61

1.4

3.08

2.85

g/l

0.53

800

Stroke, including SAH

290

1861

1.15

1.59

1.3

1.4

2.85

2.94

g/l

0.33

212

1268

Diffuse brain injury

1.96

1.59

1.1

1.4

3.07

2.98

g/l

—

Biguanides

524

2904

1.11

1.57

1.4

2.95

2.98

g/l

0.16

369

2006

Cyst of kidney

175

1.61

1.57

1.6

1.4

2.89

2.93

g/l

0.04

120

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

129

1.71

1.57

1.2

1.4

2.89

2.84

g/l

0.04

!Aliquae complicationes praecoces traumatis

114

1.76

1.56

1.3

2.30

2.93

g/l

1.17

Early complications of trauma

114

1.76

1.56

1.3

2.30

2.93

g/l

1.17

Alzheimer’s disease (Late onset), excluding more controls

234

0.60

1.55

1.1

1.4

2.72

2.86

g/l

0.14

153

Hereditary corneal dystrophies

1.94

1.54

1.1

1.3

2.54

2.76

g/l

—

Female infertility, associated with anovulation

314

1.44

1.54

1.6

1.5

3.05

3.14

g/l

0.15

218

Haemangioma, any site

281

1.46

1.54

1.6

1.3

2.89

2.88

g/l

0.02

195

Carcinoma in situ of skin of other and unspecified parts of face

145

1.66

1.54

1.1

1.3

2.23

2.88

g/l

0.78

106

Glaucoma, exfoliation

208

1.54

1.53

1.3

3.21

2.71

g/l

0.58

152

Adenomyosis (Endometriosis of uterus)

467

1.35

1.53

1.2

1.5

2.67

2.77

g/l

0.20

325

Alzheimer’s disease (Late onset)

361

0.64

1.52

1.1

1.3

2.68

2.86

g/l

0.25

265

Malignant neoplasm of digestive organs

150

1220

1.21

1.52

1.3

1.4

2.97

2.93

g/l

0.10

837

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.62

1.52

1.0

1.2

2.93

2.77

g/l

—

Hydatidiform mole

0.00

1.52

0.0

1.5

—

2.90

—

Carcinoma in situ of skin of other and unspecified parts of face

146

1.65

1.50

1.1

1.3

2.23

2.81

g/l

0.67

108

Any dementia, excluding more controls

648

0.76

1.50

1.3

1.4

2.77

2.92

g/l

0.31

447

Other disorders of breast

486

1.34

1.50

1.4

1.3

3.31

2.86

g/l

0.90

332

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

615

0.77

1.49

1.3

1.4

3.43

3.17

g/l

0.51

426

Other congenital malformations of circulatory system

1.96

1.49

2.9

1.3

2.96

2.74

g/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

2.01

1.49

1.2

1.3

3.15

2.70

g/l

0.29

Primary coxarthrosis, bilateral

116

937

1.24

1.48

1.4

2.72

2.90

g/l

0.48

642

Complications predominantly related to the puerperium

142

1172

1.21

1.47

1.5

1.4

2.87

2.96

g/l

0.28

107

823

Transient ischemic attack

228

1623

1.17

1.47

1.4

2.80

2.91

g/l

0.43

161

1115

Scabies

155

1.62

1.47

1.8

1.3

3.40

2.99

g/l

0.37

107

Ménière disease

301

1.43

1.46

1.5

1.4

2.46

2.89

g/l

0.93

208

Acute alcohol intoxication, ICD10

778

1.26

1.46

1.3

1.4

2.79

2.97

g/l

0.50

540

Insulin, fast-acting (human)

549

1.31

1.46

1.3

3.05

3.02

g/l

0.06

374

Benign neoplasm of ovary

619

1.30

1.46

1.2

1.4

2.61

2.74

g/l

0.32

423

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

664

0.78

1.45

1.3

1.4

3.43

3.20

g/l

0.48

457

Atlantoaxial subluxation

3.17

1.44

1.0

1.6

2.33

2.01

g/l

—

Ischaemic Stroke, excluding all haemorrhages

247

1615

1.16

1.44

1.3

1.4

2.90

2.93

g/l

0.08

174

1099

Parkinson's disease, including avohilmo

414

0.65

1.44

1.3

2.12

2.93

g/l

2.70

289

Inflammatory diseases of prostate (prostatitis)

412

1.36

1.44

1.2

1.3

3.05

3.17

g/l

0.18

279

Specific development disorders of speech and language

235

1.48

1.44

1.4

1.3

2.44

2.55

g/l

0.20

184

Infectious mononucleosis

336

1.40

1.43

2.1

1.4

2.84

2.97

g/l

0.25

230

Dementia in other diseases classified elsewhere

1.80

1.43

1.2

2.93

2.65

g/l

—

Mental disorders, not otherwise specified

311

1.42

1.43

1.3

1.4

3.25

2.91

g/l

0.55

219

Contact with heat and hot substances

180

1.56

1.43

1.4

1.3

2.75

2.81

g/l

0.06

125

Impacted cerumen

270

1.45

1.41

1.2

1.3

2.74

2.95

g/l

0.30

191

Benign neoplasm of urinary organs

118

1.70

1.41

1.2

1.3

2.51

2.78

g/l

0.29

Carcinoma in situ of breast, intraductal

289

0.59

1.41

1.2

1.4

3.01

2.72

g/l

—

201

Benign neoplasm: Kidney

1.86

1.40

1.3

2.56

2.79

g/l

—

Coronary revascularization (ANGIO or CABG)

192

1138

1.18

1.40

1.4

2.80

2.98

g/l

0.81

146

754

Specific development disorders of scholastic skills

195

1.53

1.39

1.4

1.3

2.60

2.70

g/l

0.12

142

Postmenopausal atrophic vaginitis

118

575

1.24

1.39

1.4

1.3

2.77

2.73

g/l

0.11

397

Benign neoplasm of ovary

625

1.28

1.37

1.2

1.5

2.61

2.90

g/l

0.96

436

Postprocedural musculoskeletal disorders, not elsewhere classified

190

1.53

1.37

1.3

1.5

2.42

2.87

g/l

0.76

132

Mental and behavioural disorders due to alcohol, excluding acute intoxication

222

1917

1.16

1.37

1.2

1.4

2.89

3.06

g/l

0.62

141

1315

Carcinoma in situ of skin

182

1.54

1.37

1.4

2.34

2.95

g/l

1.31

128

Haemangioma, any site

289

1.42

1.36

1.6

1.3

2.89

2.92

g/l

0.03

206

Macular pucker

408

1.35

1.36

1.7

1.4

3.01

2.94

g/l

0.09

295

Recurrent dislocation and subluxation of joint

248

1.46

1.35

1.2

1.4

2.58

3.10

g/l

1.52

165

Nontoxic multinodular goitre

662

1.27

1.35

1.5

1.4

2.70

2.79

g/l

0.19

459

Carcinoma in situ of skin

183

1.54

1.34

1.4

1.3

2.34

2.82

g/l

0.94

132

Amputation of toe

167

1.56

1.34

1.2

2.53

2.91

g/l

0.45

113

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

529

1.28

1.34

1.2

1.4

2.58

2.98

g/l

1.33

374

Anomalies of dental arch relationship, including avohilmo

109

795

1.23

1.34

1.3

1.4

3.03

2.80

g/l

0.64

563

Malignant neoplasm of respiratory system and intrathoracic organs

536

1.29

1.34

1.2

1.3

2.77

2.95

g/l

0.34

385

Granulomatous disorders of skin and subcutaneous tissue

1.92

1.33

1.6

1.2

3.82

2.79

g/l

—

Use of interferon beta-1a

1.79

1.33

1.4

2.81

2.84

g/l

—

Wet age-related macular degeneration

360

1.37

1.32

1.2

1.3

2.81

2.86

g/l

0.05

266

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

208

1.50

1.32

1.4

2.31

2.92

g/l

1.02

149

Sequelae of infectious and parasitic diseases

250

1.44

1.30

1.4

2.69

2.95

g/l

0.37

173

Carcinoma in situ of breast, intraductal

282

0.60

1.30

1.2

1.5

3.01

2.79

g/l

—

198

Anorexia (incl.atypical)

209

1.49

1.30

1.1

1.4

2.96

2.78

g/l

0.26

141

Delivery

159

996

0.84

1.29

1.4

2.88

2.71

g/l

0.56

735

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

137

1.61

1.29

1.2

1.4

2.89

g/l

0.01

Congenital lens malformations

2.83

1.29

1.2

1.4

2.24

2.05

g/l

—

Wide developmental disorders, excluding more controls

105

1.71

1.29

1.3

1.4

2.09

2.59

g/l

0.73

Pregnancy with abortive outcome

365

1705

1.12

1.28

1.3

1.4

2.88

2.89

g/l

0.05

253

1206

Dental pulpitis 3, only avohilmo

395

1.30

1.27

1.2

1.3

2.69

2.75

g/l

0.09

283

Benign neoplasm: Brain, supratentorial

2.06

1.27

1.4

2.88

2.59

g/l

—

Other spirochaetal diseases

122

1011

1.21

1.26

1.3

1.4

2.88

2.90

g/l

0.05

701

Vitreous haemorrhage

277

1.41

1.26

1.5

1.4

3.32

2.94

g/l

0.51

197

Calcific tendinitis of shoulder

178

1.52

1.26

1.1

1.4

3.49

2.89

g/l

0.74

120

Endometriosis diagnosis and infertility diagnosis occurring together

466

1.31

1.26

1.4

3.22

2.92

g/l

0.70

321

Open wound of abdomen, lower back and pelvis

1.75

1.25

1.1

1.3

2.93

2.79

g/l

0.07

Benign lipomatous neoplasm

137

1149

1.19

1.25

1.2

1.4

2.92

g/l

0.01

804

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.42

1.25

1.7

1.2

1.73

2.84

g/l

—

Acute myeloid leukaemia, helper endpoint

2.42

1.25

1.7

1.2

1.73

2.84

g/l

—

Fracture of shoulder and upper arm

163

1388

1.18

1.24

1.5

1.3

3.03

2.86

g/l

0.50

122

962

Eating disorder

363

1.35

1.23

1.2

1.4

2.86

2.87

g/l

0.01

253

Other renal tubulo-interstitial diseases

1.92

1.23

1.1

1.3

3.18

2.73

g/l

—

Motorcycle rider injured in other and unspecified transport accidents

212

1.47

1.23

1.5

1.2

2.82

3.05

g/l

0.36

146

Retinoschisis and retinal cysts

1.98

1.22

2.8

1.3

2.91

2.64

g/l

—

Bursitis of shoulder

1.98

1.22

1.5

3.02

2.90

g/l

—

Other and unspecified disorders of adult personality and behaviour

2.67

1.22

1.2

1.5

1.97

3.06

g/l

—

Open wound of forearm

296

1.39

1.22

1.2

1.3

2.97

3.03

g/l

0.06

207

Malignant neoplasm of breast, HER-negative

753

0.77

1.22

1.2

1.4

2.67

2.79

g/l

0.23

535

Sequelae of injuries of upper limb

356

1.35

1.21

1.2

1.4

2.85

3.01

g/l

0.25

252

Fracture of lower leg, including ankle

276

2437

1.13

1.21

1.5

1.3

2.86

2.99

g/l

0.57

202

1683

Other disorders of the genitourinary system

408

1.33

1.21

1.4

2.93

2.70

g/l

0.37

281

Delivery, wide proxy

125

798

0.83

1.20

1.4

2.89

2.76

g/l

0.35

575

Retinal detachments and breaks

147

1247

1.18

1.19

1.6

1.4

2.91

2.96

g/l

0.12

108

867

Pathological resorption of teeth

1.75

1.19

1.2

1.3

2.89

3.13

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

612

1.26

1.19

1.3

1.4

2.67

2.97

g/l

1.03

420

Female infertility, tubal origin

189

1.49

1.19

1.1

1.5

3.17

2.89

g/l

0.26

140

Vestibular neuronitis

281

1.39

1.18

1.3

1.4

3.22

2.91

g/l

0.48

202

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

117

1.63

1.18

1.2

2.61

2.88

g/l

0.29

Parkinson's disease, excluding more controls

338

0.66

1.18

1.3

1.4

2.07

2.95

g/l

2.30

224

Congenital musculoskeletal deformities of head, face, spine and chest

2.02

1.17

1.6

1.3

2.73

2.19

g/l

—

Polyp of the female genital tract

154

760

1.18

1.17

1.3

1.4

2.80

2.81

g/l

0.02

112

525

In situ neoplasms

153

1244

1.17

1.4

2.60

3.00

g/l

2.71

100

867

Benign neoplasm: Adrenal gland

215

1.45

1.16

1.2

1.5

2.88

2.95

g/l

0.07

150

Thyrotoxicosis with toxic single thyroid nodule

2.52

1.15

1.8

1.4

4.17

2.75

g/l

—

Colitis due to radiation

2.52

1.15

1.4

2.94

3.00

g/l

—

Conduct disorder

1.82

1.15

1.3

2.86

2.70

g/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

274

1.39

1.15

1.0

1.4

2.59

3.04

g/l

0.61

197

Benign neoplasm of urinary organs

126

1.59

1.14

1.2

1.4

2.51

2.97

g/l

0.60

Erectile dysfunction

224

1.43

1.14

1.5

1.2

3.34

3.00

g/l

0.39

158

Parkinson's disease, strict definition, excluding more controls

302

0.65

1.14

1.4

1.95

2.99

g/l

2.68

200

Any event in cancer register

530

2887

1.09

1.13

1.3

1.4

2.79

3.04

g/l

2.39

360

2037

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

345

1.34

1.11

1.1

1.4

3.57

2.77

g/l

1.39

234

Sequelae of injuries of lower limb

345

1.34

1.10

1.6

1.4

2.93

2.99

g/l

0.06

241

Melanocytic naevi of trunk

424

1.30

1.10

1.2

1.4

2.95

2.90

g/l

0.09

302

Pediculosis, acariasis and other infestations

201

1.45

1.10

1.7

1.3

3.48

2.96

g/l

0.58

137

Early lumbar disc prolapse operation

477

1.28

1.09

1.2

1.3

3.13

3.03

g/l

0.15

318

Diabetic nephropathy

532

1.26

1.09

1.4

1.5

2.83

2.93

g/l

0.15

351

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

286

1.37

1.08

1.2

1.4

2.68

3.09

g/l

1.14

187

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

203

1225

1.14

1.08

1.7

1.4

2.57

3.00

g/l

3.37

146

856

Benign neoplasm: Kidney

1.69

1.08

1.3

1.5

2.56

2.82

g/l

—

Superficial injury of thorax

514

1.27

1.07

1.5

1.4

2.88

2.97

g/l

0.15

364

Schizophrenia or delusion

121

1428

0.85

1.06

1.2

1.3

2.67

2.95

g/l

1.06

969

Infections of genitourinary tract in pregnancy

365

1.32

1.06

1.3

1.5

3.05

2.80

g/l

0.57

254

Impacted maxillary molar

186

1.46

1.06

1.4

3.02

2.87

g/l

0.22

123

Basal cell carcinoma

223

1569

1.13

1.05

1.6

1.4

2.53

2.95

g/l

3.58

163

1069

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

813

0.80

1.04

1.2

1.4

2.60

2.91

g/l

0.95

573

Obstructed labour due to maternal pelvic abnormality

624

1.24

1.04

1.3

1.4

2.87

2.79

g/l

0.20

438

Gilbert syndrome

2.30

1.04

2.2

1.3

2.91

2.58

g/l

—

Other congenital malformations of heart

2.09

1.03

1.4

1.2

1.23

2.61

g/l

—

Injury of muscle and tendon at hip and thigh level

341

1.32

1.03

1.1

1.4

2.90

2.94

g/l

0.05

234

Schizophrenia, schizotypal and delusional disorders

122

1433

0.85

1.02

1.2

1.3

2.65

2.96

g/l

1.18

975

Benign neoplasm: Adrenal gland

221

1.41

1.02

1.2

1.4

2.88

2.91

g/l

0.02

158

Peripheral arterial reconstruction

420

1.29

1.02

1.2

1.3

2.16

3.03

g/l

3.68

308

In situ neoplasms

153

1323

1.16

1.02

1.4

1.3

2.60

2.90

g/l

1.76

100

923

Acute alcohol intoxication

116

981

1.18

1.02

1.3

1.4

2.89

3.00

g/l

0.30

676

Peripheral retinal degeneration

1.70

1.01

1.4

1.3

2.71

2.90

g/l

—

Malignant neoplasm of brain

1.69

1.01

1.4

1.3

2.49

2.84

g/l

—

Malignant neoplasm of bronchus and lung

443

1.27

1.01

1.2

1.3

2.81

2.95

g/l

0.21

312

Chronic periodontitis, including avohilmo

476

3244

1.09

1.01

1.4

2.93

2.98

g/l

0.24

339

2232

Migraine with aura, drug-induced

2.02

1.00

2.4

1.4

3.33

2.65

g/l

—

Sequelae of injuries of head

172

1.46

1.00

1.4

2.60

2.93

g/l

0.25

115

Other disorders of pigmentation

115

1.57

0.99

1.4

1.3

2.85

2.92

g/l

0.06

Melanocytic naevi of trunk

431

1.28

0.99

1.2

1.4

2.95

2.94

g/l

0.01

309

Behavioural disorders

1.72

0.99

1.3

1.2

2.86

2.70

g/l

—

Benign neoplasm: Brain, supratentorial

1.85

0.99

1.4

1.3

2.88

2.79

g/l

—

Complications of the puerperium, not elsewhere classified

156

1.48

0.98

1.3

1.4

3.28

2.96

g/l

0.38

109

LSIL lesion of the cervix uteri

476

1.26

0.98

1.3

1.4

2.60

2.95

g/l

1.21

331

Other and unspecified vascular occlusions

206

1.41

0.98

1.2

1.3

2.61

2.83

g/l

0.29

151

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.98

0.0

1.3

—

2.78

—

Non-small cell lung cancer

414

1.28

0.98

1.2

1.3

3.04

2.91

g/l

0.21

294

Bitten or struck by other mammals

423

1.28

0.98

1.4

3.05

2.89

g/l

0.27

294

Other malignant neoplasms of skin (=non-melanoma skin cancer)

218

1527

1.13

0.98

1.5

1.4

2.62

2.94

g/l

2.17

152

1043

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.2

—

2.91

—

Impacted maxillary canine

1.96

0.97

1.3

2.43

2.44

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.3

2.87

2.64

g/l

—

Benign neoplasm of thyroid gland

1.64

0.97

2.6

1.5

2.87

2.77

g/l

—

Maternal care for other known or suspected fetal problems

134

736

1.17

0.97

1.3

1.4

3.07

3.03

g/l

0.08

532

Right hemicolectomy

132

1.52

0.97

1.3

3.67

2.84

g/l

1.12

Other disorders of breast and lactation associated with childbirth

1.86

0.97

1.3

1.82

2.88

g/l

—

Lyme disease

117

996

1.18

0.96

1.3

1.4

2.86

2.90

g/l

0.10

692

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

182

1.43

0.96

1.6

1.4

3.78

2.89

g/l

0.68

128

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

245

1496

1.12

0.96

1.6

1.4

2.62

3.01

g/l

3.28

172

1054

Benign mammary dysplasia

505

1.25

0.95

1.5

1.4

2.53

2.72

g/l

0.41

342

Other and unspecified mononeuropathies, also in other diseases

1.70

0.95

1.4

1.3

2.60

2.80

g/l

0.23

Primary ovarian failure

1.79

0.94

1.2

1.3

2.69

2.88

g/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

285

1.34

0.94

1.4

2.99

2.88

g/l

0.08

199

Intracerebral haemorrhage

294

1.33

0.93

1.2

1.3

2.91

g/l

0.00

208

Vertical strabismus

101

1.59

0.93

1.4

1.3

4.24

2.75

g/l

0.97

Melanocytic naevi of other and unspecified parts of face

183

1.43

0.93

1.3

1.5

3.12

2.91

g/l

0.23

125

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

205

1250

1.13

0.93

1.7

1.4

2.58

3.00

g/l

3.18

148

872

Torticollis

1.74

0.92

1.1

1.3

2.67

2.50

g/l

—

Long labour

975

0.84

0.92

1.3

1.4

2.95

2.94

g/l

0.03

697

Contact with machinery

375

1.28

0.91

1.2

1.3

2.81

3.11

g/l

0.49

263

Mental and behavioural disorders due to cannabinoids

102

1.58

0.90

1.1

1.3

2.78

2.90

g/l

—

Leiomyoma of uterus

251

1271

1.11

0.89

1.4

2.88

2.97

g/l

0.37

165

928

Perineal laceration during delivery

660

0.81

0.88

1.7

1.4

3.14

2.91

g/l

0.52

463

L02BA Anti-estrogens

607

0.79

0.88

1.1

1.4

2.80

g/l

0.00

424

Parodontitis

474

3244

1.08

0.86

1.4

2.94

2.98

g/l

0.19

340

2230

Dental caries 1 and operation codes, only avohilmo

141

814

0.87

0.86

1.5

1.4

3.10

2.81

g/l

1.07

587

Pedestrian injured in transport accident

212

1.37

0.86

1.2

1.3

2.98

2.94

g/l

0.02

145

Toxic effect of contact with venomous animals

128

1.49

0.86

1.2

1.3

3.08

2.66

g/l

0.35

Emotional disorders starting during childhood or adolescence

202

1.38

0.86

1.4

2.06

2.73

g/l

2.19

155

Graves disease, strict definition

370

1.27

0.85

1.4

1.5

2.86

2.88

g/l

0.02

261

Varicose veins of other sites

204

1.38

0.85

1.2

1.3

3.33

3.09

g/l

0.24

142

Premature rupture of membranes

727

0.84

0.85

1.3

1.4

3.25

3.04

g/l

0.52

516

Juvenile osteochondrosis

104

1.54

0.84

1.8

1.4

2.88

2.63

g/l

0.31

Parodontitis or operation codes

474

3245

1.08

0.84

1.4

2.94

2.98

g/l

0.19

340

2231

Fracture of skull and facial bones

834

1.18

0.84

1.4

1.3

2.96

g/l

0.01

566

Injury of eye and orbit

560

1.22

0.83

1.2

1.3

3.17

2.99

g/l

0.27

380

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

129

1.48

0.83

1.5

1.4

3.45

3.00

g/l

0.38

Melanocytic naevi of other and unspecified parts of face

188

1.39

0.83

1.3

1.4

3.12

2.92

g/l

0.22

127

Inguinal hernia

291

1788

1.10

0.82

1.3

1.4

3.03

2.99

g/l

0.13

204

1206

Assault

534

1.22

0.82

1.2

1.3

3.01

2.96

g/l

0.08

362

Injuries to the elbow and forearm

364

3034

1.08

0.82

1.4

2.97

2.90

g/l

0.33

258

2127

Parodontitis and operation codes

446

3221

1.08

0.82

1.4

2.95

2.97

g/l

0.10

318

2220

Hyperplasia of prostate

152

761

1.14

0.81

1.2

1.5

3.16

3.19

g/l

0.06

106

527

Traumatic subdural haemorrhage

288

1.30

0.81

1.6

1.4

3.24

3.02

g/l

0.30

202

L02BB Anti-androgens

201

0.65

0.81

2.2

1.2

3.12

3.04

g/l

—

142

Basal cell carcinoma, including avohilmo

226

1605

1.11

0.81

1.6

1.4

2.55

2.95

g/l

3.39

165

1092

Male infertility

172

1.40

0.81

1.3

3.53

3.20

g/l

0.26

110

Fall on and from stairs and steps

113

978

1.16

0.80

1.4

1.3

2.89

2.91

g/l

0.05

681

All dysplastic lesions of the cervix uteri, vagina or vulva

145

1269

1.14

0.80

1.3

1.4

2.74

2.99

g/l

1.22

103

893

Diabetic retinopathy

150

833

1.14

0.80

1.5

1.4

3.11

2.89

g/l

0.53

565

Dipeptidyl peptidase 4 (DPP-4) inhibitors

356

1.27

0.79

1.3

1.4

2.34

2.84

g/l

1.66

249

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.6

—

2.82

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.79

0.0

1.2

—

2.83

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

2.63

—

Graves ophthalmopathy, strict

1.68

0.79

1.3

2.70

2.68

g/l

0.02

Sequelae of cerebrovascular disease

131

1006

1.14

0.79

1.3

1.4

2.94

2.89

g/l

0.12

102

687

Autism

1.54

0.78

1.3

2.34

2.87

g/l

—

Other and unspecified corneal deformities and disorders

1.56

0.78

1.2

1.4

2.43

2.90

g/l

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.78

0.0

1.3

—

2.55

—

Benign leiomyoma with endometriosis

538

1.21

0.77

1.2

1.5

2.62

2.86

g/l

0.52

373

Ovarian dysfunction

278

1.30

0.77

1.4

2.75

3.00

g/l

0.54

191

Parodontitis or/and operation codes

331

2135

0.92

0.76

1.3

1.4

2.97

2.95

g/l

0.07

240

1460

Other osteochondropathies

261

1.31

0.76

1.4

1.3

2.41

2.90

g/l

0.67

178

Autism spe

1.52

0.76

1.3

2.34

2.73

g/l

—

Parodontitis, under 40 years and operation codes

350

1.26

0.75

1.3

3.62

2.95

g/l

1.00

246

Parodontitis, operation under 40 years and operation codes

350

1.26

0.75

1.3

3.62

2.95

g/l

1.00

246

Pre-eclampsia or poor fetal growth

156

1384

1.13

0.75

1.4

3.12

2.96

g/l

0.50

108

980

Nontoxic goitre/thyroid nodule

127

1115

1.14

0.75

1.9

1.4

2.78

2.79

g/l

0.03

779

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

406

1.23

0.75

1.2

1.4

3.04

3.02

g/l

0.03

288

Cicatricial alopecia [scarring hair loss]

2.10

0.75

1.6

1.4

2.68

2.89

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

333

1.26

0.74

1.2

1.5

3.24

2.90

g/l

0.62

234

Nontoxic single thyroid nodule

227

1.32

0.74

2.1

1.3

2.98

2.87

g/l

0.13

161

Use of levodopa decarboxylase inhibitor

324

0.74

1.4

1.3

1.95

2.91

g/l

2.74

229

Unspecified maternal hypertension

1.81

0.73

1.1

1.4

3.39

2.67

g/l

—

Fitting and adjustment of other devices

129

1057

1.14

0.72

1.4

2.70

2.96

g/l

0.98

111

723

Pregnancy, childbirth and the puerperium

109

656

0.87

0.72

1.4

1.5

2.84

2.78

g/l

0.11

467

Foreign body in alimentary tract

159

1.39

0.72

1.2

1.3

3.05

2.88

g/l

0.19

113

Injury of muscle and tendon at wrist and hand level

516

1.20

0.71

1.3

1.4

2.80

3.03

g/l

0.52

362

Emergency coronary revascularization (for ACS)

213

1387

1.10

0.71

1.4

2.82

2.95

g/l

0.60

164

932

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

378

0.77

0.71

1.3

1.4

2.36

2.97

g/l

1.31

268

Overexertion and strenuous or repetitive movements

362

1.25

0.71

1.2

1.4

2.26

2.96

g/l

2.80

253

Diabetic neuropathy

378

1.24

0.71

1.6

1.4

2.33

2.94

g/l

2.19

252

Pervasive developmental disorders excl. Autism + Asperger

1.58

0.71

1.0

1.2

1.86

2.37

g/l

—

Inflammatory disorders of breast

212

1.32

0.70

1.7

1.4

2.72

2.80

g/l

0.10

144

Supervision of normal pregnancy

621

0.86

0.68

1.1

1.4

2.81

2.96

g/l

0.42

448

Other congenital malformations of the digestive system

177

1.35

0.68

1.5

1.3

2.56

2.36

g/l

0.30

138

Crushed, pushed or stepped on by crowd or human stampede

284

1.27

0.68

1.2

1.3

2.51

2.89

g/l

0.92

199

Sequelae of other and unspecified infectious and parasitic diseases

205

1.32

0.67

1.6

1.4

2.64

2.96

g/l

0.45

141

Bipolar affective disorders

798

1.15

0.67

1.3

2.90

3.02

g/l

0.24

534

Focal brain injury

153

1.37

0.67

1.7

1.3

3.45

3.05

g/l

0.36

106

Vascular dementia

123

1.42

0.67

1.3

1.2

2.68

2.78

g/l

0.07

Organic, including symptomatic, mental disorders

153

1231

0.90

0.66

1.2

1.4

2.88

2.95

g/l

0.15

110

842

Other degenerative diseases of the basal ganglia

1.79

0.66

1.0

1.3

2.01

2.63

g/l

—

Benign neoplasm: Skin of other and unspecified parts of face

312

1.25

0.66

1.5

1.4

2.84

2.87

g/l

0.03

220

Hydrocele

357

1.23

0.66

1.4

2.67

3.14

g/l

1.11

255

Pregnancy examination and test

486

1.16

0.64

1.6

1.4

2.95

2.93

g/l

0.04

349

Spontaneous abortion

238

1486

1.09

0.63

1.3

1.4

2.94

2.91

g/l

0.11

168

1060

Malignant neoplasm of bladder

146

1.37

0.63

1.5

1.1

2.93

2.95

g/l

0.01

110

Calculus of lower urinary tract

121

1.41

0.62

1.7

1.3

3.08

3.01

g/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

333

1.23

0.62

1.0

1.4

2.55

2.99

g/l

0.65

235

Inguinal or femoral hernia, bilateral

324

1.24

0.62

1.2

1.3

3.23

2.99

g/l

0.34

228

Aneurysms, operations, SAH

553

1.18

0.62

1.4

2.90

2.86

g/l

0.06

381

1.67

0.61

1.8

1.1

2.61

2.73

g/l

—

Puerperal sepsis

498

1.19

0.61

1.7

1.4

2.82

2.81

g/l

0.02

343

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

199

0.70

0.61

1.3

1.5

2.34

2.73

g/l

—

135

Inguinal hernia, bilateral

316

1.24

0.60

1.2

1.3

3.14

3.00

g/l

0.17

222

Maternal care for known or suspected fetal abnormality and damage

638

0.85

0.60

1.4

2.95

3.09

g/l

0.29

451

Other fall from one level to another

105

928

1.13

0.60

1.3

2.83

2.89

g/l

0.15

658

HSIL lesion of the cervix uteri, vagina or vulva

887

0.87

0.60

1.4

2.75

3.02

g/l

0.92

623

Other and unspecified nonorganic psychotic disorders

855

0.86

0.60

1.2

1.4

2.72

3.00

g/l

0.71

577

Traction detachment of retina

0.00

0.59

0.0

1.2

—

2.66

—

Epidural haemorrhage

0.00

0.59

0.0

1.4

—

3.04

—

Postpartum haemorrhage due to retained placenta

541

0.83

0.58

1.2

1.3

3.21

3.07

g/l

0.19

374

Foreign body entering into or through eye or natural orifice

291

1.24

0.58

1.3

2.58

2.87

g/l

0.51

208

Femoral hernia

106

1.42

0.57

1.4

1.2

3.22

2.78

g/l

—

Alcohol dependence

119

1065

1.12

0.57

1.2

1.4

2.81

3.03

g/l

0.58

741

Mandibular retrognathia

264

1.25

0.57

1.4

2.74

2.85

g/l

0.16

186

Other and unspecified mental retardation

0.56

1.0

1.4

1.59

2.15

g/l

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.56

1.0

1.2

3.45

2.90

g/l

—

Unspecified abortion

194

1.29

0.56

1.5

1.4

2.84

2.82

g/l

0.02

133

Retinal breaks without detachment

550

1.17

0.55

1.8

1.3

3.04

2.92

g/l

0.21

385

HSIL lesion of the cervix uteri

817

0.87

0.55

1.4

2.85

3.01

g/l

0.45

573

Open wound of head

239

2182

1.08

0.55

1.5

1.3

2.68

2.95

g/l

1.48

154

1493

Intrahepatic Cholestasis of Pregnancy (ICP)

284

1.24

0.55

1.1

1.4

3.42

2.91

g/l

0.93

201

Abnormal findings in secretions and smears from cervix uteri vagina vulva

245

1785

1.08

0.55

1.4

2.85

2.94

g/l

0.41

174

1277

Congenital malformations of heart and great arteries

542

1.16

0.55

1.4

2.46

2.71

g/l

0.60

396

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

348

1.21

0.55

1.2

1.4

3.24

2.97

g/l

0.46

237

Xerosis cutis

1.59

0.54

1.3

1.2

2.36

2.79

g/l

—

Car occupant injured in other and unspecified transport accidents

776

1.14

0.54

1.6

1.4

2.92

2.99

g/l

0.15

538

Foreign body on external eye

561

1.16

0.54

1.2

1.3

2.70

3.04

g/l

0.94

378

Other blood glucose lowering drugs, excl. Insulins

543

1.16

0.53

1.2

1.4

2.98

2.82

g/l

0.23

377

Medical treatment for female infertility

106

945

1.12

0.53

1.3

1.4

3.00

3.04

g/l

0.10

659

Superficial injury of shoulder and upper arm

386

1.19

0.53

1.7

1.3

3.09

3.01

g/l

0.12

272

Polyhydramnios

169

1.31

0.53

1.4

3.18

2.95

g/l

0.18

114

Benign neoplasm: Skin of other and unspecified parts of face

322

1.21

0.53

1.5

1.3

2.84

2.83

g/l

0.01

222

Maternal care for known or suspected malpresentation of fetus

631

0.87

0.53

1.4

2.80

3.08

g/l

0.73

450

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

204

0.73

0.53

1.3

1.4

3.06

3.00

g/l

—

147

Other abnormal products of conception

170

1036

1.09

0.52

1.4

3.10

2.99

g/l

0.32

116

742

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.62

0.52

1.3

1.4

1.44

2.09

g/l

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.61

0.52

1.3

1.4

1.44

2.10

g/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

323

1.21

0.52

1.4

2.63

2.89

g/l

0.73

224

Scissor bite

134

0.67

0.52

1.1

1.5

2.59

2.46

g/l

—

108

Graves ophthalmopathy

1.47

0.51

1.3

1.4

2.70

2.69

g/l

0.01

Intermittent heterotropia

233

1.25

0.51

1.4

2.62

g/l

0.00

166

Benign leiomyoma with endometriosis

565

1.15

0.50

1.2

1.4

2.62

2.76

g/l

0.27

382

Cholera

118

1.36

0.50

1.4

1.6

2.62

2.83

g/l

0.32

Other disorders of amniotic fluid and membranes

611

0.86

0.50

1.8

1.4

2.75

3.08

g/l

0.69

431

Coronary artery bypass grafting

601

1.13

0.50

1.5

1.4

2.90

3.04

g/l

0.37

404

Foreign body or object entering through skin

216

1.25

0.49

1.4

1.3

3.11

2.89

g/l

0.23

153

Injury of muscle and tendon at lower leg level

557

1.15

0.49

2.0

1.3

3.11

3.07

g/l

0.05

384

Slow fetal growth and fetal malnutrition

1.56

0.49

2.1

1.3

1.56

2.28

g/l

—

Leiomyoma of uterus

316

1689

1.06

0.49

1.4

2.83

2.88

g/l

0.25

214

1210

Redundant prepuce, phimosis and paraphimosis

817

1.12

0.49

1.2

1.4

2.98

3.03

g/l

0.10

546

Malignant neoplasm of head and neck

217

1.25

0.47

1.2

1.3

2.45

2.97

g/l

0.91

151

Postpartum haemorrhage due to anatomy

430

0.84

0.47

1.1

1.3

3.08

3.09

g/l

0.01

296

Generalized epilepsy

155

1.29

0.46

1.4

1.3

2.83

2.75

g/l

0.09

110

Complications following abortion and ectopic and molar pregnancy

111

1.36

0.46

1.1

1.6

3.03

2.78

g/l

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

299

1.20

0.46

1.5

1.4

2.97

3.11

g/l

0.12

217

Postpartum care and examination

426

0.87

0.46

1.3

1.4

3.07

2.96

g/l

0.20

302

Pedal cyclist injured in transport accident

930

0.89

0.46

1.5

1.3

3.20

2.89

g/l

0.82

654

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

291

1.21

0.46

1.1

1.4

3.42

3.00

g/l

0.71

202

Bulimia nervosa (incl. atypical)

120

1.34

0.46

1.3

1.4

2.94

2.79

g/l

0.14

Manic episode

1.43

0.45

1.4

1.3

2.42

2.73

g/l

—

All dysplastic lesions of the cervix uteri

125

1138

1.10

0.45

1.3

1.4

2.72

3.02

g/l

1.66

808

Focal epilepsy, mode (most common among epilepsy diagnosis)

684

1.13

0.45

1.3

1.4

2.94

2.90

g/l

0.05

488

Malignant neoplasm of kidney, except renal pelvis

228

1.23

0.45

1.0

1.3

2.70

2.92

g/l

0.25

162

Focal epilepsy

817

1.11

0.45

1.3

2.83

2.87

g/l

0.06

580

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

293

1.20

0.43

1.2

1.3

2.47

3.02

g/l

1.44

204

Diabetic retinopathy, strict definition

586

1.13

0.43

1.4

3.06

2.90

g/l

0.24

392

Non-small cell lung cancer, squamous, helper endpoint

1.41

0.43

1.5

1.2

2.79

2.72

g/l

—

Non-small cell lung cancer, squamous

1.41

0.43

1.5

1.2

2.79

2.72

g/l

—

Non-small cell lung cancer, adenocarcinoma

140

1.29

0.42

1.1

1.2

3.00

2.83

g/l

—

100

Non-small cell lung cancer, adenocarcinoma, helper endpoint

140

1.29

0.42

1.1

1.2

3.00

2.83

g/l

—

100

Pedal cyclist injured in noncollision transport accidents

435

0.85

0.42

1.5

1.3

2.87

2.88

g/l

0.02

301

Malignant melanoma

453

1.15

0.41

1.3

2.69

2.91

g/l

0.36

315

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

0.77

0.41

1.3

1.5

3.06

2.96

g/l

—

132

Frostbite

1.52

0.41

1.4

2.68

2.62

g/l

—

Parodontitis, under 40 years

379

1.16

0.41

1.3

1.4

3.62

3.01

g/l

0.86

266

Parodontitis, under 40 years, or operation codes

379

1.16

0.41

1.3

1.4

3.62

3.01

g/l

0.86

266

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.41

0.0

1.4

—

2.67

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

114

1.32

0.40

1.4

1.3

2.46

2.62

g/l

—

Pre-eclampsia

872

1.10

0.40

1.5

1.4

3.09

2.89

g/l

0.52

602

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.1

—

2.03

—

Antenatal screening

104

643

0.91

0.40

1.2

1.4

3.12

2.95

g/l

0.50

463

0.00

0.39

0.0

1.1

—

3.01

—

Noise effects on inner ear

124

1.29

0.38

1.2

1.3

2.42

3.09

g/l

0.94

Wide developmental disorders

142

1.27

0.38

1.3

2.09

2.54

g/l

0.66

107

Multiple gestation

391

1.15

0.38

1.4

1.3

3.23

3.00

g/l

0.44

271

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

261

1.19

0.38

1.1

1.5

2.79

2.69

g/l

0.10

178

Kela-code for severe mental illness

157

1683

0.93

0.37

1.2

1.4

2.85

2.97

g/l

0.34

107

1147

Colorectal cancer, excluding all cancers (controls excluding all cancers)

834

0.90

0.37

1.2

1.4

2.77

3.00

g/l

0.57

574

Open bite

216

1.21

0.37

1.2

1.4

3.44

2.67

g/l

1.05

154

Dental caries 3 and operation codes, only avohilmo

181

971

0.94

0.36

1.4

2.90

g/l

0.01

121

703

Polycystic ovarian syndrome, broad definition

450

1.13

0.36

1.5

1.4

3.03

g/l

0.00

320

Unspecified lump in breast

583

1.12

0.35

1.6

1.4

2.45

2.83

g/l

1.16

404

Follow-up examination after treatment for malignant neoplasms

217

1.20

0.35

1.2

1.3

2.67

2.82

g/l

0.12

130

Malignant neoplasm of urinary organs

245

1.19

0.35

1.0

1.3

3.00

2.98

g/l

0.01

177

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.34

0.34

1.2

1.3

3.19

2.76

g/l

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

145

1.24

0.33

1.1

1.4

3.00

3.05

g/l

—

103

Type 1 diabetes, strict (exclude DM2)

461

1.13

0.33

1.2

1.4

3.00

2.88

g/l

0.16

335

Maternal care related to the fetus and amniotic cavity and possible delivery problems

236

1316

1.06

0.33

1.4

2.93

2.94

g/l

0.04

174

943

Colorectal adenocarcinoma

573

0.89

0.33

1.3

2.72

2.91

g/l

0.34

405

Focal epilepsy, strict definition

739

1.10

0.33

1.3

2.82

2.90

g/l

0.11

529

Twin gestation

378

1.14

0.33

1.4

1.3

3.23

3.00

g/l

0.42

261

Single delivery by forceps and vacuum extractor

458

0.90

0.33

1.2

1.4

3.19

2.87

g/l

0.77

346

Nontraumatic intracranial haemmorrhage

596

1.11

0.33

1.3

1.4

2.98

2.86

g/l

0.23

418

Assault by bodily force

303

1.16

0.32

1.2

1.3

2.90

3.04

g/l

0.20

211

Pedestrian injured in collision with pedal cycle

1.33

0.32

1.2

1.3

2.44

2.83

g/l

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

1.33

0.32

1.5

1.2

2.79

3.07

g/l

—

Type 1 diabetes, definitions combined

463

1.12

0.32

1.2

1.3

3.00

2.89

g/l

0.15

338

Labour and delivery complicated by fetal stress [distress]

123

763

1.08

0.32

1.2

1.4

3.32

2.96

g/l

1.43

546

Malignant melanoma, excluding all cancers (controls excluding all cancers)

550

1.11

0.32

1.3

1.4

2.55

2.95

g/l

0.96

385

Obstructed labour due to malposition and malpresentation of fetus

979

0.92

0.31

1.3

1.4

3.20

2.95

g/l

0.75

701

Toxic effects of substances chiefly nonmedicinal as to source

427

1.13

0.31

1.3

3.09

2.90

g/l

0.20

304

Deep bite

423

1.12

0.31

1.3

1.4

2.86

2.74

g/l

0.26

311

Malignant neoplasm of skin

247

1771

1.05

0.31

1.5

1.4

2.59

2.96

g/l

2.92

173

1219

Acute and transient psychotic disorders

484

0.89

0.30

1.1

1.4

2.69

2.97

g/l

0.47

334

Carcinoma in situ of cervix uteri

346

0.87

0.29

1.5

1.4

2.62

2.91

g/l

0.77

234

Transient global amnesia

260

0.85

0.29

2.5

1.4

2.49

2.91

g/l

0.73

179

Viral hepatitis

269

1.15

0.29

1.1

1.3

3.13

3.08

g/l

0.04

188

Burn and corrosion of head and neck

1.23

0.27

1.3

2.62

2.87

g/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

113

1.24

0.26

1.0

1.3

3.01

2.95

g/l

—

Clear cell adenocarcinoma of kidney

113

1.24

0.26

1.0

1.3

3.01

2.90

g/l

—

Colorectal cancer

708

0.92

0.26

1.2

1.4

2.74

2.92

g/l

0.36

503

Otosclerosis

244

1.15

0.25

1.0

1.5

2.88

2.82

g/l

0.08

170

Postpartum hemorraghe, all women as controls

109

1156

0.94

0.25

1.2

1.4

3.15

3.00

g/l

0.43

819

Macular hole

127

0.79

0.25

1.1

1.5

2.08

2.76

g/l

—

Benign neoplasm of other and unspecified female genital organs

123

1.22

0.25

1.5

1.7

2.72

2.92

g/l

—

Supervision of high-risk pregnancy

107

606

1.07

0.25

1.4

3.22

2.96

g/l

0.75

439

416

1.11

0.24

1.2

1.4

2.80

3.07

g/l

0.52

283

Sulfonylureas

110

934

0.94

0.24

1.1

1.4

2.67

2.92

g/l

0.69

632

Diabetes mellitus in pregnancy

163

1004

1.05

0.24

1.2

1.4

3.16

3.04

g/l

0.39

117

722

Polycystic ovarian syndrome

198

1.16

0.24

1.4

2.63

2.94

g/l

0.61

128

Pre-eclampsia or eclampsia

101

947

1.07

0.24

1.5

1.4

3.10

2.88

g/l

0.61

656

Other disorders of penis

340

1.12

0.24

1.6

1.3

2.93

3.00

g/l

0.11

247

Burn and corrosion of trunk

1.27

0.24

1.3

3.15

2.83

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

503

1.09

0.24

1.2

1.3

3.02

2.97

g/l

0.08

355

Benign neoplasm of breast

444

0.90

0.24

1.3

1.4

2.51

2.81

g/l

0.46

311

Postpartum haemorrhage

109

1008

0.94

0.24

1.2

1.4

3.15

2.94

g/l

0.67

723

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

254

0.87

0.23

1.4

1.3

2.30

3.01

g/l

1.90

179

Other and unspecified injuries of head

171

1.17

0.23

1.3

2.64

2.84

g/l

0.20

116

Carcinoma in situ of cervix uteri

338

0.89

0.23

1.5

1.4

2.62

2.90

g/l

0.73

231

malignant neoplasm of female genital organs

474

0.91

0.23

1.2

1.5

2.72

2.64

g/l

0.09

316

Memory loss

237

1.14

0.23

1.2

1.4

2.69

2.89

g/l

0.26

163

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

264

0.87

0.23

1.3

1.4

2.25

3.01

g/l

2.24

187

Abnormalities of forces of labour

463

0.91

0.22

1.3

1.4

2.73

2.91

g/l

0.33

326

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

505

1.09

0.22

1.2

1.3

3.02

2.96

g/l

0.09

357

Left ventricular outflow tract obstruction, narrow definition

181

1.16

0.22

1.5

1.3

1.92

2.74

g/l

1.91

128

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

556

0.92

0.22

1.3

1.4

2.72

2.98

g/l

0.50

388

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

462

0.91

0.22

1.4

2.34

2.94

g/l

1.80

326

Complications of labour and delivery

320

1726

1.03

0.22

1.3

1.4

3.05

2.84

g/l

1.25

220

1218

HSIL lesion of the vagina

1.19

0.21

1.4

2.51

2.64

g/l

—

Ectopic pregnancy

749

1.07

0.21

1.4

2.90

2.88

g/l

0.04

527

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.21

0.0

1.1

—

3.22

—

Convergent concomitant strabismus

239

1.13

0.21

1.5

1.4

2.49

2.80

g/l

0.45

170

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.16

0.21

1.0

1.4

2.43

2.67

g/l

—

Dental caries 2 and operation codes, only avohilmo

411

2481

1.03

0.21

1.4

3.09

2.89

g/l

1.41

314

1694

Poor fetal growth

566

1.08

0.20

1.2

1.4

3.30

2.94

g/l

0.68

400

Other viral hepatitis

230

1.13

0.20

1.1

1.3

2.83

3.09

g/l

0.28

159

Type 1 diabetes, strict definition, subgroup 1

344

1.10

0.20

1.3

2.87

2.84

g/l

0.04

262

Other and/or unspecified nontoxic goitre

261

0.88

0.20

3.3

1.3

2.85

2.76

g/l

0.12

183

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.18

0.19

1.2

1.3

2.79

3.11

g/l

—

Malignant neoplasm of ovary

122

0.82

0.19

1.4

1.6

2.31

2.82

g/l

—

Placenta praevia

184

1.14

0.19

1.3

1.4

3.44

2.99

g/l

0.38

125

Family history of malignant neoplasm

386

1.09

0.18

1.2

1.4

2.37

2.87

g/l

1.44

275

Alcohol withdrawal state with delirium

223

1.12

0.18

1.1

1.2

2.53

3.08

g/l

1.19

156

Chronic viral hepatitis

195

0.87

0.17

1.1

1.3

3.10

3.04

g/l

0.03

135

Renal cell carcinoma of kidney

0.72

0.17

1.0

1.2

2.92

2.78

g/l

—

Abnormal spermatozoa

359

1.09

0.16

1.2

1.3

3.12

3.08

g/l

0.05

257

Retinal detachment with retinal break

402

0.92

0.16

1.6

1.4

3.12

2.95

g/l

0.28

290

Myocardial infarction, unclassifiable

515

0.93

0.16

1.3

2.84

3.04

g/l

0.37

366

Malignant neoplasm of rectum

246

0.89

0.16

1.4

1.3

2.23

3.01

g/l

1.85

172

Struck by thrown, projected or falling objec

158

1.14

0.16

1.3

2.73

2.97

g/l

—

108

Other complications of labour and delivery, not elsewhere classified

470

1.07

0.14

1.1

1.4

3.10

2.96

g/l

0.31

334

Gonococcal infection

1.18

0.14

1.5

2.57

2.98

g/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.83

0.14

1.4

1.3

2.25

2.00

g/l

—

Lesion of plantar nerve

189

1.11

0.13

2.2

1.4

3.26

2.88

g/l

0.43

133

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

725

0.95

0.13

1.2

1.4

2.66

2.99

g/l

1.03

508

Single delivery by caesarean section

100

555

1.04

0.13

1.4

3.23

2.83

g/l

1.40

422

Adenocarcinoma and papilloma adenocarcinoma of rectum

242

0.91

0.13

1.4

1.3

2.30

3.03

g/l

1.95

172

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

252

0.91

0.12

1.3

1.4

2.25

2.99

g/l

2.16

178

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

143

1.12

0.11

1.4

1.3

2.34

2.86

g/l

—

102

Pedal cyclist injured in collision with motor vehicle

1.16

0.11

2.0

1.3

2.76

2.81

g/l

—

Other obstructed labour

299

1.07

0.10

1.2

1.4

2.81

2.78

g/l

0.04

206

Acute appendicitis, with complications

760

0.96

0.10

1.4

1.3

2.74

2.99

g/l

0.64

535

Malignant melanoma of skin

321

0.93

0.10

1.4

2.45

2.97

g/l

1.06

228

HSIL lesion of the vulva

1.14

0.10

1.2

1.3

2.25

2.56

g/l

—

Abnormal findings on antenatal screening of mother

351

0.94

0.10

1.5

3.05

2.97

g/l

0.07

251

Dislocation, sprain and strain of joints and ligaments of elbow

232

1.08

0.09

2.0

1.4

3.24

2.90

g/l

0.43

166

Benign neoplasm of breast

422

0.95

0.09

1.3

1.5

2.51

2.85

g/l

0.54

293

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.06

0.09

1.0

1.3

2.43

2.62

g/l

—

Malignant neoplasm of corpus uteri

213

1.08

0.09

1.1

1.4

3.00

2.69

g/l

0.27

150

Unspecified mental disorder

195

1913

1.02

0.08

1.2

1.4

2.91

2.99

g/l

0.21

137

1313

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

552

0.96

0.08

1.2

1.4

3.02

2.97

g/l

0.08

378

Congenital malformations of aortic and mitral valves

146

1.10

0.08

1.4

1.3

1.75

2.71

g/l

2.22

103

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.77

0.08

1.0

1.2

2.92

2.78

g/l

—

Family history of certain disabilities and chronic diseases leading to disablement

156

1.09

0.08

1.1

1.3

2.99

g/l

0.01

111

Other disorders of prostate

1.05

0.08

1.6

1.2

3.27

3.15

g/l

—

Spermatocele

225

1.07

0.07

1.5

1.3

2.82

3.14

g/l

0.41

156

Burns and corrosions of external body surface, specified by site

422

1.04

0.07

1.6

1.3

2.82

2.87

g/l

0.08

297

Failed induction of labour

216

1.07

0.06

1.3

1.4

2.68

2.91

g/l

0.34

149

Use of disulfiram, acamprosate or naltrexone

344

1.05

0.06

1.4

1.3

2.82

3.06

g/l

0.36

232

Benign neoplasm of other and unspecified female genital organs

138

1.09

0.06

1.5

1.6

2.72

2.84

g/l

—

Multiple delivery

364

1.04

0.06

1.4

1.3

3.64

2.68

g/l

1.48

278

Gestational diabetes (for exclusion)

176

1266

0.98

0.06

1.2

1.4

3.20

2.98

g/l

0.92

129

905

Uterine polyps

335

0.95

0.06

1.4

2.29

2.75

g/l

1.24

239

Subarachnoid haemorrhage

294

0.95

0.06

1.4

3.08

2.93

g/l

0.18

207

Antepartum haemorrhage, not elsewhere classified

385

0.96

0.05

1.3

2.60

3.01

g/l

0.93

273

Crowding of teeth, including avohilmo

334

0.96

0.05

1.3

1.4

2.80

2.66

g/l

0.19

239

Fall on and from ladder

228

1.05

0.05

1.4

1.2

3.11

2.99

g/l

0.11

161

severe traumatic brain injury, does not include concussion

704

1.02

0.04

1.5

1.3

3.10

2.99

g/l

0.20

496

Fracture of forearm

249

2354

0.99

0.04

1.3

1.4

3.00

2.87

g/l

0.54

176

1634

Traumatic amputation of wrist and hand

119

0.92

0.04

1.5

1.3

2.29

3.22

g/l

—

Postpartum hemorraghe, parous women as controls

109

966

0.99

0.03

1.2

1.3

3.15

3.03

g/l

0.33

677

Colon adenocarcinoma

282

1.03

0.02

1.2

1.3

3.07

2.91

g/l

0.16

201

Maternal care for known or suspected abnormality of pelvic organs

116

793

1.01

0.01

1.3

1.4

2.92

3.03

g/l

0.22

567

Contact with sharp glass

127

0.94

0.01

1.2

1.3

2.29

2.86

g/l

—

Schizophrenia or delusion, excluding more controls

121

1191

1.01

0.01

1.2

1.4

2.67

3.03

g/l

1.51

794

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

297

0.98

0.01

1.2

1.4

3.07

3.00

g/l

0.06

209

Divergent concomitant strabismus

283

1.02

0.01

1.7

1.4

3.05

2.92

g/l

0.10

194

Orchitis and epididymitis

294

1.02

0.00

1.3

3.23

3.18

g/l

0.04

205

Retained placenta and membranes, without haemorrhage

494

1.01

0.00

1.3

1.4

2.57

2.79

g/l

0.37

339

Type1 diabetes, definitions combined, early onset

323

1.02

0.00

1.3

2.89

2.72

g/l

0.24

236

Malignant neoplasm of colon

391

1.00

0.00

1.1

1.3

3.17

2.90

g/l

0.37

277

Thyrotoxicosis with toxic multinodular goitre

151

0.99

0.00

1.9

1.5

3.29

2.86

g/l

—

107

Burns and corrosions

565

0.99

0.00

1.5

1.3

2.64

2.94

g/l

0.73

393

Combinations of oral blood glucose lowering drugs

103

1035

1.00

0.00

1.3

1.4

3.10

3.01

g/l

0.17

707

Respiratory and cardiovascular disorders specific to the perinatal period

141

1.01

0.00

1.8

1.3

1.91

2.20

g/l

0.52

123

Pedal cyclist injured in other and unspecified transport accidents

404

0.99

0.00

1.4

1.3

3.56

2.96

g/l

1.50

281

Burn and corrosion of wrist and hand

108

1.02

0.00

2.1

1.3

2.81

2.68

g/l

0.09

Other sexually transmitted chlamydial diseases

252

0.99

0.00

1.3

1.4

2.84

3.05

g/l

0.25

166

Maternal care for cervical incompetence

119

1.01

0.00

1.3

1.5

2.59

2.91

g/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

590

1.00

0.00

1.2

1.5

2.73

2.86

g/l

0.19

406

Type 1 diabetes, strict definition

394

1.01

0.00

1.3

2.78

2.85

g/l

0.10

290

Respiratory distress of newborn

107

1.04

0.00

2.0

1.3

1.75

2.05

g/l

0.54

Rubella [German measles]

123

0.98

0.00

2.5

1.3

3.22

2.83

g/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

1.2

—

2.21

—

Liveborn infants according to place of birth

0.94

0.00

1.0

1.2

2.04

2.26

g/l

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.97

0.00

1.2

1.78

2.65

g/l

—

Hirsprung

0.00

0.0

1.0

—

2.00

—

Congenital malformation of optic disc

0.00

0.0

1.0

—

3.06

—

Birth injury to skeleton

0.00

0.0

1.5

—

2.41

—

Malignant neoplasm of testis

1.02

0.00

1.2

1.4

3.17

3.01

g/l

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.3

—

3.16

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.0

1.0

—

3.80

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.0

1.4

—

2.45

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.0

—

3.61

—

Other perinatal haematological disorders

0.00

0.0

1.1

—

2.33

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

1.4

—

2.05

—

Acne varioliformis

0.00

0.0

1.0

—

4.03

—

Exposure to other and unspecified man-made environmental factors

1.02

0.00

1.0

1.3

2.63

2.65

g/l

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.2

—

2.25

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 2 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS